id	sid	tid	token	lemma	pos
bam-10779	1	1	recurrence	recurrence	NOUN
bam-10779	1	2	and	and	CCONJ
bam-10779	1	3	5	5	NUM
bam-10779	1	4	-	-	PUNCT
bam-10779	1	5	year	year	NOUN
bam-10779	1	6	survival	survival	NOUN
bam-10779	1	7	of	of	ADP
bam-10779	1	8	borderline	borderline	NOUN
bam-10779	1	9	ovarian	ovarian	ADJ
bam-10779	1	10	tumor	tumor	NOUN
bam-10779	1	11	eur	eur	PROPN
bam-10779	1	12	j	j	PROPN
bam-10779	1	13	transl	transl	PROPN
bam-10779	1	14	myol	myol	ADV
bam-10779	1	15	33	33	NUM
bam-10779	1	16	(	(	PUNCT
bam-10779	1	17	1	1	NUM
bam-10779	1	18	)	)	PUNCT
bam-10779	1	19	10779	10779	NUM
bam-10779	1	20	,	,	PUNCT
bam-10779	1	21	2023	2023	NUM
bam-10779	1	22	doi	doi	NOUN
bam-10779	1	23	:	:	PUNCT
bam-10779	1	24	10.4081	10.4081	NUM
bam-10779	1	25	/	/	SYM
bam-10779	1	26	ejtm.2023.10779	ejtm.2023.10779	ADJ
bam-10779	1	27	1	1	NUM
bam-10779	1	28	recurrence	recurrence	NOUN
bam-10779	1	29	and	and	CCONJ
bam-10779	1	30	5	5	NUM
bam-10779	1	31	-	-	PUNCT
bam-10779	1	32	year	year	NOUN
bam-10779	1	33	survival	survival	NOUN
bam-10779	1	34	rate	rate	NOUN
bam-10779	1	35	in	in	ADP
bam-10779	1	36	patients	patient	NOUN
bam-10779	1	37	with	with	ADP
bam-10779	1	38	borderline	borderline	NOUN
bam-10779	1	39	ovarian	ovarian	ADJ
bam-10779	1	40	tumors	tumor	NOUN
bam-10779	1	41	and	and	CCONJ
bam-10779	1	42	related	related	ADJ
bam-10779	1	43	factors	factor	NOUN
bam-10779	1	44	in	in	ADP
bam-10779	1	45	kurdistan	kurdistan	PROPN
bam-10779	1	46	seyedeh	seyedeh	PROPN
bam-10779	1	47	reyhaneh	reyhaneh	PROPN
bam-10779	1	48	yousefi	yousefi	PROPN
bam-10779	1	49	sharami	sharami	PROPN
bam-10779	1	50	(	(	PUNCT
bam-10779	1	51	1	1	NUM
bam-10779	1	52	)	)	PUNCT
bam-10779	1	53	,	,	PUNCT
bam-10779	1	54	fariba	fariba	NOUN
bam-10779	1	55	farhadifar	farhadifar	ADV
bam-10779	1	56	(	(	PUNCT
bam-10779	1	57	2	2	NUM
bam-10779	1	58	)	)	PUNCT
bam-10779	1	59	,	,	PUNCT
bam-10779	1	60	roya	roya	NOUN
bam-10779	1	61	tabatabaei	tabatabaei	NOUN
bam-10779	1	62	(	(	PUNCT
bam-10779	1	63	1	1	NUM
bam-10779	1	64	)	)	PUNCT
bam-10779	1	65	(	(	PUNCT
bam-10779	1	66	1	1	X
bam-10779	1	67	)	)	PUNCT
bam-10779	1	68	department	department	NOUN
bam-10779	1	69	of	of	ADP
bam-10779	1	70	obstetrics	obstetric	NOUN
bam-10779	1	71	and	and	CCONJ
bam-10779	1	72	gynecology	gynecology	NOUN
bam-10779	1	73	,	,	PUNCT
bam-10779	1	74	kurdistan	kurdistan	PROPN
bam-10779	1	75	university	university	PROPN
bam-10779	1	76	of	of	ADP
bam-10779	1	77	medical	medical	ADJ
bam-10779	1	78	sciences	sciences	PROPN
bam-10779	1	79	,	,	PUNCT
bam-10779	1	80	sanandaj	sanandaj	NOUN
bam-10779	1	81	,	,	PUNCT
bam-10779	1	82	iran	iran	PROPN
bam-10779	1	83	;	;	PUNCT
bam-10779	1	84	(	(	PUNCT
bam-10779	1	85	2	2	X
bam-10779	1	86	)	)	PUNCT
bam-10779	1	87	social	social	ADJ
bam-10779	1	88	determinants	determinant	NOUN
bam-10779	1	89	of	of	ADP
bam-10779	1	90	health	health	NOUN
bam-10779	1	91	research	research	NOUN
bam-10779	1	92	center	center	NOUN
bam-10779	1	93	,	,	PUNCT
bam-10779	1	94	department	department	NOUN
bam-10779	1	95	of	of	ADP
bam-10779	1	96	gynecology	gynecology	NOUN
bam-10779	1	97	,	,	PUNCT
bam-10779	1	98	faculty	faculty	NOUN
bam-10779	1	99	of	of	ADP
bam-10779	1	100	medicine	medicine	NOUN
bam-10779	1	101	,	,	PUNCT
bam-10779	1	102	kurdistan	kurdistan	PROPN
bam-10779	1	103	university	university	PROPN
bam-10779	1	104	of	of	ADP
bam-10779	1	105	medical	medical	ADJ
bam-10779	1	106	science	science	NOUN
bam-10779	1	107	,	,	PUNCT
bam-10779	1	108	sanandaj	sanandaj	NOUN
bam-10779	1	109	,	,	PUNCT
bam-10779	1	110	iran	iran	PROPN
bam-10779	1	111	.	.	PUNCT
bam-10779	2	1	this	this	DET
bam-10779	2	2	article	article	NOUN
bam-10779	2	3	is	be	AUX
bam-10779	2	4	distributed	distribute	VERB
bam-10779	2	5	under	under	ADP
bam-10779	2	6	the	the	DET
bam-10779	2	7	terms	term	NOUN
bam-10779	2	8	of	of	ADP
bam-10779	2	9	the	the	DET
bam-10779	2	10	creative	creative	ADJ
bam-10779	2	11	commons	common	NOUN
bam-10779	2	12	attribution	attribution	NOUN
bam-10779	2	13	noncommercial	noncommercial	ADJ
bam-10779	2	14	license	license	NOUN
bam-10779	2	15	(	(	PUNCT
bam-10779	2	16	cc	cc	NOUN
bam-10779	2	17	by	by	ADP
bam-10779	2	18	-	-	PUNCT
bam-10779	2	19	nc	nc	PROPN
bam-10779	2	20	4.0	4.0	NUM
bam-10779	2	21	)	)	PUNCT
bam-10779	2	22	which	which	PRON
bam-10779	2	23	permits	permit	VERB
bam-10779	2	24	any	any	DET
bam-10779	2	25	noncommercial	noncommercial	ADJ
bam-10779	2	26	use	use	NOUN
bam-10779	2	27	,	,	PUNCT
bam-10779	2	28	distribution	distribution	NOUN
bam-10779	2	29	,	,	PUNCT
bam-10779	2	30	and	and	CCONJ
bam-10779	2	31	reproduction	reproduction	NOUN
bam-10779	2	32	in	in	ADP
bam-10779	2	33	any	any	DET
bam-10779	2	34	medium	medium	NOUN
bam-10779	2	35	,	,	PUNCT
bam-10779	2	36	provided	provide	VERB
bam-10779	2	37	the	the	DET
bam-10779	2	38	original	original	ADJ
bam-10779	2	39	author(s	author(s	NOUN
bam-10779	2	40	)	)	PUNCT
bam-10779	2	41	and	and	CCONJ
bam-10779	2	42	source	source	NOUN
bam-10779	2	43	are	be	AUX
bam-10779	2	44	credited	credit	VERB
bam-10779	2	45	.	.	PUNCT
bam-10779	3	1	abstract	abstract	ADJ
bam-10779	3	2	the	the	DET
bam-10779	3	3	aim	aim	NOUN
bam-10779	3	4	of	of	ADP
bam-10779	3	5	this	this	DET
bam-10779	3	6	study	study	NOUN
bam-10779	3	7	was	be	AUX
bam-10779	3	8	to	to	PART
bam-10779	3	9	investigate	investigate	VERB
bam-10779	3	10	the	the	DET
bam-10779	3	11	recurrence	recurrence	NOUN
bam-10779	3	12	rate	rate	NOUN
bam-10779	3	13	and	and	CCONJ
bam-10779	3	14	five	five	NUM
bam-10779	3	15	-	-	PUNCT
bam-10779	3	16	year	year	NOUN
bam-10779	3	17	survival	survival	NOUN
bam-10779	3	18	in	in	ADP
bam-10779	3	19	patients	patient	NOUN
bam-10779	3	20	with	with	ADP
bam-10779	3	21	borderline	borderline	NOUN
bam-10779	3	22	ovarian	ovarian	ADJ
bam-10779	3	23	tumors	tumor	NOUN
bam-10779	3	24	and	and	CCONJ
bam-10779	3	25	related	related	ADJ
bam-10779	3	26	factors	factor	NOUN
bam-10779	3	27	.	.	PUNCT
bam-10779	4	1	this	this	DET
bam-10779	4	2	retrospective	retrospective	ADJ
bam-10779	4	3	cohort	cohort	NOUN
bam-10779	4	4	study	study	NOUN
bam-10779	4	5	was	be	AUX
bam-10779	4	6	performed	perform	VERB
bam-10779	4	7	on	on	ADP
bam-10779	4	8	20	20	NUM
bam-10779	4	9	women	woman	NOUN
bam-10779	4	10	diagnosed	diagnose	VERB
bam-10779	4	11	with	with	ADP
bam-10779	4	12	a	a	DET
bam-10779	4	13	borderline	borderline	NOUN
bam-10779	4	14	ovarian	ovarian	ADJ
bam-10779	4	15	tumor	tumor	NOUN
bam-10779	4	16	in	in	ADP
bam-10779	4	17	kurdistan	kurdistan	PROPN
bam-10779	4	18	province	province	PROPN
bam-10779	4	19	,	,	PUNCT
bam-10779	4	20	iran	iran	PROPN
bam-10779	4	21	,	,	PUNCT
bam-10779	4	22	between	between	ADP
bam-10779	4	23	2007	2007	NUM
bam-10779	4	24	and	and	CCONJ
bam-10779	4	25	2019	2019	NUM
bam-10779	4	26	.	.	PUNCT
bam-10779	5	1	patients	patient	NOUN
bam-10779	5	2	'	'	PART
bam-10779	5	3	records	record	NOUN
bam-10779	5	4	were	be	AUX
bam-10779	5	5	reviewed	review	VERB
bam-10779	5	6	and	and	CCONJ
bam-10779	5	7	a	a	DET
bam-10779	5	8	researcher	researcher	NOUN
bam-10779	5	9	-	-	PUNCT
bam-10779	5	10	made	make	VERB
bam-10779	5	11	questionnaire	questionnaire	NOUN
bam-10779	5	12	was	be	AUX
bam-10779	5	13	completed	complete	VERB
bam-10779	5	14	for	for	ADP
bam-10779	5	15	each	each	DET
bam-10779	5	16	patient	patient	NOUN
bam-10779	5	17	,	,	PUNCT
bam-10779	5	18	which	which	PRON
bam-10779	5	19	included	include	VERB
bam-10779	5	20	demographic	demographic	ADJ
bam-10779	5	21	and	and	CCONJ
bam-10779	5	22	clinical	clinical	ADJ
bam-10779	5	23	variables	variable	NOUN
bam-10779	5	24	related	relate	VERB
bam-10779	5	25	to	to	ADP
bam-10779	5	26	patient	patient	ADJ
bam-10779	5	27	survival	survival	NOUN
bam-10779	5	28	.	.	PUNCT
bam-10779	6	1	the	the	DET
bam-10779	6	2	most	most	ADV
bam-10779	6	3	common	common	ADJ
bam-10779	6	4	type	type	NOUN
bam-10779	6	5	of	of	ADP
bam-10779	6	6	ovarian	ovarian	ADJ
bam-10779	6	7	borderline	borderline	NOUN
bam-10779	6	8	tumor	tumor	NOUN
bam-10779	6	9	was	be	AUX
bam-10779	6	10	the	the	DET
bam-10779	6	11	serous	serous	ADJ
bam-10779	6	12	borderline	borderline	NOUN
bam-10779	6	13	ovarian	ovarian	ADJ
bam-10779	6	14	tumor	tumor	NOUN
bam-10779	6	15	(	(	PUNCT
bam-10779	6	16	75	75	NUM
bam-10779	6	17	%	%	NOUN
bam-10779	6	18	)	)	PUNCT
bam-10779	6	19	.	.	PUNCT
bam-10779	7	1	in	in	ADP
bam-10779	7	2	fifty	fifty	NUM
bam-10779	7	3	percent	percent	NOUN
bam-10779	7	4	of	of	ADP
bam-10779	7	5	the	the	DET
bam-10779	7	6	cases	case	NOUN
bam-10779	7	7	,	,	PUNCT
bam-10779	7	8	cystectomy	cystectomy	NOUN
bam-10779	7	9	was	be	AUX
bam-10779	7	10	used	use	VERB
bam-10779	7	11	as	as	ADP
bam-10779	7	12	th	th	NUM
bam-10779	7	13	treatment	treatment	NOUN
bam-10779	7	14	.	.	PUNCT
bam-10779	8	1	recurrence	recurrence	NOUN
bam-10779	8	2	was	be	AUX
bam-10779	8	3	observed	observe	VERB
bam-10779	8	4	in	in	ADP
bam-10779	8	5	three	three	NUM
bam-10779	8	6	patients	patient	NOUN
bam-10779	8	7	(	(	PUNCT
bam-10779	8	8	15	15	NUM
bam-10779	8	9	%	%	NOUN
bam-10779	8	10	)	)	PUNCT
bam-10779	8	11	,	,	PUNCT
bam-10779	8	12	two	two	NUM
bam-10779	8	13	of	of	ADP
bam-10779	8	14	which	which	PRON
bam-10779	8	15	were	be	AUX
bam-10779	8	16	treated	treat	VERB
bam-10779	8	17	with	with	ADP
bam-10779	8	18	cystectomy	cystectomy	NOUN
bam-10779	8	19	,	,	PUNCT
bam-10779	8	20	and	and	CCONJ
bam-10779	8	21	the	the	DET
bam-10779	8	22	other	other	ADJ
bam-10779	8	23	case	case	NOUN
bam-10779	8	24	was	be	AUX
bam-10779	8	25	treated	treat	VERB
bam-10779	8	26	by	by	ADP
bam-10779	8	27	tah	tah	PROPN
bam-10779	8	28	+	+	CCONJ
bam-10779	8	29	bso	bso	PROPN
bam-10779	8	30	method	method	NOUN
bam-10779	8	31	(	(	PUNCT
bam-10779	8	32	p	p	X
bam-10779	8	33	=	=	NOUN
bam-10779	8	34	0.64	0.64	NUM
bam-10779	8	35	)	)	PUNCT
bam-10779	8	36	.	.	PUNCT
bam-10779	9	1	there	there	PRON
bam-10779	9	2	was	be	VERB
bam-10779	9	3	no	no	DET
bam-10779	9	4	significant	significant	ADJ
bam-10779	9	5	difference	difference	NOUN
bam-10779	9	6	in	in	ADP
bam-10779	9	7	terms	term	NOUN
bam-10779	9	8	of	of	ADP
bam-10779	9	9	the	the	DET
bam-10779	9	10	type	type	NOUN
bam-10779	9	11	of	of	ADP
bam-10779	9	12	surgery	surgery	NOUN
bam-10779	9	13	,	,	PUNCT
bam-10779	9	14	history	history	NOUN
bam-10779	9	15	of	of	ADP
bam-10779	9	16	infertility	infertility	NOUN
bam-10779	9	17	,	,	PUNCT
bam-10779	9	18	history	history	NOUN
bam-10779	9	19	of	of	ADP
bam-10779	9	20	taking	take	VERB
bam-10779	9	21	contraceptive	contraceptive	ADJ
bam-10779	9	22	pills	pill	NOUN
bam-10779	9	23	,	,	PUNCT
bam-10779	9	24	age	age	NOUN
bam-10779	9	25	,	,	PUNCT
bam-10779	9	26	age	age	NOUN
bam-10779	9	27	at	at	ADP
bam-10779	9	28	diagnosis	diagnosis	NOUN
bam-10779	9	29	,	,	PUNCT
bam-10779	9	30	and	and	CCONJ
bam-10779	9	31	bmi	bmi	NOUN
bam-10779	9	32	between	between	ADP
bam-10779	9	33	the	the	DET
bam-10779	9	34	two	two	NUM
bam-10779	9	35	groups	group	NOUN
bam-10779	9	36	with	with	ADP
bam-10779	9	37	and	and	CCONJ
bam-10779	9	38	without	without	ADP
bam-10779	9	39	recurrence	recurrence	NOUN
bam-10779	9	40	(	(	PUNCT
bam-10779	9	41	p	p	X
bam-10779	9	42	>	>	X
bam-10779	9	43	0.05	0.05	NUM
bam-10779	9	44	)	)	PUNCT
bam-10779	9	45	.	.	PUNCT
bam-10779	10	1	the	the	DET
bam-10779	10	2	overall	overall	ADJ
bam-10779	10	3	survival	survival	NOUN
bam-10779	10	4	rate	rate	NOUN
bam-10779	10	5	was	be	AUX
bam-10779	10	6	100	100	NUM
bam-10779	10	7	%	%	NOUN
bam-10779	10	8	and	and	CCONJ
bam-10779	10	9	none	none	NOUN
bam-10779	10	10	of	of	ADP
bam-10779	10	11	the	the	DET
bam-10779	10	12	patients	patient	NOUN
bam-10779	10	13	died	die	VERB
bam-10779	10	14	at	at	ADP
bam-10779	10	15	the	the	DET
bam-10779	10	16	end	end	NOUN
bam-10779	10	17	of	of	ADP
bam-10779	10	18	follow	follow	NOUN
bam-10779	10	19	-	-	PUNCT
bam-10779	10	20	up	up	NOUN
bam-10779	10	21	.	.	PUNCT
bam-10779	11	1	there	there	PRON
bam-10779	11	2	was	be	VERB
bam-10779	11	3	no	no	DET
bam-10779	11	4	relationship	relationship	NOUN
bam-10779	11	5	between	between	ADP
bam-10779	11	6	any	any	PRON
bam-10779	11	7	of	of	ADP
bam-10779	11	8	the	the	DET
bam-10779	11	9	clinical	clinical	ADJ
bam-10779	11	10	and	and	CCONJ
bam-10779	11	11	demographic	demographic	ADJ
bam-10779	11	12	variables	variable	NOUN
bam-10779	11	13	with	with	ADP
bam-10779	11	14	disease	disease	NOUN
bam-10779	11	15	recurrence	recurrence	NOUN
bam-10779	11	16	,	,	PUNCT
bam-10779	11	17	and	and	CCONJ
bam-10779	11	18	since	since	SCONJ
bam-10779	11	19	all	all	DET
bam-10779	11	20	patients	patient	NOUN
bam-10779	11	21	were	be	AUX
bam-10779	11	22	alive	alive	ADJ
bam-10779	11	23	after	after	ADP
bam-10779	11	24	the	the	DET
bam-10779	11	25	end	end	NOUN
bam-10779	11	26	of	of	ADP
bam-10779	11	27	the	the	DET
bam-10779	11	28	followup	followup	ADJ
bam-10779	11	29	period	period	NOUN
bam-10779	11	30	.	.	PUNCT
bam-10779	12	1	in	in	ADP
bam-10779	12	2	summary	summary	NOUN
bam-10779	12	3	,	,	PUNCT
bam-10779	12	4	it	it	PRON
bam-10779	12	5	was	be	AUX
bam-10779	12	6	not	not	PART
bam-10779	12	7	possible	possible	ADJ
bam-10779	12	8	to	to	PART
bam-10779	12	9	assess	assess	VERB
bam-10779	12	10	the	the	DET
bam-10779	12	11	relationship	relationship	NOUN
bam-10779	12	12	between	between	ADP
bam-10779	12	13	patients	patient	NOUN
bam-10779	12	14	'	'	PART
bam-10779	12	15	survival	survival	NOUN
bam-10779	12	16	rate	rate	NOUN
bam-10779	12	17	and	and	CCONJ
bam-10779	12	18	studied	studied	ADJ
bam-10779	12	19	variables	variable	NOUN
bam-10779	12	20	.	.	PUNCT
bam-10779	13	1	key	key	ADJ
bam-10779	13	2	words	word	NOUN
bam-10779	13	3	:	:	PUNCT
bam-10779	13	4	recurrence	recurrence	NOUN
bam-10779	13	5	;	;	PUNCT
bam-10779	13	6	survival	survival	NOUN
bam-10779	13	7	;	;	PUNCT
bam-10779	13	8	borderline	borderline	ADJ
bam-10779	13	9	ovarian	ovarian	ADJ
bam-10779	13	10	tumors	tumor	NOUN
bam-10779	13	11	,	,	PUNCT
bam-10779	13	12	ovary	ovary	ADJ
bam-10779	13	13	;	;	PUNCT
bam-10779	13	14	serous	serous	ADJ
bam-10779	13	15	borderline	borderline	NOUN
bam-10779	13	16	ovarian	ovarian	ADJ
bam-10779	13	17	tumor	tumor	NOUN
bam-10779	13	18	.	.	PUNCT
bam-10779	14	1	eur	eur	PROPN
bam-10779	14	2	j	j	PROPN
bam-10779	14	3	transl	transl	PROPN
bam-10779	14	4	myol	myol	ADV
bam-10779	14	5	33	33	NUM
bam-10779	14	6	(	(	PUNCT
bam-10779	14	7	1	1	NUM
bam-10779	14	8	)	)	PUNCT
bam-10779	14	9	10779	10779	NUM
bam-10779	14	10	,	,	PUNCT
bam-10779	14	11	2023	2023	NUM
bam-10779	14	12	doi	doi	NOUN
bam-10779	14	13	:	:	PUNCT
bam-10779	14	14	10.4081	10.4081	NUM
bam-10779	14	15	/	/	SYM
bam-10779	14	16	ejtm.2023.10779	ejtm.2023.10779	PROPN
bam-10779	14	17	ovarian	ovarian	ADJ
bam-10779	14	18	cancers	cancer	NOUN
bam-10779	14	19	are	be	AUX
bam-10779	14	20	among	among	ADP
bam-10779	14	21	the	the	DET
bam-10779	14	22	most	most	ADV
bam-10779	14	23	important	important	ADJ
bam-10779	14	24	cancers	cancer	NOUN
bam-10779	14	25	in	in	ADP
bam-10779	14	26	women	woman	NOUN
bam-10779	14	27	.	.	PUNCT
bam-10779	15	1	the	the	DET
bam-10779	15	2	lifetime	lifetime	NOUN
bam-10779	15	3	risk	risk	NOUN
bam-10779	15	4	of	of	ADP
bam-10779	15	5	developing	develop	VERB
bam-10779	15	6	ovarian	ovarian	ADJ
bam-10779	15	7	cancer	cancer	NOUN
bam-10779	15	8	in	in	ADP
bam-10779	15	9	women	woman	NOUN
bam-10779	15	10	is	be	AUX
bam-10779	15	11	about	about	ADV
bam-10779	15	12	1.5	1.5	NUM
bam-10779	15	13	%	%	NOUN
bam-10779	15	14	and	and	CCONJ
bam-10779	15	15	its	its	PRON
bam-10779	15	16	mortality	mortality	NOUN
bam-10779	15	17	rate	rate	NOUN
bam-10779	15	18	is	be	AUX
bam-10779	15	19	about	about	ADP
bam-10779	15	20	0.5%.1,2	0.5%.1,2	NUM
bam-10779	15	21	although	although	SCONJ
bam-10779	15	22	ovarian	ovarian	ADJ
bam-10779	15	23	cancer	cancer	NOUN
bam-10779	15	24	accounts	account	VERB
bam-10779	15	25	for	for	ADP
bam-10779	15	26	a	a	DET
bam-10779	15	27	small	small	ADJ
bam-10779	15	28	percentage	percentage	NOUN
bam-10779	15	29	of	of	ADP
bam-10779	15	30	cancers	cancer	NOUN
bam-10779	15	31	in	in	ADP
bam-10779	15	32	women	woman	NOUN
bam-10779	15	33	,	,	PUNCT
bam-10779	15	34	it	it	PRON
bam-10779	15	35	is	be	AUX
bam-10779	15	36	the	the	DET
bam-10779	15	37	fifth	fifth	ADJ
bam-10779	15	38	leading	leading	ADJ
bam-10779	15	39	cause	cause	NOUN
bam-10779	15	40	of	of	ADP
bam-10779	15	41	death	death	NOUN
bam-10779	15	42	from	from	ADP
bam-10779	15	43	malignancy	malignancy	NOUN
bam-10779	15	44	in	in	ADP
bam-10779	15	45	women.2,3	women.2,3	ADJ
bam-10779	15	46	borderline	borderline	NOUN
bam-10779	15	47	ovarian	ovarian	ADJ
bam-10779	15	48	tumors	tumor	NOUN
bam-10779	15	49	(	(	PUNCT
bam-10779	15	50	bot	bot	NOUN
bam-10779	15	51	)	)	PUNCT
bam-10779	15	52	are	be	AUX
bam-10779	15	53	a	a	DET
bam-10779	15	54	group	group	NOUN
bam-10779	15	55	of	of	ADP
bam-10779	15	56	ovarian	ovarian	ADJ
bam-10779	15	57	tumors	tumor	NOUN
bam-10779	15	58	that	that	PRON
bam-10779	15	59	are	be	AUX
bam-10779	15	60	associated	associate	VERB
bam-10779	15	61	with	with	ADP
bam-10779	15	62	a	a	DET
bam-10779	15	63	low	low	ADJ
bam-10779	15	64	potential	potential	NOUN
bam-10779	15	65	for	for	ADP
bam-10779	15	66	malignancy	malignancy	NOUN
bam-10779	15	67	and	and	CCONJ
bam-10779	15	68	remain	remain	VERB
bam-10779	15	69	confined	confine	VERB
bam-10779	15	70	to	to	ADP
bam-10779	15	71	the	the	DET
bam-10779	15	72	pelvis	pelvi	NOUN
bam-10779	15	73	for	for	ADP
bam-10779	15	74	a	a	DET
bam-10779	15	75	long	long	ADJ
bam-10779	15	76	period	period	NOUN
bam-10779	15	77	of	of	ADP
bam-10779	15	78	time.1,4	time.1,4	ADV
bam-10779	15	79	these	these	DET
bam-10779	15	80	tumors	tumor	NOUN
bam-10779	15	81	make	make	VERB
bam-10779	15	82	up	up	ADP
bam-10779	15	83	about	about	ADV
bam-10779	15	84	20	20	NUM
bam-10779	15	85	%	%	NOUN
bam-10779	15	86	of	of	ADP
bam-10779	15	87	ovarian	ovarian	ADJ
bam-10779	15	88	epithelial	epithelial	ADJ
bam-10779	15	89	tumors.5	tumors.5	PROPN
bam-10779	15	90	in	in	ADP
bam-10779	15	91	fact	fact	NOUN
bam-10779	15	92	,	,	PUNCT
bam-10779	15	93	bot	bot	NOUN
bam-10779	15	94	represent	represent	VERB
bam-10779	15	95	a	a	DET
bam-10779	15	96	heterogeneous	heterogeneous	ADJ
bam-10779	15	97	group	group	NOUN
bam-10779	15	98	of	of	ADP
bam-10779	15	99	non	non	ADJ
bam-10779	15	100	-	-	ADJ
bam-10779	15	101	invasive	invasive	ADJ
bam-10779	15	102	tumors	tumor	NOUN
bam-10779	15	103	with	with	ADP
bam-10779	15	104	unknown	unknown	ADJ
bam-10779	15	105	malignant	malignant	ADJ
bam-10779	15	106	potential	potential	NOUN
bam-10779	15	107	.	.	PUNCT
bam-10779	16	1	these	these	DET
bam-10779	16	2	tumors	tumor	NOUN
bam-10779	16	3	are	be	AUX
bam-10779	16	4	clearly	clearly	ADV
bam-10779	16	5	associated	associate	VERB
bam-10779	16	6	with	with	ADP
bam-10779	16	7	a	a	DET
bam-10779	16	8	relatively	relatively	ADV
bam-10779	16	9	good	good	ADJ
bam-10779	16	10	prognosis	prognosis	NOUN
bam-10779	16	11	.	.	PUNCT
bam-10779	17	1	molecular	molecular	ADJ
bam-10779	17	2	changes	change	NOUN
bam-10779	17	3	in	in	ADP
bam-10779	17	4	bot	bot	NOUN
bam-10779	17	5	indicate	indicate	VERB
bam-10779	17	6	an	an	DET
bam-10779	17	7	association	association	NOUN
bam-10779	17	8	between	between	ADP
bam-10779	17	9	this	this	DET
bam-10779	17	10	disease	disease	NOUN
bam-10779	17	11	and	and	CCONJ
bam-10779	17	12	type	type	NOUN
bam-10779	17	13	i	i	PRON
bam-10779	17	14	ovarian	ovarian	ADJ
bam-10779	17	15	tumors	tumor	NOUN
bam-10779	17	16	(	(	PUNCT
bam-10779	17	17	low	low	ADJ
bam-10779	17	18	-	-	PUNCT
bam-10779	17	19	grade	grade	NOUN
bam-10779	17	20	ovarian	ovarian	NOUN
bam-10779	17	21	carcinoma).6,7	carcinoma).6,7	ADP
bam-10779	17	22	one	one	NUM
bam-10779	17	23	of	of	ADP
bam-10779	17	24	the	the	DET
bam-10779	17	25	special	special	ADJ
bam-10779	17	26	histological	histological	ADJ
bam-10779	17	27	features	feature	NOUN
bam-10779	17	28	of	of	ADP
bam-10779	17	29	interstitial	interstitial	ADJ
bam-10779	17	30	ovarian	ovarian	ADJ
bam-10779	17	31	tumors	tumor	NOUN
bam-10779	17	32	is	be	AUX
bam-10779	17	33	that	that	SCONJ
bam-10779	17	34	the	the	DET
bam-10779	17	35	malignant	malignant	ADJ
bam-10779	17	36	cells	cell	NOUN
bam-10779	17	37	do	do	AUX
bam-10779	17	38	not	not	PART
bam-10779	17	39	invade	invade	VERB
bam-10779	17	40	the	the	DET
bam-10779	17	41	ovarian	ovarian	ADJ
bam-10779	17	42	stromal	stromal	ADJ
bam-10779	17	43	tissue	tissue	NOUN
bam-10779	17	44	.	.	PUNCT
bam-10779	18	1	however	however	ADV
bam-10779	18	2	,	,	PUNCT
bam-10779	18	3	there	there	PRON
bam-10779	18	4	are	be	VERB
bam-10779	18	5	other	other	ADJ
bam-10779	18	6	malignant	malignant	ADJ
bam-10779	18	7	changes	change	NOUN
bam-10779	18	8	such	such	ADJ
bam-10779	18	9	as	as	ADP
bam-10779	18	10	malignant	malignant	ADJ
bam-10779	18	11	cell	cell	NOUN
bam-10779	18	12	proliferation	proliferation	NOUN
bam-10779	18	13	,	,	PUNCT
bam-10779	18	14	nuclear	nuclear	ADJ
bam-10779	18	15	atypia	atypia	NOUN
bam-10779	18	16	,	,	PUNCT
bam-10779	18	17	and	and	CCONJ
bam-10779	18	18	mitotic	mitotic	ADJ
bam-10779	18	19	changes.7	changes.7	NOUN
bam-10779	18	20	the	the	DET
bam-10779	18	21	age	age	NOUN
bam-10779	18	22	of	of	ADP
bam-10779	18	23	onset	onset	NOUN
bam-10779	18	24	of	of	ADP
bam-10779	18	25	these	these	DET
bam-10779	18	26	tumors	tumor	NOUN
bam-10779	18	27	is	be	AUX
bam-10779	18	28	lower	low	ADJ
bam-10779	18	29	than	than	ADP
bam-10779	18	30	invasive	invasive	ADJ
bam-10779	18	31	ovarian	ovarian	ADJ
bam-10779	18	32	tumors	tumor	NOUN
bam-10779	18	33	and	and	CCONJ
bam-10779	18	34	they	they	PRON
bam-10779	18	35	are	be	AUX
bam-10779	18	36	mostly	mostly	ADV
bam-10779	18	37	seen	see	VERB
bam-10779	18	38	in	in	ADP
bam-10779	18	39	the	the	DET
bam-10779	18	40	age	age	NOUN
bam-10779	18	41	group	group	NOUN
bam-10779	18	42	of	of	ADP
bam-10779	18	43	30	30	NUM
bam-10779	18	44	-	-	SYM
bam-10779	18	45	50	50	NUM
bam-10779	18	46	years.8	years.8	NOUN
bam-10779	18	47	the	the	DET
bam-10779	18	48	pathological	pathological	ADJ
bam-10779	18	49	stage	stage	NOUN
bam-10779	18	50	of	of	ADP
bam-10779	18	51	the	the	DET
bam-10779	18	52	disease	disease	NOUN
bam-10779	18	53	and	and	CCONJ
bam-10779	18	54	the	the	DET
bam-10779	18	55	sub	sub	NOUN
bam-10779	18	56	-	-	NOUN
bam-10779	18	57	classification	classification	NOUN
bam-10779	18	58	of	of	ADP
bam-10779	18	59	extra	extra	ADJ
bam-10779	18	60	-	-	ADJ
bam-10779	18	61	ovarian	ovarian	ADJ
bam-10779	18	62	disease	disease	NOUN
bam-10779	18	63	into	into	ADP
bam-10779	18	64	invasive	invasive	ADJ
bam-10779	18	65	and	and	CCONJ
bam-10779	18	66	non	non	ADJ
bam-10779	18	67	-	-	ADJ
bam-10779	18	68	invasive	invasive	ADJ
bam-10779	18	69	implants	implant	NOUN
bam-10779	18	70	,	,	PUNCT
bam-10779	18	71	along	along	ADP
bam-10779	18	72	with	with	ADP
bam-10779	18	73	the	the	DET
bam-10779	18	74	presence	presence	NOUN
bam-10779	18	75	of	of	ADP
bam-10779	18	76	postoperative	postoperative	ADJ
bam-10779	18	77	macroscopic	macroscopic	ADJ
bam-10779	18	78	disease	disease	NOUN
bam-10779	18	79	,	,	PUNCT
bam-10779	18	80	are	be	AUX
bam-10779	18	81	the	the	DET
bam-10779	18	82	main	main	ADJ
bam-10779	18	83	predictors	predictor	NOUN
bam-10779	18	84	of	of	ADP
bam-10779	18	85	recurrence	recurrence	NOUN
bam-10779	18	86	and	and	CCONJ
bam-10779	18	87	survival	survival	NOUN
bam-10779	18	88	in	in	ADP
bam-10779	18	89	these	these	DET
bam-10779	18	90	patients.5,9	patients.5,9	NOUN
bam-10779	18	91	however	however	ADV
bam-10779	18	92	,	,	PUNCT
bam-10779	18	93	it	it	PRON
bam-10779	18	94	should	should	AUX
bam-10779	18	95	be	be	AUX
bam-10779	18	96	emphasized	emphasize	VERB
bam-10779	18	97	that	that	SCONJ
bam-10779	18	98	the	the	DET
bam-10779	18	99	most	most	ADV
bam-10779	18	100	important	important	ADJ
bam-10779	18	101	factor	factor	NOUN
bam-10779	18	102	in	in	ADP
bam-10779	18	103	the	the	DET
bam-10779	18	104	negative	negative	ADJ
bam-10779	18	105	prognosis	prognosis	NOUN
bam-10779	18	106	of	of	ADP
bam-10779	18	107	recurrence	recurrence	NOUN
bam-10779	18	108	is	be	AUX
bam-10779	18	109	the	the	DET
bam-10779	18	110	use	use	NOUN
bam-10779	18	111	of	of	ADP
bam-10779	18	112	conservative	conservative	ADJ
bam-10779	18	113	surgery	surgery	NOUN
bam-10779	18	114	without	without	ADP
bam-10779	18	115	affecting	affect	VERB
bam-10779	18	116	the	the	DET
bam-10779	18	117	patient	patient	NOUN
bam-10779	18	118	's	's	PART
bam-10779	18	119	survival	survival	NOUN
bam-10779	18	120	because	because	SCONJ
bam-10779	18	121	most	most	ADJ
bam-10779	18	122	recurrent	recurrent	ADJ
bam-10779	18	123	diseases	disease	NOUN
bam-10779	18	124	are	be	AUX
bam-10779	18	125	borderline	borderline	NOUN
bam-10779	18	126	types	type	NOUN
bam-10779	18	127	that	that	PRON
bam-10779	18	128	are	be	AUX
bam-10779	18	129	easily	easily	ADV
bam-10779	18	130	treated	treat	VERB
bam-10779	18	131	and	and	CCONJ
bam-10779	18	132	have	have	VERB
bam-10779	18	133	an	an	DET
bam-10779	18	134	excellent	excellent	ADJ
bam-10779	18	135	prognosis.10,11	prognosis.10,11	NOUN
bam-10779	18	136	as	as	SCONJ
bam-10779	18	137	mentioned	mention	VERB
bam-10779	18	138	,	,	PUNCT
bam-10779	18	139	ovarian	ovarian	ADJ
bam-10779	18	140	cancer	cancer	NOUN
bam-10779	18	141	is	be	AUX
bam-10779	18	142	one	one	NUM
bam-10779	18	143	of	of	ADP
bam-10779	18	144	the	the	DET
bam-10779	18	145	most	most	ADV
bam-10779	18	146	important	important	ADJ
bam-10779	18	147	types	type	NOUN
bam-10779	18	148	of	of	ADP
bam-10779	18	149	cancer	cancer	NOUN
bam-10779	18	150	in	in	ADP
bam-10779	18	151	women	woman	NOUN
bam-10779	18	152	and	and	CCONJ
bam-10779	18	153	can	can	AUX
bam-10779	18	154	have	have	VERB
bam-10779	18	155	a	a	DET
bam-10779	18	156	high	high	ADJ
bam-10779	18	157	mortality	mortality	NOUN
bam-10779	18	158	rate	rate	NOUN
bam-10779	18	159	.	.	PUNCT
bam-10779	19	1	also	also	ADV
bam-10779	19	2	,	,	PUNCT
bam-10779	19	3	bot	bot	PROPN
bam-10779	19	4	are	be	AUX
bam-10779	19	5	one	one	NUM
bam-10779	19	6	of	of	ADP
bam-10779	19	7	the	the	DET
bam-10779	19	8	most	most	ADV
bam-10779	19	9	important	important	ADJ
bam-10779	19	10	types	type	NOUN
bam-10779	19	11	of	of	ADP
bam-10779	19	12	ovarian	ovarian	ADJ
bam-10779	19	13	cancer	cancer	NOUN
bam-10779	19	14	,	,	PUNCT
bam-10779	19	15	and	and	CCONJ
bam-10779	19	16	these	these	DET
bam-10779	19	17	types	type	NOUN
bam-10779	19	18	of	of	ADP
bam-10779	19	19	tumors	tumor	NOUN
bam-10779	19	20	can	can	AUX
bam-10779	19	21	be	be	AUX
bam-10779	19	22	associated	associate	VERB
bam-10779	19	23	with	with	ADP
bam-10779	19	24	recurrence	recurrence	NOUN
bam-10779	19	25	in	in	ADP
bam-10779	19	26	some	some	DET
bam-10779	19	27	people	people	NOUN
bam-10779	19	28	.	.	PUNCT
bam-10779	20	1	therefore	therefore	ADV
bam-10779	20	2	,	,	PUNCT
bam-10779	20	3	recognizing	recognize	VERB
bam-10779	20	4	the	the	DET
bam-10779	20	5	non	non	ADJ
bam-10779	20	6	-co	-co	PROPN
bam-10779	20	7	mmerc	mmerc	PROPN
bam-10779	20	8	ial	ial	PROPN
bam-10779	20	9	us	us	PROPN
bam-10779	20	10	e	e	NOUN
bam-10779	20	11	o	o	NOUN
bam-10779	20	12	nly	nly	ADV
bam-10779	20	13	recurrence	recurrence	NOUN
bam-10779	20	14	and	and	CCONJ
bam-10779	20	15	5	5	NUM
bam-10779	20	16	-	-	PUNCT
bam-10779	20	17	year	year	NOUN
bam-10779	20	18	survival	survival	NOUN
bam-10779	20	19	of	of	ADP
bam-10779	20	20	borderline	borderline	NOUN
bam-10779	20	21	ovarian	ovarian	ADJ
bam-10779	20	22	tumor	tumor	NOUN
bam-10779	20	23	eur	eur	PROPN
bam-10779	20	24	j	j	PROPN
bam-10779	20	25	transl	transl	PROPN
bam-10779	20	26	myol	myol	ADV
bam-10779	20	27	33	33	NUM
bam-10779	20	28	(	(	PUNCT
bam-10779	20	29	1	1	NUM
bam-10779	20	30	)	)	PUNCT
bam-10779	20	31	10779	10779	NUM
bam-10779	20	32	,	,	PUNCT
bam-10779	20	33	2023	2023	NUM
bam-10779	20	34	doi	doi	NOUN
bam-10779	20	35	:	:	PUNCT
bam-10779	20	36	10.4081	10.4081	NUM
bam-10779	20	37	/	/	SYM
bam-10779	20	38	ejtm.2023.10779	ejtm.2023.10779	ADJ
bam-10779	20	39	2	2	NUM
bam-10779	20	40	factors	factor	NOUN
bam-10779	20	41	related	relate	VERB
bam-10779	20	42	to	to	ADP
bam-10779	20	43	recurrence	recurrence	NOUN
bam-10779	20	44	in	in	ADP
bam-10779	20	45	patients	patient	NOUN
bam-10779	20	46	is	be	AUX
bam-10779	20	47	necessary	necessary	ADJ
bam-10779	20	48	and	and	CCONJ
bam-10779	20	49	important	important	ADJ
bam-10779	20	50	in	in	ADP
bam-10779	20	51	order	order	NOUN
bam-10779	20	52	to	to	PART
bam-10779	20	53	prevent	prevent	VERB
bam-10779	20	54	its	its	PRON
bam-10779	20	55	occurrence	occurrence	NOUN
bam-10779	20	56	.	.	PUNCT
bam-10779	21	1	thus	thus	ADV
bam-10779	21	2	,	,	PUNCT
bam-10779	21	3	the	the	DET
bam-10779	21	4	aim	aim	NOUN
bam-10779	21	5	of	of	ADP
bam-10779	21	6	this	this	DET
bam-10779	21	7	study	study	NOUN
bam-10779	21	8	was	be	AUX
bam-10779	21	9	to	to	PART
bam-10779	21	10	investigate	investigate	VERB
bam-10779	21	11	the	the	DET
bam-10779	21	12	recurrence	recurrence	NOUN
bam-10779	21	13	and	and	CCONJ
bam-10779	21	14	5	5	NUM
bam-10779	21	15	-	-	PUNCT
bam-10779	21	16	year	year	NOUN
bam-10779	21	17	survival	survival	NOUN
bam-10779	21	18	rate	rate	NOUN
bam-10779	21	19	in	in	ADP
bam-10779	21	20	patients	patient	NOUN
bam-10779	21	21	with	with	ADP
bam-10779	21	22	bot	bot	NOUN
bam-10779	21	23	in	in	ADP
bam-10779	21	24	kurdistan	kurdistan	PROPN
bam-10779	21	25	province	province	PROPN
bam-10779	21	26	.	.	PUNCT
bam-10779	22	1	materials	material	NOUN
bam-10779	22	2	and	and	CCONJ
bam-10779	22	3	methods	method	NOUN
bam-10779	22	4	this	this	DET
bam-10779	22	5	retrospective	retrospective	ADJ
bam-10779	22	6	cohort	cohort	NOUN
bam-10779	22	7	study	study	NOUN
bam-10779	22	8	was	be	AUX
bam-10779	22	9	performed	perform	VERB
bam-10779	22	10	on	on	ADP
bam-10779	22	11	all	all	DET
bam-10779	22	12	women	woman	NOUN
bam-10779	22	13	with	with	ADP
bam-10779	22	14	borderline	borderline	NOUN
bam-10779	22	15	ovarian	ovarian	ADJ
bam-10779	22	16	tumor	tumor	NOUN
bam-10779	22	17	at	at	ADP
bam-10779	22	18	besat	besat	PROPN
bam-10779	22	19	hospital	hospital	NOUN
bam-10779	22	20	in	in	ADP
bam-10779	22	21	sanandaj	sanandaj	NOUN
bam-10779	22	22	,	,	PUNCT
bam-10779	22	23	kurdistan	kurdistan	PROPN
bam-10779	22	24	province	province	NOUN
bam-10779	22	25	,	,	PUNCT
bam-10779	22	26	west	west	NOUN
bam-10779	22	27	of	of	ADP
bam-10779	22	28	iran	iran	PROPN
bam-10779	22	29	,	,	PUNCT
bam-10779	22	30	from	from	ADP
bam-10779	22	31	2007	2007	NUM
bam-10779	22	32	to	to	ADP
bam-10779	22	33	2019	2019	NUM
bam-10779	22	34	.	.	PUNCT
bam-10779	23	1	eligible	eligible	ADJ
bam-10779	23	2	patients	patient	NOUN
bam-10779	23	3	who	who	PRON
bam-10779	23	4	had	have	VERB
bam-10779	23	5	a	a	DET
bam-10779	23	6	medical	medical	ADJ
bam-10779	23	7	record	record	NOUN
bam-10779	23	8	in	in	ADP
bam-10779	23	9	besat	besat	PROPN
bam-10779	23	10	hospital	hospital	NOUN
bam-10779	23	11	in	in	ADP
bam-10779	23	12	sanandaj	sanandaj	NOUN
bam-10779	23	13	were	be	AUX
bam-10779	23	14	selected	select	VERB
bam-10779	23	15	.	.	PUNCT
bam-10779	24	1	samples	sample	NOUN
bam-10779	24	2	were	be	AUX
bam-10779	24	3	selected	select	VERB
bam-10779	24	4	using	use	VERB
bam-10779	24	5	the	the	DET
bam-10779	24	6	census	census	NOUN
bam-10779	24	7	method	method	NOUN
bam-10779	24	8	.	.	PUNCT
bam-10779	25	1	the	the	DET
bam-10779	25	2	number	number	NOUN
bam-10779	25	3	of	of	ADP
bam-10779	25	4	samples	sample	NOUN
bam-10779	25	5	,	,	PUNCT
bam-10779	25	6	considering	consider	VERB
bam-10779	25	7	the	the	DET
bam-10779	25	8	type	type	NOUN
bam-10779	25	9	of	of	ADP
bam-10779	25	10	study	study	NOUN
bam-10779	25	11	,	,	PUNCT
bam-10779	25	12	was	be	AUX
bam-10779	25	13	considered	consider	VERB
bam-10779	25	14	to	to	PART
bam-10779	25	15	be	be	AUX
bam-10779	25	16	100	100	NUM
bam-10779	25	17	people	people	NOUN
bam-10779	25	18	,	,	PUNCT
bam-10779	25	19	and	and	CCONJ
bam-10779	25	20	after	after	ADP
bam-10779	25	21	considering	consider	VERB
bam-10779	25	22	the	the	DET
bam-10779	25	23	inclusion	inclusion	NOUN
bam-10779	25	24	and	and	CCONJ
bam-10779	25	25	exclusion	exclusion	NOUN
bam-10779	25	26	criteria	criterion	NOUN
bam-10779	25	27	,	,	PUNCT
bam-10779	25	28	the	the	DET
bam-10779	25	29	number	number	NOUN
bam-10779	25	30	of	of	ADP
bam-10779	25	31	people	people	NOUN
bam-10779	25	32	in	in	ADP
bam-10779	25	33	the	the	DET
bam-10779	25	34	study	study	NOUN
bam-10779	25	35	was	be	AUX
bam-10779	25	36	reduced	reduce	VERB
bam-10779	25	37	to	to	ADP
bam-10779	25	38	20	20	NUM
bam-10779	25	39	people	people	NOUN
bam-10779	25	40	.	.	PUNCT
bam-10779	26	1	therefore	therefore	ADV
bam-10779	26	2	,	,	PUNCT
bam-10779	26	3	in	in	ADP
bam-10779	26	4	this	this	DET
bam-10779	26	5	study	study	NOUN
bam-10779	26	6	,	,	PUNCT
bam-10779	26	7	the	the	DET
bam-10779	26	8	files	file	NOUN
bam-10779	26	9	of	of	ADP
bam-10779	26	10	20	20	NUM
bam-10779	26	11	patients	patient	NOUN
bam-10779	26	12	with	with	ADP
bam-10779	26	13	bot	bot	NOUN
bam-10779	26	14	were	be	AUX
bam-10779	26	15	investigated	investigate	VERB
bam-10779	26	16	.	.	PUNCT
bam-10779	27	1	inclusion	inclusion	NOUN
bam-10779	27	2	criteria	criterion	NOUN
bam-10779	27	3	were	be	AUX
bam-10779	27	4	definitive	definitive	ADJ
bam-10779	27	5	diagnosis	diagnosis	NOUN
bam-10779	27	6	of	of	ADP
bam-10779	27	7	borderline	borderline	NOUN
bam-10779	27	8	ovarian	ovarian	ADJ
bam-10779	27	9	tumor	tumor	NOUN
bam-10779	27	10	and	and	CCONJ
bam-10779	27	11	completeness	completeness	NOUN
bam-10779	27	12	of	of	ADP
bam-10779	27	13	the	the	DET
bam-10779	27	14	clinical	clinical	ADJ
bam-10779	27	15	record	record	NOUN
bam-10779	27	16	.	.	PUNCT
bam-10779	28	1	exclusion	exclusion	NOUN
bam-10779	28	2	criteria	criterion	NOUN
bam-10779	28	3	included	include	VERB
bam-10779	28	4	any	any	DET
bam-10779	28	5	type	type	NOUN
bam-10779	28	6	of	of	ADP
bam-10779	28	7	cancer	cancer	NOUN
bam-10779	28	8	other	other	ADJ
bam-10779	28	9	than	than	ADP
bam-10779	28	10	borderline	borderline	ADJ
bam-10779	28	11	ovarian	ovarian	ADJ
bam-10779	28	12	cancer	cancer	NOUN
bam-10779	28	13	,	,	PUNCT
bam-10779	28	14	patients	patient	NOUN
bam-10779	28	15	who	who	PRON
bam-10779	28	16	had	have	AUX
bam-10779	28	17	been	be	AUX
bam-10779	28	18	diagnosed	diagnose	VERB
bam-10779	28	19	with	with	ADP
bam-10779	28	20	borderline	borderline	NOUN
bam-10779	28	21	ovarian	ovarian	ADJ
bam-10779	28	22	cancer	cancer	NOUN
bam-10779	28	23	before	before	ADP
bam-10779	28	24	the	the	DET
bam-10779	28	25	study	study	NOUN
bam-10779	28	26	period	period	NOUN
bam-10779	28	27	(	(	PUNCT
bam-10779	28	28	previous	previous	ADJ
bam-10779	28	29	visit	visit	NOUN
bam-10779	28	30	)	)	PUNCT
bam-10779	28	31	,	,	PUNCT
bam-10779	28	32	and	and	CCONJ
bam-10779	28	33	patients	patient	NOUN
bam-10779	28	34	who	who	PRON
bam-10779	28	35	came	come	VERB
bam-10779	28	36	to	to	ADP
bam-10779	28	37	kurdistan	kurdistan	PROPN
bam-10779	28	38	from	from	ADP
bam-10779	28	39	other	other	ADJ
bam-10779	28	40	provinces	province	NOUN
bam-10779	28	41	for	for	ADP
bam-10779	28	42	treatment	treatment	NOUN
bam-10779	28	43	.	.	PUNCT
bam-10779	29	1	in	in	ADP
bam-10779	29	2	order	order	NOUN
bam-10779	29	3	to	to	PART
bam-10779	29	4	collect	collect	VERB
bam-10779	29	5	information	information	NOUN
bam-10779	29	6	,	,	PUNCT
bam-10779	29	7	based	base	VERB
bam-10779	29	8	on	on	ADP
bam-10779	29	9	the	the	DET
bam-10779	29	10	studied	study	VERB
bam-10779	29	11	variables	variable	NOUN
bam-10779	29	12	,	,	PUNCT
bam-10779	29	13	a	a	DET
bam-10779	29	14	researcher	researcher	NOUN
bam-10779	29	15	-	-	PUNCT
bam-10779	29	16	made	make	VERB
bam-10779	29	17	checklist	checklist	NOUN
bam-10779	29	18	was	be	AUX
bam-10779	29	19	completed	complete	VERB
bam-10779	29	20	,	,	PUNCT
bam-10779	29	21	which	which	PRON
bam-10779	29	22	recorded	record	VERB
bam-10779	29	23	the	the	DET
bam-10779	29	24	demographic	demographic	ADJ
bam-10779	29	25	and	and	CCONJ
bam-10779	29	26	clinical	clinical	ADJ
bam-10779	29	27	variables	variable	NOUN
bam-10779	29	28	of	of	ADP
bam-10779	29	29	patients	patient	NOUN
bam-10779	29	30	in	in	ADP
bam-10779	29	31	two	two	NUM
bam-10779	29	32	study	study	NOUN
bam-10779	29	33	groups	group	NOUN
bam-10779	29	34	.	.	PUNCT
bam-10779	30	1	after	after	ADP
bam-10779	30	2	approval	approval	NOUN
bam-10779	30	3	of	of	ADP
bam-10779	30	4	the	the	DET
bam-10779	30	5	plan	plan	NOUN
bam-10779	30	6	by	by	ADP
bam-10779	30	7	the	the	DET
bam-10779	30	8	research	research	NOUN
bam-10779	30	9	council	council	NOUN
bam-10779	30	10	of	of	ADP
bam-10779	30	11	the	the	DET
bam-10779	30	12	besat	besat	PROPN
bam-10779	30	13	hospital	hospital	NOUN
bam-10779	30	14	and	and	CCONJ
bam-10779	30	15	sanandaj	sanandaj	NOUN
bam-10779	30	16	hospital	hospital	NOUN
bam-10779	30	17	and	and	CCONJ
bam-10779	30	18	the	the	DET
bam-10779	30	19	ethics	ethic	NOUN
bam-10779	30	20	committee	committee	PROPN
bam-10779	30	21	of	of	ADP
bam-10779	30	22	sanandaj	sanandaj	PROPN
bam-10779	30	23	university	university	PROPN
bam-10779	30	24	,	,	PUNCT
bam-10779	30	25	a	a	DET
bam-10779	30	26	total	total	NOUN
bam-10779	30	27	of	of	ADP
bam-10779	30	28	20	20	NUM
bam-10779	30	29	patients	patient	NOUN
bam-10779	30	30	who	who	PRON
bam-10779	30	31	met	meet	VERB
bam-10779	30	32	the	the	DET
bam-10779	30	33	inclusion	inclusion	NOUN
bam-10779	30	34	criteria	criterion	NOUN
bam-10779	30	35	were	be	AUX
bam-10779	30	36	included	include	VERB
bam-10779	30	37	in	in	ADP
bam-10779	30	38	the	the	DET
bam-10779	30	39	study	study	NOUN
bam-10779	30	40	.	.	PUNCT
bam-10779	31	1	records	record	NOUN
bam-10779	31	2	and	and	CCONJ
bam-10779	31	3	pathology	pathology	NOUN
bam-10779	31	4	reports	report	NOUN
bam-10779	31	5	of	of	ADP
bam-10779	31	6	all	all	DET
bam-10779	31	7	patients	patient	NOUN
bam-10779	31	8	with	with	ADP
bam-10779	31	9	bot	bot	NOUN
bam-10779	31	10	were	be	AUX
bam-10779	31	11	investigated	investigate	VERB
bam-10779	31	12	and	and	CCONJ
bam-10779	31	13	a	a	DET
bam-10779	31	14	researcher	researcher	NOUN
bam-10779	31	15	-	-	PUNCT
bam-10779	31	16	made	make	VERB
bam-10779	31	17	questionnaire	questionnaire	NOUN
bam-10779	31	18	was	be	AUX
bam-10779	31	19	completed	complete	VERB
bam-10779	31	20	for	for	ADP
bam-10779	31	21	each	each	DET
bam-10779	31	22	patient	patient	NOUN
bam-10779	31	23	,	,	PUNCT
bam-10779	31	24	which	which	PRON
bam-10779	31	25	included	include	VERB
bam-10779	31	26	the	the	DET
bam-10779	31	27	variables	variable	NOUN
bam-10779	31	28	of	of	ADP
bam-10779	31	29	age	age	NOUN
bam-10779	31	30	,	,	PUNCT
bam-10779	31	31	age	age	NOUN
bam-10779	31	32	at	at	ADP
bam-10779	31	33	the	the	DET
bam-10779	31	34	time	time	NOUN
bam-10779	31	35	of	of	ADP
bam-10779	31	36	diagnosis	diagnosis	NOUN
bam-10779	31	37	,	,	PUNCT
bam-10779	31	38	history	history	NOUN
bam-10779	31	39	of	of	ADP
bam-10779	31	40	infertility	infertility	NOUN
bam-10779	31	41	,	,	PUNCT
bam-10779	31	42	number	number	NOUN
bam-10779	31	43	of	of	ADP
bam-10779	31	44	deliveries	delivery	NOUN
bam-10779	31	45	,	,	PUNCT
bam-10779	31	46	history	history	NOUN
bam-10779	31	47	of	of	ADP
bam-10779	31	48	contraceptive	contraceptive	ADJ
bam-10779	31	49	use	use	NOUN
bam-10779	31	50	,	,	PUNCT
bam-10779	31	51	duration	duration	NOUN
bam-10779	31	52	of	of	ADP
bam-10779	31	53	pregnancy	pregnancy	NOUN
bam-10779	31	54	(	(	PUNCT
bam-10779	31	55	weeks	week	NOUN
bam-10779	31	56	)	)	PUNCT
bam-10779	31	57	,	,	PUNCT
bam-10779	31	58	body	body	NOUN
bam-10779	31	59	mass	mass	NOUN
bam-10779	31	60	index	index	NOUN
bam-10779	31	61	(	(	PUNCT
bam-10779	31	62	bmi	bmi	PROPN
bam-10779	31	63	)	)	PUNCT
bam-10779	31	64	,	,	PUNCT
bam-10779	31	65	type	type	NOUN
bam-10779	31	66	of	of	ADP
bam-10779	31	67	pathology	pathology	NOUN
bam-10779	31	68	,	,	PUNCT
bam-10779	31	69	table	table	NOUN
bam-10779	31	70	2	2	NUM
bam-10779	31	71	.	.	PUNCT
bam-10779	31	72	frequency	frequency	NOUN
bam-10779	31	73	of	of	ADP
bam-10779	31	74	surgical	surgical	ADJ
bam-10779	31	75	methods	method	NOUN
bam-10779	31	76	used	use	VERB
bam-10779	31	77	based	base	VERB
bam-10779	31	78	on	on	ADP
bam-10779	31	79	the	the	DET
bam-10779	31	80	pathological	pathological	ADJ
bam-10779	31	81	types	type	NOUN
bam-10779	31	82	of	of	ADP
bam-10779	31	83	borderline	borderline	NOUN
bam-10779	31	84	ovarian	ovarian	ADJ
bam-10779	31	85	tumors	tumor	NOUN
bam-10779	31	86	..	..	PUNCT
bam-10779	31	87	type	type	NOUN
bam-10779	31	88	of	of	ADP
bam-10779	31	89	surgery	surgery	NOUN
bam-10779	31	90	types	type	NOUN
bam-10779	31	91	of	of	ADP
bam-10779	31	92	tumors	tumor	NOUN
bam-10779	32	1	so	so	ADV
bam-10779	32	2	cystectomy	cystectomy	VERB
bam-10779	32	3	tah+bso	tah+bso	PRON
bam-10779	32	4	serous	serous	ADJ
bam-10779	32	5	borderline	borderline	NOUN
bam-10779	32	6	tumor	tumor	NOUN
bam-10779	32	7	(	(	PUNCT
bam-10779	32	8	n=15	n=15	SYM
bam-10779	32	9	)	)	PUNCT
bam-10779	32	10	4	4	NUM
bam-10779	32	11	(	(	PUNCT
bam-10779	32	12	6/26	6/26	NUM
bam-10779	32	13	)	)	PUNCT
bam-10779	32	14	7	7	NUM
bam-10779	32	15	(	(	PUNCT
bam-10779	32	16	8/46	8/46	NUM
bam-10779	32	17	)	)	PUNCT
bam-10779	32	18	4	4	NUM
bam-10779	32	19	(	(	PUNCT
bam-10779	32	20	6/26	6/26	NUM
bam-10779	32	21	)	)	PUNCT
bam-10779	32	22	mucinous	mucinous	ADJ
bam-10779	32	23	tumor	tumor	NOUN
bam-10779	32	24	(	(	PUNCT
bam-10779	32	25	n=4	n=4	NOUN
bam-10779	32	26	)	)	PUNCT
bam-10779	32	27	1(25	1(25	NUM
bam-10779	32	28	)	)	PUNCT
bam-10779	32	29	3(75	3(75	NUM
bam-10779	32	30	)	)	PUNCT
bam-10779	32	31	0(0	0(0	NUM
bam-10779	32	32	)	)	PUNCT
bam-10779	32	33	endometrioid	endometrioid	VERB
bam-10779	32	34	borderline	borderline	NOUN
bam-10779	32	35	tumor	tumor	NOUN
bam-10779	32	36	(	(	PUNCT
bam-10779	32	37	n=1	n=1	PROPN
bam-10779	32	38	)	)	PUNCT
bam-10779	32	39	1(25	1(25	NUM
bam-10779	32	40	)	)	PUNCT
bam-10779	32	41	0(0	0(0	NUM
bam-10779	32	42	)	)	PUNCT
bam-10779	32	43	0(0	0(0	NUM
bam-10779	32	44	)	)	PUNCT
bam-10779	32	45	total	total	NOUN
bam-10779	32	46	(	(	PUNCT
bam-10779	32	47	n=20	n=20	NOUN
bam-10779	32	48	)	)	PUNCT
bam-10779	32	49	6(30	6(30	NOUN
bam-10779	32	50	)	)	PUNCT
bam-10779	32	51	10(50	10(50	NUM
bam-10779	32	52	)	)	PUNCT
bam-10779	32	53	4(20	4(20	NUM
bam-10779	32	54	)	)	PUNCT
bam-10779	32	55	table	table	NOUN
bam-10779	33	1	1	1	NUM
bam-10779	33	2	.	.	PUNCT
bam-10779	33	3	frequency	frequency	NOUN
bam-10779	33	4	distribution	distribution	NOUN
bam-10779	33	5	of	of	ADP
bam-10779	33	6	history	history	NOUN
bam-10779	33	7	of	of	ADP
bam-10779	33	8	infertility	infertility	NOUN
bam-10779	33	9	,	,	PUNCT
bam-10779	33	10	number	number	NOUN
bam-10779	33	11	of	of	ADP
bam-10779	33	12	deliveries	delivery	NOUN
bam-10779	33	13	,	,	PUNCT
bam-10779	33	14	and	and	CCONJ
bam-10779	33	15	history	history	NOUN
bam-10779	33	16	of	of	ADP
bam-10779	33	17	contraceptive	contraceptive	ADJ
bam-10779	33	18	use	use	NOUN
bam-10779	33	19	.	.	PUNCT
bam-10779	34	1	variable	variable	ADJ
bam-10779	34	2	variable	variable	ADJ
bam-10779	34	3	levels	level	NOUN
bam-10779	34	4	frequency	frequency	NOUN
bam-10779	34	5	(	(	PUNCT
bam-10779	34	6	percentage	percentage	NOUN
bam-10779	34	7	)	)	PUNCT
bam-10779	34	8	history	history	NOUN
bam-10779	34	9	of	of	ADP
bam-10779	34	10	infertility	infertility	NOUN
bam-10779	34	11	no	no	DET
bam-10779	34	12	18(90	18(90	NUM
bam-10779	34	13	)	)	PUNCT
bam-10779	34	14	yes	yes	NOUN
bam-10779	34	15	2(10	2(10	NOUN
bam-10779	34	16	)	)	PUNCT
bam-10779	34	17	number	number	NOUN
bam-10779	34	18	of	of	ADP
bam-10779	34	19	deliveries	delivery	NOUN
bam-10779	34	20	0	0	NUM
bam-10779	34	21	4(20	4(20	NUM
bam-10779	34	22	)	)	PUNCT
bam-10779	34	23	1	1	NUM
bam-10779	34	24	4(20	4(20	NUM
bam-10779	34	25	)	)	PUNCT
bam-10779	35	1	≥2	≥2	PROPN
bam-10779	35	2	12(60	12(60	NUM
bam-10779	35	3	)	)	PUNCT
bam-10779	35	4	history	history	NOUN
bam-10779	35	5	of	of	ADP
bam-10779	35	6	contraceptive	contraceptive	ADJ
bam-10779	35	7	use	use	NOUN
bam-10779	35	8	no	no	DET
bam-10779	35	9	16(80	16(80	NUM
bam-10779	35	10	)	)	PUNCT
bam-10779	35	11	yes	yes	INTJ
bam-10779	35	12	4(20	4(20	NUM
bam-10779	35	13	)	)	PUNCT
bam-10779	35	14	type	type	NOUN
bam-10779	35	15	of	of	ADP
bam-10779	35	16	tumor	tumor	NOUN
bam-10779	35	17	serous	serous	ADJ
bam-10779	35	18	borderline	borderline	NOUN
bam-10779	35	19	tumor	tumor	NOUN
bam-10779	35	20	15(75	15(75	NUM
bam-10779	35	21	)	)	PUNCT
bam-10779	35	22	mucinous	mucinous	ADJ
bam-10779	35	23	tumor	tumor	NOUN
bam-10779	35	24	4(20	4(20	NUM
bam-10779	35	25	)	)	PUNCT
bam-10779	35	26	endometrioid	endometrioid	VERB
bam-10779	35	27	borderline	borderline	NOUN
bam-10779	35	28	tumor	tumor	NOUN
bam-10779	35	29	1(5	1(5	NUM
bam-10779	35	30	)	)	PUNCT
bam-10779	35	31	non	non	PART
bam-10779	36	1	-co	-co	PROPN
bam-10779	36	2	mmerc	mmerc	PROPN
bam-10779	36	3	ial	ial	PROPN
bam-10779	36	4	us	us	PROPN
bam-10779	36	5	e	e	NOUN
bam-10779	36	6	o	o	NOUN
bam-10779	36	7	nly	nly	ADV
bam-10779	36	8	recurrence	recurrence	NOUN
bam-10779	36	9	and	and	CCONJ
bam-10779	36	10	5	5	NUM
bam-10779	36	11	-	-	PUNCT
bam-10779	36	12	year	year	NOUN
bam-10779	36	13	survival	survival	NOUN
bam-10779	36	14	of	of	ADP
bam-10779	36	15	borderline	borderline	NOUN
bam-10779	36	16	ovarian	ovarian	ADJ
bam-10779	36	17	tumor	tumor	NOUN
bam-10779	36	18	eur	eur	PROPN
bam-10779	36	19	j	j	PROPN
bam-10779	36	20	transl	transl	PROPN
bam-10779	36	21	myol	myol	ADV
bam-10779	36	22	33	33	NUM
bam-10779	36	23	(	(	PUNCT
bam-10779	36	24	1	1	NUM
bam-10779	36	25	)	)	PUNCT
bam-10779	36	26	10779	10779	NUM
bam-10779	36	27	,	,	PUNCT
bam-10779	36	28	2023	2023	NUM
bam-10779	36	29	doi	doi	NOUN
bam-10779	36	30	:	:	PUNCT
bam-10779	36	31	10.4081	10.4081	NUM
bam-10779	36	32	/	/	SYM
bam-10779	36	33	ejtm.2023.10779	ejtm.2023.10779	PROPN
bam-10779	36	34	3	3	NUM
bam-10779	36	35	type	type	NOUN
bam-10779	36	36	of	of	ADP
bam-10779	36	37	surgery	surgery	NOUN
bam-10779	36	38	,	,	PUNCT
bam-10779	36	39	recurrence	recurrence	NOUN
bam-10779	36	40	treatment	treatment	NOUN
bam-10779	36	41	,	,	PUNCT
bam-10779	36	42	disease	disease	NOUN
bam-10779	36	43	stage	stage	NOUN
bam-10779	36	44	,	,	PUNCT
bam-10779	36	45	mean	mean	VERB
bam-10779	36	46	time	time	NOUN
bam-10779	36	47	of	of	ADP
bam-10779	36	48	recurrence	recurrence	NOUN
bam-10779	36	49	,	,	PUNCT
bam-10779	36	50	site	site	NOUN
bam-10779	36	51	of	of	ADP
bam-10779	36	52	recurrence	recurrence	NOUN
bam-10779	36	53	,	,	PUNCT
bam-10779	36	54	5	5	NUM
bam-10779	36	55	-	-	PUNCT
bam-10779	36	56	year	year	NOUN
bam-10779	36	57	survival	survival	NOUN
bam-10779	36	58	,	,	PUNCT
bam-10779	36	59	recurrence	recurrence	NOUN
bam-10779	36	60	,	,	PUNCT
bam-10779	36	61	and	and	CCONJ
bam-10779	36	62	outcomes	outcome	NOUN
bam-10779	36	63	(	(	PUNCT
bam-10779	36	64	death	death	NOUN
bam-10779	36	65	)	)	PUNCT
bam-10779	36	66	.	.	PUNCT
bam-10779	37	1	data	datum	NOUN
bam-10779	37	2	were	be	AUX
bam-10779	37	3	first	first	ADV
bam-10779	37	4	summarized	summarize	VERB
bam-10779	37	5	using	use	VERB
bam-10779	37	6	descriptive	descriptive	ADJ
bam-10779	37	7	indicators	indicator	NOUN
bam-10779	37	8	such	such	ADJ
bam-10779	37	9	as	as	ADP
bam-10779	37	10	mean	mean	ADJ
bam-10779	37	11	,	,	PUNCT
bam-10779	37	12	standard	standard	ADJ
bam-10779	37	13	deviation	deviation	NOUN
bam-10779	37	14	,	,	PUNCT
bam-10779	37	15	and	and	CCONJ
bam-10779	37	16	frequency	frequency	NOUN
bam-10779	37	17	.	.	PUNCT
bam-10779	38	1	data	datum	NOUN
bam-10779	38	2	were	be	AUX
bam-10779	38	3	statistically	statistically	ADV
bam-10779	38	4	analyzed	analyze	VERB
bam-10779	38	5	by	by	ADP
bam-10779	38	6	stata	stata	NOUN
bam-10779	38	7	software	software	PROPN
bam-10779	38	8	version	version	PROPN
bam-10779	38	9	14	14	NUM
bam-10779	38	10	.	.	PUNCT
bam-10779	39	1	relationships	relationship	NOUN
bam-10779	39	2	between	between	ADP
bam-10779	39	3	variables	variable	NOUN
bam-10779	39	4	were	be	AUX
bam-10779	39	5	analyzed	analyze	VERB
bam-10779	39	6	using	use	VERB
bam-10779	39	7	fisher	fisher	PROPN
bam-10779	39	8	's	's	PART
bam-10779	39	9	exact	exact	ADJ
bam-10779	39	10	test	test	NOUN
bam-10779	39	11	,	,	PUNCT
bam-10779	39	12	independent	independent	ADJ
bam-10779	39	13	t	t	NOUN
bam-10779	39	14	-	-	PUNCT
bam-10779	39	15	test	test	NOUN
bam-10779	39	16	,	,	PUNCT
bam-10779	39	17	and	and	CCONJ
bam-10779	39	18	mannwhitney	mannwhitney	NOUN
bam-10779	39	19	u	u	PROPN
bam-10779	39	20	test	test	NOUN
bam-10779	39	21	,	,	PUNCT
bam-10779	39	22	depending	depend	VERB
bam-10779	39	23	on	on	ADP
bam-10779	39	24	the	the	DET
bam-10779	39	25	type	type	NOUN
bam-10779	39	26	of	of	ADP
bam-10779	39	27	variable	variable	NOUN
bam-10779	39	28	.	.	PUNCT
bam-10779	40	1	also	also	ADV
bam-10779	40	2	,	,	PUNCT
bam-10779	40	3	fisher	fisher	PROPN
bam-10779	40	4	's	's	PART
bam-10779	40	5	exact	exact	ADJ
bam-10779	40	6	test	test	NOUN
bam-10779	40	7	was	be	AUX
bam-10779	40	8	used	use	VERB
bam-10779	40	9	to	to	PART
bam-10779	40	10	investigate	investigate	VERB
bam-10779	40	11	the	the	DET
bam-10779	40	12	differences	difference	NOUN
bam-10779	40	13	in	in	ADP
bam-10779	40	14	the	the	DET
bam-10779	40	15	frequency	frequency	NOUN
bam-10779	40	16	of	of	ADP
bam-10779	40	17	qualitative	qualitative	ADJ
bam-10779	40	18	variables	variable	NOUN
bam-10779	40	19	in	in	ADP
bam-10779	40	20	the	the	DET
bam-10779	40	21	group	group	NOUN
bam-10779	40	22	of	of	ADP
bam-10779	40	23	patients	patient	NOUN
bam-10779	40	24	with	with	ADP
bam-10779	40	25	and	and	CCONJ
bam-10779	40	26	without	without	ADP
bam-10779	40	27	recurrence	recurrence	NOUN
bam-10779	40	28	.	.	PUNCT
bam-10779	41	1	kaplan	kaplan	PROPN
bam-10779	41	2	-	-	PUNCT
bam-10779	41	3	meyer	meyer	PROPN
bam-10779	41	4	method	method	NOUN
bam-10779	41	5	was	be	AUX
bam-10779	41	6	used	use	VERB
bam-10779	41	7	to	to	PART
bam-10779	41	8	calculate	calculate	VERB
bam-10779	41	9	the	the	DET
bam-10779	41	10	survival	survival	NOUN
bam-10779	41	11	ratio	ratio	NOUN
bam-10779	41	12	at	at	ADP
bam-10779	41	13	any	any	DET
bam-10779	41	14	point	point	NOUN
bam-10779	41	15	in	in	ADP
bam-10779	41	16	time	time	NOUN
bam-10779	41	17	when	when	SCONJ
bam-10779	41	18	mortality	mortality	NOUN
bam-10779	41	19	was	be	AUX
bam-10779	41	20	observed	observe	VERB
bam-10779	41	21	.	.	PUNCT
bam-10779	42	1	results	result	VERB
bam-10779	42	2	twenty	twenty	NUM
bam-10779	42	3	patients	patient	NOUN
bam-10779	42	4	with	with	ADP
bam-10779	42	5	a	a	DET
bam-10779	42	6	mean	mean	ADJ
bam-10779	42	7	age	age	NOUN
bam-10779	42	8	of	of	ADP
bam-10779	42	9	44.9	44.9	NUM
bam-10779	42	10	years	year	NOUN
bam-10779	42	11	and	and	CCONJ
bam-10779	42	12	a	a	DET
bam-10779	42	13	standard	standard	ADJ
bam-10779	42	14	deviation	deviation	NOUN
bam-10779	42	15	of	of	ADP
bam-10779	42	16	15.6	15.6	NUM
bam-10779	42	17	were	be	AUX
bam-10779	42	18	studied	study	VERB
bam-10779	42	19	.	.	PUNCT
bam-10779	43	1	the	the	DET
bam-10779	43	2	mean	mean	ADJ
bam-10779	43	3	follow	follow	VERB
bam-10779	43	4	-	-	PUNCT
bam-10779	43	5	up	up	ADP
bam-10779	43	6	duration	duration	NOUN
bam-10779	43	7	was	be	AUX
bam-10779	43	8	60.6	60.6	NUM
bam-10779	43	9	months	month	NOUN
bam-10779	43	10	(	(	PUNCT
bam-10779	43	11	minimum	minimum	NOUN
bam-10779	43	12	22	22	NUM
bam-10779	43	13	and	and	CCONJ
bam-10779	43	14	maximum	maximum	ADJ
bam-10779	43	15	158	158	NUM
bam-10779	43	16	months	month	NOUN
bam-10779	43	17	)	)	PUNCT
bam-10779	43	18	.	.	PUNCT
bam-10779	44	1	90	90	NUM
bam-10779	44	2	%	%	NOUN
bam-10779	44	3	of	of	ADP
bam-10779	44	4	women	woman	NOUN
bam-10779	44	5	surveyed	survey	VERB
bam-10779	44	6	had	have	VERB
bam-10779	44	7	no	no	DET
bam-10779	44	8	history	history	NOUN
bam-10779	44	9	of	of	ADP
bam-10779	44	10	infertility	infertility	NOUN
bam-10779	44	11	,	,	PUNCT
bam-10779	44	12	and	and	CCONJ
bam-10779	44	13	20	20	NUM
bam-10779	44	14	%	%	NOUN
bam-10779	44	15	of	of	ADP
bam-10779	44	16	them	they	PRON
bam-10779	44	17	had	have	VERB
bam-10779	44	18	no	no	DET
bam-10779	44	19	history	history	NOUN
bam-10779	44	20	of	of	ADP
bam-10779	44	21	delivery	delivery	NOUN
bam-10779	44	22	.	.	PUNCT
bam-10779	45	1	the	the	DET
bam-10779	45	2	most	most	ADV
bam-10779	45	3	common	common	ADJ
bam-10779	45	4	type	type	NOUN
bam-10779	45	5	of	of	ADP
bam-10779	45	6	borderline	borderline	NOUN
bam-10779	45	7	ovarian	ovarian	ADJ
bam-10779	45	8	tumor	tumor	NOUN
bam-10779	45	9	was	be	AUX
bam-10779	45	10	serous	serous	ADJ
bam-10779	45	11	borderline	borderline	NOUN
bam-10779	45	12	tumor	tumor	NOUN
bam-10779	45	13	,	,	PUNCT
bam-10779	45	14	which	which	PRON
bam-10779	45	15	was	be	AUX
bam-10779	45	16	observed	observe	VERB
bam-10779	45	17	in	in	ADP
bam-10779	45	18	15	15	NUM
bam-10779	45	19	patients	patient	NOUN
bam-10779	45	20	(	(	PUNCT
bam-10779	45	21	75	75	NUM
bam-10779	45	22	%	%	NOUN
bam-10779	45	23	)	)	PUNCT
bam-10779	45	24	.	.	PUNCT
bam-10779	46	1	(	(	PUNCT
bam-10779	46	2	table	table	NOUN
bam-10779	46	3	1	1	NUM
bam-10779	46	4	)	)	PUNCT
bam-10779	46	5	.	.	PUNCT
bam-10779	47	1	treatments	treatment	NOUN
bam-10779	47	2	for	for	ADP
bam-10779	47	3	each	each	DET
bam-10779	47	4	pathogenic	pathogenic	ADJ
bam-10779	47	5	type	type	NOUN
bam-10779	47	6	of	of	ADP
bam-10779	47	7	borderline	borderline	NOUN
bam-10779	47	8	ovarian	ovarian	ADJ
bam-10779	47	9	tumor	tumor	NOUN
bam-10779	47	10	are	be	AUX
bam-10779	47	11	listed	list	VERB
bam-10779	47	12	in	in	ADP
bam-10779	47	13	table	table	NOUN
bam-10779	47	14	2	2	NUM
bam-10779	47	15	.	.	PUNCT
bam-10779	48	1	in	in	ADP
bam-10779	48	2	50	50	NUM
bam-10779	48	3	%	%	NOUN
bam-10779	48	4	of	of	ADP
bam-10779	48	5	cases	case	NOUN
bam-10779	48	6	cystectomy	cystectomy	NOUN
bam-10779	48	7	,	,	PUNCT
bam-10779	48	8	in	in	ADP
bam-10779	48	9	30	30	NUM
bam-10779	48	10	%	%	NOUN
bam-10779	48	11	so	so	ADV
bam-10779	48	12	,	,	PUNCT
bam-10779	48	13	and	and	CCONJ
bam-10779	48	14	in	in	ADP
bam-10779	48	15	20	20	NUM
bam-10779	48	16	%	%	NOUN
bam-10779	48	17	tah	tah	PROPN
bam-10779	48	18	+	+	CCONJ
bam-10779	48	19	bso	bso	PROPN
bam-10779	48	20	treatments	treatment	NOUN
bam-10779	48	21	were	be	AUX
bam-10779	48	22	used	use	VERB
bam-10779	48	23	.	.	PUNCT
bam-10779	49	1	in	in	ADP
bam-10779	49	2	three	three	NUM
bam-10779	49	3	cases	case	NOUN
bam-10779	49	4	(	(	PUNCT
bam-10779	49	5	15	15	NUM
bam-10779	49	6	%	%	NOUN
bam-10779	49	7	)	)	PUNCT
bam-10779	49	8	recurrence	recurrence	NOUN
bam-10779	49	9	was	be	AUX
bam-10779	49	10	observed	observe	VERB
bam-10779	49	11	.	.	PUNCT
bam-10779	50	1	the	the	DET
bam-10779	50	2	recurrence	recurrence	NOUN
bam-10779	50	3	site	site	NOUN
bam-10779	50	4	was	be	AUX
bam-10779	50	5	in	in	ADP
bam-10779	50	6	the	the	DET
bam-10779	50	7	pelvis	pelvis	NOUN
bam-10779	50	8	.	.	PUNCT
bam-10779	51	1	the	the	DET
bam-10779	51	2	mean	mean	ADJ
bam-10779	51	3	recurrence	recurrence	NOUN
bam-10779	51	4	time	time	NOUN
bam-10779	51	5	in	in	ADP
bam-10779	51	6	the	the	DET
bam-10779	51	7	present	present	ADJ
bam-10779	51	8	study	study	NOUN
bam-10779	51	9	was	be	AUX
bam-10779	51	10	about	about	ADV
bam-10779	51	11	65.6	65.6	NUM
bam-10779	51	12	months	month	NOUN
bam-10779	51	13	.	.	PUNCT
bam-10779	52	1	details	detail	NOUN
bam-10779	52	2	of	of	ADP
bam-10779	52	3	recurrences	recurrence	NOUN
bam-10779	52	4	can	can	AUX
bam-10779	52	5	be	be	AUX
bam-10779	52	6	seen	see	VERB
bam-10779	52	7	in	in	ADP
bam-10779	52	8	table	table	NOUN
bam-10779	52	9	3	3	NUM
bam-10779	52	10	.	.	PUNCT
bam-10779	53	1	according	accord	VERB
bam-10779	53	2	to	to	ADP
bam-10779	53	3	table	table	NOUN
bam-10779	53	4	4	4	NUM
bam-10779	53	5	,	,	PUNCT
bam-10779	53	6	2	2	NUM
bam-10779	53	7	cases	case	NOUN
bam-10779	53	8	of	of	ADP
bam-10779	53	9	tumor	tumor	NOUN
bam-10779	53	10	recurrence	recurrence	NOUN
bam-10779	53	11	were	be	AUX
bam-10779	53	12	related	relate	VERB
bam-10779	53	13	to	to	ADP
bam-10779	53	14	patients	patient	NOUN
bam-10779	53	15	treated	treat	VERB
bam-10779	53	16	with	with	ADP
bam-10779	53	17	cystectomy	cystectomy	NOUN
bam-10779	53	18	and	and	CCONJ
bam-10779	53	19	the	the	DET
bam-10779	53	20	other	other	ADJ
bam-10779	53	21	case	case	NOUN
bam-10779	53	22	underwent	undergo	VERB
bam-10779	53	23	tah	tah	PROPN
bam-10779	53	24	+	+	CCONJ
bam-10779	53	25	bso	bso	PROPN
bam-10779	53	26	operation	operation	NOUN
bam-10779	53	27	.	.	PUNCT
bam-10779	54	1	although	although	SCONJ
bam-10779	54	2	no	no	DET
bam-10779	54	3	recurrence	recurrence	NOUN
bam-10779	54	4	was	be	AUX
bam-10779	54	5	seen	see	VERB
bam-10779	54	6	in	in	ADP
bam-10779	54	7	patients	patient	NOUN
bam-10779	54	8	treated	treat	VERB
bam-10779	54	9	with	with	ADP
bam-10779	54	10	the	the	DET
bam-10779	54	11	so	so	ADJ
bam-10779	54	12	method	method	NOUN
bam-10779	54	13	,	,	PUNCT
bam-10779	54	14	no	no	DET
bam-10779	54	15	statistically	statistically	ADV
bam-10779	54	16	significant	significant	ADJ
bam-10779	54	17	difference	difference	NOUN
bam-10779	54	18	was	be	AUX
bam-10779	54	19	observed	observe	VERB
bam-10779	54	20	between	between	ADP
bam-10779	54	21	different	different	ADJ
bam-10779	54	22	treatment	treatment	NOUN
bam-10779	54	23	methods	method	NOUN
bam-10779	54	24	in	in	ADP
bam-10779	54	25	terms	term	NOUN
bam-10779	54	26	of	of	ADP
bam-10779	54	27	the	the	DET
bam-10779	54	28	frequency	frequency	NOUN
bam-10779	54	29	of	of	ADP
bam-10779	54	30	recurrence	recurrence	NOUN
bam-10779	54	31	cases	case	NOUN
bam-10779	54	32	(	(	PUNCT
bam-10779	54	33	p	p	X
bam-10779	54	34	=	=	NOUN
bam-10779	54	35	0.64	0.64	NUM
bam-10779	54	36	)	)	PUNCT
bam-10779	54	37	..	..	PUNCT
bam-10779	54	38	two	two	NUM
bam-10779	54	39	of	of	ADP
bam-10779	54	40	the	the	DET
bam-10779	54	41	women	woman	NOUN
bam-10779	54	42	had	have	VERB
bam-10779	54	43	a	a	DET
bam-10779	54	44	history	history	NOUN
bam-10779	54	45	of	of	ADP
bam-10779	54	46	infertility	infertility	NOUN
bam-10779	54	47	,	,	PUNCT
bam-10779	54	48	one	one	NUM
bam-10779	54	49	of	of	ADP
bam-10779	54	50	table	table	NOUN
bam-10779	54	51	3	3	NUM
bam-10779	54	52	.	.	PUNCT
bam-10779	55	1	characteristics	characteristic	NOUN
bam-10779	55	2	of	of	ADP
bam-10779	55	3	recurrences	recurrence	NOUN
bam-10779	55	4	of	of	ADP
bam-10779	55	5	borderline	borderline	NOUN
bam-10779	55	6	ovarian	ovarian	ADJ
bam-10779	55	7	tumors	tumor	NOUN
bam-10779	55	8	in	in	ADP
bam-10779	55	9	women	woman	NOUN
bam-10779	55	10	.	.	PUNCT
bam-10779	56	1	characteristics	characteristic	NOUN
bam-10779	56	2	of	of	ADP
bam-10779	56	3	patients	patient	NOUN
bam-10779	56	4	cases	case	NOUN
bam-10779	56	5	of	of	ADP
bam-10779	56	6	recurrence	recurrence	NOUN
bam-10779	56	7	first	first	ADJ
bam-10779	56	8	case	case	NOUN
bam-10779	56	9	second	second	ADJ
bam-10779	56	10	case	case	NOUN
bam-10779	56	11	third	third	ADJ
bam-10779	56	12	case	case	NOUN
bam-10779	56	13	age	age	NOUN
bam-10779	56	14	at	at	ADP
bam-10779	56	15	the	the	DET
bam-10779	56	16	time	time	NOUN
bam-10779	56	17	of	of	ADP
bam-10779	56	18	diagnosis	diagnosis	NOUN
bam-10779	56	19	(	(	PUNCT
bam-10779	56	20	years	year	NOUN
bam-10779	56	21	)	)	PUNCT
bam-10779	56	22	32	32	NUM
bam-10779	56	23	54	54	NUM
bam-10779	56	24	34	34	NUM
bam-10779	56	25	age	age	NOUN
bam-10779	56	26	at	at	ADP
bam-10779	56	27	recurrence	recurrence	NOUN
bam-10779	56	28	(	(	PUNCT
bam-10779	56	29	years	year	NOUN
bam-10779	56	30	)	)	PUNCT
bam-10779	56	31	42	42	NUM
bam-10779	56	32	61	61	NUM
bam-10779	56	33	36	36	NUM
bam-10779	56	34	the	the	DET
bam-10779	56	35	time	time	NOUN
bam-10779	56	36	between	between	ADP
bam-10779	56	37	diagnosis	diagnosis	NOUN
bam-10779	56	38	and	and	CCONJ
bam-10779	56	39	treatment	treatment	NOUN
bam-10779	56	40	until	until	ADP
bam-10779	56	41	recurrence	recurrence	NOUN
bam-10779	56	42	(	(	PUNCT
bam-10779	56	43	months	month	NOUN
bam-10779	56	44	)	)	PUNCT
bam-10779	56	45	136	136	NUM
bam-10779	56	46	25	25	NUM
bam-10779	56	47	36	36	NUM
bam-10779	56	48	site	site	NOUN
bam-10779	56	49	of	of	ADP
bam-10779	56	50	recurrence	recurrence	NOUN
bam-10779	56	51	pelvis	pelvi	VERB
bam-10779	56	52	pelvic	pelvic	ADJ
bam-10779	56	53	mass	mass	NOUN
bam-10779	56	54	pelvis	pelvi	VERB
bam-10779	56	55	type	type	NOUN
bam-10779	56	56	of	of	ADP
bam-10779	56	57	surgery	surgery	NOUN
bam-10779	56	58	used	use	VERB
bam-10779	56	59	cystectomy	cystectomy	NOUN
bam-10779	56	60	tah+bso	tah+bso	PROPN
bam-10779	56	61	cystectomy	cystectomy	NOUN
bam-10779	56	62	table	table	NOUN
bam-10779	56	63	4	4	NUM
bam-10779	56	64	.	.	X
bam-10779	56	65	relationship	relationship	NOUN
bam-10779	56	66	between	between	ADP
bam-10779	56	67	surgical	surgical	ADJ
bam-10779	56	68	procedure	procedure	NOUN
bam-10779	56	69	and	and	CCONJ
bam-10779	56	70	recurrence	recurrence	NOUN
bam-10779	56	71	of	of	ADP
bam-10779	56	72	borderline	borderline	NOUN
bam-10779	56	73	ovarian	ovarian	ADJ
bam-10779	56	74	tumors	tumor	NOUN
bam-10779	56	75	.	.	PUNCT
bam-10779	57	1	recurrence	recurrence	NOUN
bam-10779	57	2	*	*	PUNCT
bam-10779	57	3	p	p	NOUN
bam-10779	57	4	value	value	NOUN
bam-10779	57	5	type	type	NOUN
bam-10779	57	6	of	of	ADP
bam-10779	57	7	surgical	surgical	ADJ
bam-10779	57	8	procedure	procedure	NOUN
bam-10779	57	9	no	no	DET
bam-10779	57	10	n(%	n(%	NOUN
bam-10779	57	11	)	)	PUNCT
bam-10779	58	1	yes	yes	INTJ
bam-10779	58	2	n(%	n(%	PROPN
bam-10779	58	3	)	)	PUNCT
bam-10779	59	1	so	so	CCONJ
bam-10779	59	2	(	(	PUNCT
bam-10779	59	3	6(100	6(100	NUM
bam-10779	59	4	)	)	PUNCT
bam-10779	59	5	0	0	NUM
bam-10779	60	1	0.64	0.64	NUM
bam-10779	60	2	*	*	PUNCT
bam-10779	60	3	cystectomy	cystectomy	NOUN
bam-10779	60	4	8(80	8(80	NUM
bam-10779	60	5	)	)	PUNCT
bam-10779	60	6	2(25	2(25	NOUN
bam-10779	60	7	)	)	PUNCT
bam-10779	60	8	tah+bso	tah+bso	PROPN
bam-10779	60	9	3(75	3(75	NUM
bam-10779	60	10	)	)	PUNCT
bam-10779	60	11	1(25	1(25	NUM
bam-10779	60	12	)	)	PUNCT
bam-10779	60	13	*	*	PUNCT
bam-10779	61	1	fisher	fisher	PROPN
bam-10779	61	2	's	's	PART
bam-10779	61	3	exact	exact	ADJ
bam-10779	61	4	test	test	NOUN
bam-10779	61	5	non	non	ADJ
bam-10779	61	6	-co	-co	PROPN
bam-10779	61	7	mmerc	mmerc	PROPN
bam-10779	61	8	ial	ial	PROPN
bam-10779	61	9	us	us	PROPN
bam-10779	61	10	e	e	NOUN
bam-10779	61	11	o	o	NOUN
bam-10779	61	12	nly	nly	ADV
bam-10779	61	13	recurrence	recurrence	NOUN
bam-10779	61	14	and	and	CCONJ
bam-10779	61	15	5	5	NUM
bam-10779	61	16	-	-	PUNCT
bam-10779	61	17	year	year	NOUN
bam-10779	61	18	survival	survival	NOUN
bam-10779	61	19	of	of	ADP
bam-10779	61	20	borderline	borderline	NOUN
bam-10779	61	21	ovarian	ovarian	ADJ
bam-10779	61	22	tumor	tumor	NOUN
bam-10779	61	23	eur	eur	PROPN
bam-10779	61	24	j	j	PROPN
bam-10779	61	25	transl	transl	PROPN
bam-10779	61	26	myol	myol	ADV
bam-10779	61	27	33	33	NUM
bam-10779	61	28	(	(	PUNCT
bam-10779	61	29	1	1	NUM
bam-10779	61	30	)	)	PUNCT
bam-10779	61	31	10779	10779	NUM
bam-10779	61	32	,	,	PUNCT
bam-10779	61	33	2023	2023	NUM
bam-10779	61	34	doi	doi	NOUN
bam-10779	61	35	:	:	PUNCT
bam-10779	61	36	10.4081	10.4081	NUM
bam-10779	61	37	/	/	SYM
bam-10779	61	38	ejtm.2023.10779	ejtm.2023.10779	PROPN
bam-10779	61	39	4	4	NUM
bam-10779	61	40	whom	whom	PRON
bam-10779	61	41	(	(	PUNCT
bam-10779	61	42	50	50	NUM
bam-10779	61	43	%	%	NOUN
bam-10779	61	44	)	)	PUNCT
bam-10779	61	45	had	have	VERB
bam-10779	61	46	tumor	tumor	NOUN
bam-10779	61	47	recurrence	recurrence	NOUN
bam-10779	61	48	,	,	PUNCT
bam-10779	61	49	and	and	CCONJ
bam-10779	61	50	among	among	ADP
bam-10779	61	51	the	the	DET
bam-10779	61	52	other	other	ADJ
bam-10779	61	53	18	18	NUM
bam-10779	61	54	who	who	PRON
bam-10779	61	55	had	have	VERB
bam-10779	61	56	no	no	DET
bam-10779	61	57	history	history	NOUN
bam-10779	61	58	of	of	ADP
bam-10779	61	59	infertility	infertility	NOUN
bam-10779	61	60	,	,	PUNCT
bam-10779	61	61	one	one	NUM
bam-10779	61	62	(	(	PUNCT
bam-10779	61	63	1.11	1.11	NUM
bam-10779	61	64	%	%	NOUN
bam-10779	61	65	)	)	PUNCT
bam-10779	61	66	had	have	VERB
bam-10779	61	67	recurrence	recurrence	NOUN
bam-10779	61	68	(	(	PUNCT
bam-10779	61	69	p	p	X
bam-10779	61	70	=	=	NOUN
bam-10779	61	71	0.26	0.26	NUM
bam-10779	61	72	)	)	PUNCT
bam-10779	61	73	.	.	PUNCT
bam-10779	62	1	four	four	NUM
bam-10779	62	2	of	of	ADP
bam-10779	62	3	the	the	DET
bam-10779	62	4	women	woman	NOUN
bam-10779	62	5	in	in	ADP
bam-10779	62	6	the	the	DET
bam-10779	62	7	study	study	NOUN
bam-10779	62	8	had	have	VERB
bam-10779	62	9	a	a	DET
bam-10779	62	10	history	history	NOUN
bam-10779	62	11	of	of	ADP
bam-10779	62	12	taking	take	VERB
bam-10779	62	13	contraceptives	contraceptive	NOUN
bam-10779	62	14	,	,	PUNCT
bam-10779	62	15	but	but	CCONJ
bam-10779	62	16	none	none	NOUN
bam-10779	62	17	of	of	ADP
bam-10779	62	18	them	they	PRON
bam-10779	62	19	had	have	VERB
bam-10779	62	20	a	a	DET
bam-10779	62	21	recurrence	recurrence	NOUN
bam-10779	62	22	of	of	ADP
bam-10779	62	23	the	the	DET
bam-10779	62	24	tumor	tumor	NOUN
bam-10779	62	25	,	,	PUNCT
bam-10779	62	26	and	and	CCONJ
bam-10779	62	27	out	out	ADP
bam-10779	62	28	of	of	ADP
bam-10779	62	29	16	16	NUM
bam-10779	62	30	other	other	ADJ
bam-10779	62	31	people	people	NOUN
bam-10779	62	32	who	who	PRON
bam-10779	62	33	did	do	AUX
bam-10779	62	34	not	not	PART
bam-10779	62	35	have	have	VERB
bam-10779	62	36	a	a	DET
bam-10779	62	37	history	history	NOUN
bam-10779	62	38	of	of	ADP
bam-10779	62	39	using	use	VERB
bam-10779	62	40	contraceptives	contraceptive	NOUN
bam-10779	62	41	,	,	PUNCT
bam-10779	62	42	three	three	NUM
bam-10779	62	43	(	(	PUNCT
bam-10779	62	44	18.7	18.7	NUM
bam-10779	62	45	%	%	NOUN
bam-10779	62	46	)	)	PUNCT
bam-10779	62	47	had	have	VERB
bam-10779	62	48	a	a	DET
bam-10779	62	49	recurrence	recurrence	NOUN
bam-10779	62	50	(	(	PUNCT
bam-10779	62	51	p	p	X
bam-10779	62	52	=	=	NOUN
bam-10779	62	53	0.58	0.58	NUM
bam-10779	62	54	)	)	PUNCT
bam-10779	62	55	.	.	PUNCT
bam-10779	63	1	in	in	ADP
bam-10779	63	2	addition	addition	NOUN
bam-10779	63	3	,	,	PUNCT
bam-10779	63	4	the	the	DET
bam-10779	63	5	difference	difference	NOUN
bam-10779	63	6	between	between	ADP
bam-10779	63	7	the	the	DET
bam-10779	63	8	two	two	NUM
bam-10779	63	9	groups	group	NOUN
bam-10779	63	10	with	with	ADP
bam-10779	63	11	and	and	CCONJ
bam-10779	63	12	without	without	ADP
bam-10779	63	13	recurrence	recurrence	NOUN
bam-10779	63	14	in	in	ADP
bam-10779	63	15	terms	term	NOUN
bam-10779	63	16	of	of	ADP
bam-10779	63	17	mean	mean	ADJ
bam-10779	63	18	age	age	NOUN
bam-10779	63	19	,	,	PUNCT
bam-10779	63	20	age	age	NOUN
bam-10779	63	21	at	at	ADP
bam-10779	63	22	diagnosis	diagnosis	NOUN
bam-10779	63	23	,	,	PUNCT
bam-10779	63	24	and	and	CCONJ
bam-10779	63	25	bmi	bmi	NOUN
bam-10779	63	26	was	be	AUX
bam-10779	63	27	not	not	PART
bam-10779	63	28	statistically	statistically	ADV
bam-10779	63	29	significant	significant	ADJ
bam-10779	63	30	(	(	PUNCT
bam-10779	63	31	p	p	X
bam-10779	63	32	>	>	X
bam-10779	63	33	0.05	0.05	NUM
bam-10779	63	34	)	)	PUNCT
bam-10779	63	35	(	(	PUNCT
bam-10779	63	36	table	table	NOUN
bam-10779	63	37	5	5	NUM
bam-10779	63	38	)	)	PUNCT
bam-10779	63	39	.	.	PUNCT
bam-10779	64	1	the	the	DET
bam-10779	64	2	kaplan	kaplan	PROPN
bam-10779	64	3	-	-	PUNCT
bam-10779	64	4	meier	meier	PROPN
bam-10779	64	5	curves	curve	NOUN
bam-10779	64	6	are	be	AUX
bam-10779	64	7	based	base	VERB
bam-10779	64	8	on	on	ADP
bam-10779	64	9	survival	survival	NOUN
bam-10779	64	10	probability	probability	NOUN
bam-10779	64	11	scores	score	NOUN
bam-10779	64	12	(	(	PUNCT
bam-10779	64	13	figure	figure	NOUN
bam-10779	64	14	1	1	NUM
bam-10779	64	15	)	)	PUNCT
bam-10779	64	16	.	.	PUNCT
bam-10779	65	1	the	the	DET
bam-10779	65	2	overall	overall	ADJ
bam-10779	65	3	survival	survival	NOUN
bam-10779	65	4	rate	rate	NOUN
bam-10779	65	5	was	be	AUX
bam-10779	65	6	100	100	NUM
bam-10779	65	7	%	%	NOUN
bam-10779	65	8	and	and	CCONJ
bam-10779	65	9	none	none	NOUN
bam-10779	65	10	of	of	ADP
bam-10779	65	11	the	the	DET
bam-10779	65	12	patients	patient	NOUN
bam-10779	65	13	died	die	VERB
bam-10779	65	14	at	at	ADP
bam-10779	65	15	the	the	DET
bam-10779	65	16	end	end	NOUN
bam-10779	65	17	of	of	ADP
bam-10779	65	18	follow	follow	NOUN
bam-10779	65	19	-	-	PUNCT
bam-10779	65	20	up	up	NOUN
bam-10779	65	21	.	.	PUNCT
bam-10779	66	1	discussion	discussion	NOUN
bam-10779	66	2	ovarian	ovarian	ADJ
bam-10779	66	3	cancer	cancer	NOUN
bam-10779	66	4	is	be	AUX
bam-10779	66	5	the	the	DET
bam-10779	66	6	second	second	ADJ
bam-10779	66	7	most	most	ADV
bam-10779	66	8	common	common	ADJ
bam-10779	66	9	malignancy	malignancy	NOUN
bam-10779	66	10	in	in	ADP
bam-10779	66	11	women	woman	NOUN
bam-10779	66	12	worldwide	worldwide	ADV
bam-10779	66	13	and	and	CCONJ
bam-10779	66	14	induces	induce	VERB
bam-10779	66	15	many	many	ADJ
bam-10779	66	16	complications	complication	NOUN
bam-10779	66	17	for	for	ADP
bam-10779	66	18	women	woman	NOUN
bam-10779	66	19	every	every	DET
bam-10779	66	20	year.5	year.5	NOUN
bam-10779	66	21	therefore	therefore	ADV
bam-10779	66	22	,	,	PUNCT
bam-10779	66	23	the	the	DET
bam-10779	66	24	study	study	NOUN
bam-10779	66	25	of	of	ADP
bam-10779	66	26	survival	survival	NOUN
bam-10779	66	27	and	and	CCONJ
bam-10779	66	28	recurrence	recurrence	NOUN
bam-10779	66	29	of	of	ADP
bam-10779	66	30	this	this	DET
bam-10779	66	31	disease	disease	NOUN
bam-10779	66	32	can	can	AUX
bam-10779	66	33	be	be	AUX
bam-10779	66	34	effective	effective	ADJ
bam-10779	66	35	in	in	ADP
bam-10779	66	36	understanding	understand	VERB
bam-10779	66	37	the	the	DET
bam-10779	66	38	treatment	treatment	NOUN
bam-10779	66	39	strategies	strategy	NOUN
bam-10779	66	40	and	and	CCONJ
bam-10779	66	41	their	their	PRON
bam-10779	66	42	effectiveness	effectiveness	NOUN
bam-10779	66	43	.	.	PUNCT
bam-10779	67	1	our	our	PRON
bam-10779	67	2	findings	finding	NOUN
bam-10779	67	3	with	with	ADP
bam-10779	67	4	an	an	DET
bam-10779	67	5	average	average	ADJ
bam-10779	67	6	follow	follow	NOUN
bam-10779	67	7	-	-	PUNCT
bam-10779	67	8	up	up	NOUN
bam-10779	67	9	time	time	NOUN
bam-10779	67	10	of	of	ADP
bam-10779	67	11	60.6	60.6	NUM
bam-10779	67	12	months	month	NOUN
bam-10779	67	13	show	show	VERB
bam-10779	67	14	that	that	SCONJ
bam-10779	67	15	the	the	DET
bam-10779	67	16	5	5	NUM
bam-10779	67	17	-	-	PUNCT
bam-10779	67	18	year	year	NOUN
bam-10779	67	19	survival	survival	NOUN
bam-10779	67	20	rate	rate	NOUN
bam-10779	67	21	of	of	ADP
bam-10779	67	22	patients	patient	NOUN
bam-10779	67	23	during	during	ADP
bam-10779	67	24	the	the	DET
bam-10779	67	25	follow	follow	NOUN
bam-10779	67	26	-	-	PUNCT
bam-10779	67	27	up	up	NOUN
bam-10779	67	28	period	period	NOUN
bam-10779	67	29	was	be	AUX
bam-10779	67	30	100	100	NUM
bam-10779	67	31	%	%	NOUN
bam-10779	67	32	and	and	CCONJ
bam-10779	67	33	none	none	NOUN
bam-10779	67	34	of	of	ADP
bam-10779	67	35	the	the	DET
bam-10779	67	36	patients	patient	NOUN
bam-10779	67	37	died	die	VERB
bam-10779	67	38	at	at	ADP
bam-10779	67	39	the	the	DET
bam-10779	67	40	end	end	NOUN
bam-10779	67	41	of	of	ADP
bam-10779	67	42	follow	follow	NOUN
bam-10779	67	43	-	-	PUNCT
bam-10779	67	44	up	up	NOUN
bam-10779	67	45	.	.	PUNCT
bam-10779	68	1	a	a	DET
bam-10779	68	2	similar	similar	ADJ
bam-10779	68	3	study	study	NOUN
bam-10779	68	4	in	in	ADP
bam-10779	68	5	iran	iran	PROPN
bam-10779	68	6	aimed	aim	VERB
bam-10779	68	7	to	to	PART
bam-10779	68	8	assess	assess	VERB
bam-10779	68	9	the	the	DET
bam-10779	68	10	recurrence	recurrence	NOUN
bam-10779	68	11	rate	rate	NOUN
bam-10779	68	12	and	and	CCONJ
bam-10779	68	13	5	5	NUM
bam-10779	68	14	-	-	PUNCT
bam-10779	68	15	year	year	NOUN
bam-10779	68	16	survival	survival	NOUN
bam-10779	68	17	in	in	ADP
bam-10779	68	18	patients	patient	NOUN
bam-10779	68	19	with	with	ADP
bam-10779	68	20	borderline	borderline	NOUN
bam-10779	68	21	ovarian	ovarian	ADJ
bam-10779	68	22	tumor	tumor	NOUN
bam-10779	68	23	and	and	CCONJ
bam-10779	68	24	reported	report	VERB
bam-10779	68	25	that	that	SCONJ
bam-10779	68	26	the	the	DET
bam-10779	68	27	survival	survival	NOUN
bam-10779	68	28	rate	rate	NOUN
bam-10779	68	29	of	of	ADP
bam-10779	68	30	these	these	DET
bam-10779	68	31	patients	patient	NOUN
bam-10779	68	32	was	be	AUX
bam-10779	68	33	not	not	PART
bam-10779	68	34	measurable	measurable	ADJ
bam-10779	68	35	because	because	SCONJ
bam-10779	68	36	none	none	NOUN
bam-10779	68	37	of	of	ADP
bam-10779	68	38	the	the	DET
bam-10779	68	39	patients	patient	NOUN
bam-10779	68	40	died	die	VERB
bam-10779	68	41	during	during	ADP
bam-10779	68	42	this	this	DET
bam-10779	68	43	study	study	NOUN
bam-10779	68	44	.	.	PUNCT
bam-10779	69	1	however	however	ADV
bam-10779	69	2	,	,	PUNCT
bam-10779	69	3	according	accord	VERB
bam-10779	69	4	to	to	ADP
bam-10779	69	5	statistical	statistical	ADJ
bam-10779	69	6	analysis	analysis	NOUN
bam-10779	69	7	,	,	PUNCT
bam-10779	69	8	there	there	PRON
bam-10779	69	9	was	be	VERB
bam-10779	69	10	no	no	DET
bam-10779	69	11	significant	significant	ADJ
bam-10779	69	12	relationship	relationship	NOUN
bam-10779	69	13	between	between	ADP
bam-10779	69	14	postoperative	postoperative	ADJ
bam-10779	69	15	drug	drug	NOUN
bam-10779	69	16	therapy	therapy	NOUN
bam-10779	69	17	(	(	PUNCT
bam-10779	69	18	chemotherapy	chemotherapy	NOUN
bam-10779	69	19	)	)	PUNCT
bam-10779	69	20	and	and	CCONJ
bam-10779	69	21	recurrence	recurrence	NOUN
bam-10779	69	22	rate	rate	NOUN
bam-10779	69	23	.	.	PUNCT
bam-10779	70	1	they	they	PRON
bam-10779	70	2	reported	report	VERB
bam-10779	70	3	that	that	SCONJ
bam-10779	70	4	the	the	DET
bam-10779	70	5	mean	mean	ADJ
bam-10779	70	6	recurrence	recurrence	NOUN
bam-10779	70	7	time	time	NOUN
bam-10779	70	8	of	of	ADP
bam-10779	70	9	bot	bot	NOUN
bam-10779	70	10	was	be	AUX
bam-10779	70	11	14	14	NUM
bam-10779	70	12	months.12	months.12	NOUN
bam-10779	70	13	the	the	DET
bam-10779	70	14	survival	survival	NOUN
bam-10779	70	15	rate	rate	NOUN
bam-10779	70	16	of	of	ADP
bam-10779	70	17	interstitial	interstitial	ADJ
bam-10779	70	18	ovarian	ovarian	ADJ
bam-10779	70	19	tumors	tumor	NOUN
bam-10779	70	20	is	be	AUX
bam-10779	70	21	higher	high	ADJ
bam-10779	70	22	than	than	ADP
bam-10779	70	23	ovarian	ovarian	ADJ
bam-10779	70	24	cancer	cancer	NOUN
bam-10779	70	25	.	.	PUNCT
bam-10779	71	1	the	the	DET
bam-10779	71	2	findings	finding	NOUN
bam-10779	71	3	of	of	ADP
bam-10779	71	4	a	a	DET
bam-10779	71	5	study	study	NOUN
bam-10779	71	6	by	by	ADP
bam-10779	71	7	momenimovahed	momenimovahe	VERB
bam-10779	71	8	et	et	PROPN
bam-10779	71	9	al	al	PROPN
bam-10779	71	10	.	.	PROPN
bam-10779	71	11	showed	show	VERB
bam-10779	71	12	that	that	SCONJ
bam-10779	71	13	the	the	DET
bam-10779	71	14	5	5	NUM
bam-10779	71	15	-	-	PUNCT
bam-10779	71	16	year	year	NOUN
bam-10779	71	17	survival	survival	NOUN
bam-10779	71	18	rate	rate	NOUN
bam-10779	71	19	for	for	ADP
bam-10779	71	20	patients	patient	NOUN
bam-10779	71	21	with	with	ADP
bam-10779	71	22	ovarian	ovarian	ADJ
bam-10779	71	23	cancer	cancer	NOUN
bam-10779	71	24	was	be	AUX
bam-10779	71	25	approximately	approximately	ADV
bam-10779	71	26	45%.13	45%.13	NUM
bam-10779	71	27	our	our	PRON
bam-10779	71	28	studies	study	NOUN
bam-10779	71	29	showed	show	VERB
bam-10779	71	30	that	that	SCONJ
bam-10779	71	31	in	in	ADP
bam-10779	71	32	15	15	NUM
bam-10779	71	33	%	%	NOUN
bam-10779	71	34	(	(	PUNCT
bam-10779	71	35	3	3	NUM
bam-10779	71	36	cases	case	NOUN
bam-10779	71	37	)	)	PUNCT
bam-10779	71	38	of	of	ADP
bam-10779	71	39	patients	patient	NOUN
bam-10779	71	40	undergoing	undergo	VERB
bam-10779	71	41	surgery	surgery	NOUN
bam-10779	71	42	,	,	PUNCT
bam-10779	71	43	the	the	DET
bam-10779	71	44	tumor	tumor	NOUN
bam-10779	71	45	recurred	recur	VERB
bam-10779	71	46	.	.	PUNCT
bam-10779	72	1	two	two	NUM
bam-10779	72	2	cases	case	NOUN
bam-10779	72	3	of	of	ADP
bam-10779	72	4	tumor	tumor	NOUN
bam-10779	72	5	recurrence	recurrence	NOUN
bam-10779	72	6	were	be	AUX
bam-10779	72	7	related	relate	VERB
bam-10779	72	8	to	to	ADP
bam-10779	72	9	patients	patient	NOUN
bam-10779	72	10	treated	treat	VERB
bam-10779	72	11	with	with	ADP
bam-10779	72	12	cystectomy	cystectomy	NOUN
bam-10779	72	13	and	and	CCONJ
bam-10779	72	14	the	the	DET
bam-10779	72	15	other	other	ADJ
bam-10779	72	16	patient	patient	NOUN
bam-10779	72	17	underwent	underwent	NOUN
bam-10779	72	18	tah	tah	X
bam-10779	72	19	+	+	CCONJ
bam-10779	72	20	bso	bso	PROPN
bam-10779	72	21	operation	operation	NOUN
bam-10779	72	22	.	.	PUNCT
bam-10779	73	1	the	the	DET
bam-10779	73	2	mean	mean	ADJ
bam-10779	73	3	recurrence	recurrence	NOUN
bam-10779	73	4	time	time	NOUN
bam-10779	73	5	in	in	ADP
bam-10779	73	6	the	the	DET
bam-10779	73	7	present	present	ADJ
bam-10779	73	8	study	study	NOUN
bam-10779	73	9	was	be	AUX
bam-10779	73	10	about	about	ADV
bam-10779	73	11	65.6	65.6	NUM
bam-10779	73	12	months	month	NOUN
bam-10779	73	13	.	.	PUNCT
bam-10779	74	1	similar	similar	ADJ
bam-10779	74	2	studies	study	NOUN
bam-10779	74	3	have	have	AUX
bam-10779	74	4	estimated	estimate	VERB
bam-10779	74	5	the	the	DET
bam-10779	74	6	rate	rate	NOUN
bam-10779	74	7	of	of	ADP
bam-10779	74	8	borderline	borderline	NOUN
bam-10779	74	9	tumor	tumor	NOUN
bam-10779	74	10	recurrence	recurrence	NOUN
bam-10779	74	11	to	to	PART
bam-10779	74	12	be	be	AUX
bam-10779	74	13	10	10	NUM
bam-10779	74	14	to	to	PART
bam-10779	74	15	32	32	NUM
bam-10779	74	16	%	%	NOUN
bam-10779	74	17	.	.	PUNCT
bam-10779	75	1	in	in	ADP
bam-10779	75	2	a	a	DET
bam-10779	75	3	study	study	NOUN
bam-10779	75	4	by	by	ADP
bam-10779	75	5	morris	morris	PROPN
bam-10779	75	6	et	et	PROPN
bam-10779	75	7	al	al	PROPN
bam-10779	75	8	,	,	PUNCT
bam-10779	75	9	patients	patient	NOUN
bam-10779	75	10	with	with	ADP
bam-10779	75	11	bot	bot	NOUN
bam-10779	75	12	were	be	AUX
bam-10779	75	13	followed	follow	VERB
bam-10779	75	14	for	for	ADP
bam-10779	75	15	about	about	ADV
bam-10779	75	16	6	6	NUM
bam-10779	75	17	years	year	NOUN
bam-10779	75	18	.	.	PUNCT
bam-10779	76	1	they	they	PRON
bam-10779	76	2	reported	report	VERB
bam-10779	76	3	that	that	SCONJ
bam-10779	76	4	recurrent	recurrent	ADJ
bam-10779	76	5	tumors	tumor	NOUN
bam-10779	76	6	were	be	AUX
bam-10779	76	7	observed	observe	VERB
bam-10779	76	8	in	in	ADP
bam-10779	76	9	32	32	NUM
bam-10779	76	10	%	%	NOUN
bam-10779	76	11	of	of	ADP
bam-10779	76	12	patients.14	patients.14	PROPN
bam-10779	76	13	the	the	DET
bam-10779	76	14	findings	finding	NOUN
bam-10779	76	15	of	of	ADP
bam-10779	76	16	a	a	DET
bam-10779	76	17	study	study	NOUN
bam-10779	76	18	by	by	ADP
bam-10779	76	19	sanci	sanci	PROPN
bam-10779	76	20	et	et	PROPN
bam-10779	76	21	al	al	PROPN
bam-10779	76	22	.	.	PROPN
bam-10779	76	23	have	have	AUX
bam-10779	76	24	shown	show	VERB
bam-10779	76	25	that	that	SCONJ
bam-10779	76	26	bot	bot	NOUN
bam-10779	76	27	recur	recur	VERB
bam-10779	76	28	in	in	ADP
bam-10779	76	29	about	about	ADV
bam-10779	76	30	10	10	NUM
bam-10779	76	31	%	%	NOUN
bam-10779	76	32	of	of	ADP
bam-10779	76	33	patients.15	patients.15	PROPN
bam-10779	76	34	sobiczewski	sobiczewski	PROPN
bam-10779	76	35	et	et	PROPN
bam-10779	76	36	al	al	PROPN
bam-10779	76	37	.	.	PROPN
bam-10779	76	38	reported	report	VERB
bam-10779	76	39	that	that	SCONJ
bam-10779	76	40	in	in	ADP
bam-10779	76	41	many	many	ADJ
bam-10779	76	42	patients	patient	NOUN
bam-10779	76	43	no	no	DET
bam-10779	76	44	recurrence	recurrence	NOUN
bam-10779	76	45	of	of	ADP
bam-10779	76	46	the	the	DET
bam-10779	76	47	disease	disease	NOUN
bam-10779	76	48	was	be	AUX
bam-10779	76	49	observed	observe	VERB
bam-10779	76	50	for	for	ADP
bam-10779	76	51	several	several	ADJ
bam-10779	76	52	years	year	NOUN
bam-10779	76	53	,	,	PUNCT
bam-10779	76	54	and	and	CCONJ
bam-10779	76	55	recurrence	recurrence	NOUN
bam-10779	76	56	of	of	ADP
bam-10779	76	57	borderline	borderline	NOUN
bam-10779	76	58	ovarian	ovarian	ADJ
bam-10779	76	59	tumor	tumor	NOUN
bam-10779	76	60	occurred	occur	VERB
bam-10779	76	61	in	in	ADP
bam-10779	76	62	10	10	NUM
bam-10779	76	63	%	%	NOUN
bam-10779	76	64	of	of	ADP
bam-10779	76	65	patients	patient	NOUN
bam-10779	76	66	.	.	PUNCT
bam-10779	77	1	also	also	ADV
bam-10779	77	2	,	,	PUNCT
bam-10779	77	3	invasive	invasive	ADJ
bam-10779	77	4	recurrences	recurrence	NOUN
bam-10779	77	5	were	be	AUX
bam-10779	77	6	rare	rare	ADJ
bam-10779	77	7	and	and	CCONJ
bam-10779	77	8	occurred	occur	VERB
bam-10779	77	9	in	in	ADP
bam-10779	77	10	only	only	ADV
bam-10779	77	11	3	3	NUM
bam-10779	77	12	%	%	NOUN
bam-10779	77	13	of	of	ADP
bam-10779	77	14	patients	patient	NOUN
bam-10779	77	15	;	;	PUNCT
bam-10779	77	16	however	however	ADV
bam-10779	77	17	,	,	PUNCT
bam-10779	77	18	these	these	DET
bam-10779	77	19	recurrences	recurrence	NOUN
bam-10779	77	20	are	be	AUX
bam-10779	77	21	often	often	ADV
bam-10779	77	22	associated	associate	VERB
bam-10779	77	23	with	with	ADP
bam-10779	77	24	high	high	ADJ
bam-10779	77	25	mortality	mortality	NOUN
bam-10779	77	26	despite	despite	SCONJ
bam-10779	77	27	treatment.16	treatment.16	PROPN
bam-10779	77	28	in	in	ADP
bam-10779	77	29	our	our	PRON
bam-10779	77	30	study	study	NOUN
bam-10779	77	31	,	,	PUNCT
bam-10779	77	32	75	75	NUM
bam-10779	77	33	%	%	NOUN
bam-10779	77	34	of	of	ADP
bam-10779	77	35	patients	patient	NOUN
bam-10779	77	36	had	have	VERB
bam-10779	77	37	interstitial	interstitial	ADJ
bam-10779	77	38	serous	serous	ADJ
bam-10779	77	39	tumors	tumor	NOUN
bam-10779	77	40	,	,	PUNCT
bam-10779	77	41	20	20	NUM
bam-10779	77	42	%	%	NOUN
bam-10779	77	43	had	have	VERB
bam-10779	77	44	mucinous	mucinous	ADJ
bam-10779	77	45	tumors	tumor	NOUN
bam-10779	77	46	,	,	PUNCT
bam-10779	77	47	and	and	CCONJ
bam-10779	77	48	5	5	NUM
bam-10779	77	49	%	%	NOUN
bam-10779	77	50	had	have	VERB
bam-10779	77	51	endometriosis	endometriosis	NOUN
bam-10779	77	52	.	.	PUNCT
bam-10779	78	1	our	our	PRON
bam-10779	78	2	findings	finding	NOUN
bam-10779	78	3	showed	show	VERB
bam-10779	78	4	that	that	SCONJ
bam-10779	78	5	the	the	DET
bam-10779	78	6	most	most	ADV
bam-10779	78	7	common	common	ADJ
bam-10779	78	8	type	type	NOUN
bam-10779	78	9	of	of	ADP
bam-10779	78	10	borderline	borderline	NOUN
bam-10779	78	11	ovarian	ovarian	ADJ
bam-10779	78	12	tumor	tumor	NOUN
bam-10779	78	13	was	be	AUX
bam-10779	78	14	serous	serous	ADJ
bam-10779	78	15	interstitial	interstitial	ADJ
bam-10779	78	16	tumor	tumor	NOUN
bam-10779	78	17	.	.	PUNCT
bam-10779	79	1	in	in	ADP
bam-10779	79	2	similar	similar	ADJ
bam-10779	79	3	studies	study	NOUN
bam-10779	79	4	,	,	PUNCT
bam-10779	79	5	the	the	DET
bam-10779	79	6	frequency	frequency	NOUN
bam-10779	79	7	of	of	ADP
bam-10779	79	8	serous	serous	ADJ
bam-10779	79	9	interstitial	interstitial	ADJ
bam-10779	79	10	tumors	tumor	NOUN
bam-10779	79	11	was	be	AUX
bam-10779	79	12	the	the	DET
bam-10779	79	13	highest	high	ADJ
bam-10779	79	14	in	in	ADP
bam-10779	79	15	comparison	comparison	NOUN
bam-10779	79	16	to	to	ADP
bam-10779	79	17	other	other	ADJ
bam-10779	79	18	types	type	NOUN
bam-10779	79	19	of	of	ADP
bam-10779	79	20	tumors.14	tumors.14	PROPN
bam-10779	79	21	in	in	ADP
bam-10779	79	22	some	some	DET
bam-10779	79	23	studies	study	NOUN
bam-10779	79	24	,	,	PUNCT
bam-10779	79	25	the	the	DET
bam-10779	79	26	number	number	NOUN
bam-10779	79	27	of	of	ADP
bam-10779	79	28	serous	serous	ADJ
bam-10779	79	29	borderline	borderline	NOUN
bam-10779	79	30	tumors	tumor	NOUN
bam-10779	79	31	was	be	AUX
bam-10779	79	32	less	less	ADJ
bam-10779	79	33	than	than	ADP
bam-10779	79	34	half	half	NOUN
bam-10779	79	35	of	of	ADP
bam-10779	79	36	the	the	DET
bam-10779	79	37	population	population	NOUN
bam-10779	79	38	,	,	PUNCT
bam-10779	79	39	but	but	CCONJ
bam-10779	79	40	in	in	ADP
bam-10779	79	41	general	general	ADJ
bam-10779	79	42	,	,	PUNCT
bam-10779	79	43	the	the	DET
bam-10779	79	44	frequency	frequency	NOUN
bam-10779	79	45	of	of	ADP
bam-10779	79	46	these	these	DET
bam-10779	79	47	tumors	tumor	NOUN
bam-10779	79	48	was	be	AUX
bam-10779	79	49	higher	high	ADJ
bam-10779	79	50	than	than	ADP
bam-10779	79	51	other	other	ADJ
bam-10779	79	52	types	type	NOUN
bam-10779	79	53	of	of	ADP
bam-10779	79	54	borderline	borderline	NOUN
bam-10779	79	55	tumors.17,18	tumors.17,18	NOUN
bam-10779	79	56	in	in	ADP
bam-10779	79	57	their	their	PRON
bam-10779	79	58	study	study	NOUN
bam-10779	79	59	,	,	PUNCT
bam-10779	79	60	auer	auer	PROPN
bam-10779	79	61	et	et	PROPN
bam-10779	79	62	al	al	PROPN
bam-10779	79	63	.	.	PROPN
bam-10779	79	64	reported	report	VERB
bam-10779	79	65	that	that	SCONJ
bam-10779	79	66	most	most	ADJ
bam-10779	79	67	frequent	frequent	ADJ
bam-10779	79	68	bot	bot	NOUN
bam-10779	79	69	table	table	NOUN
bam-10779	79	70	5	5	NUM
bam-10779	79	71	.	.	X
bam-10779	79	72	relationship	relationship	NOUN
bam-10779	79	73	between	between	ADP
bam-10779	79	74	demographic	demographic	ADJ
bam-10779	79	75	parameters	parameter	NOUN
bam-10779	79	76	and	and	CCONJ
bam-10779	79	77	recurrence	recurrence	NOUN
bam-10779	79	78	of	of	ADP
bam-10779	79	79	borderline	borderline	NOUN
bam-10779	79	80	ovarian	ovarian	ADJ
bam-10779	79	81	tumors	tumor	NOUN
bam-10779	79	82	.	.	PUNCT
bam-10779	80	1	recurrence	recurrence	NOUN
bam-10779	80	2	p	p	NOUN
bam-10779	80	3	value	value	NOUN
bam-10779	80	4	paramteres	paramtere	VERB
bam-10779	80	5	no	no	DET
bam-10779	80	6	number	number	NOUN
bam-10779	80	7	(	(	PUNCT
bam-10779	80	8	%	%	INTJ
bam-10779	80	9	)	)	PUNCT
bam-10779	81	1	yes	yes	INTJ
bam-10779	81	2	number	number	NOUN
bam-10779	81	3	(	(	PUNCT
bam-10779	81	4	%	%	INTJ
bam-10779	81	5	)	)	PUNCT
bam-10779	81	6	history	history	NOUN
bam-10779	81	7	of	of	ADP
bam-10779	81	8	infertility	infertility	NOUN
bam-10779	81	9	no	no	DET
bam-10779	81	10	16(9/88	16(9/88	PROPN
bam-10779	81	11	)	)	PUNCT
bam-10779	81	12	2(1/11	2(1/11	PROPN
bam-10779	81	13	)	)	PUNCT
bam-10779	81	14	0/26	0/26	NUM
bam-10779	81	15	yes	yes	NOUN
bam-10779	81	16	1(50	1(50	NOUN
bam-10779	81	17	)	)	PUNCT
bam-10779	81	18	(	(	PUNCT
bam-10779	81	19	1(50	1(50	NOUN
bam-10779	81	20	)	)	PUNCT
bam-10779	81	21	history	history	NOUN
bam-10779	81	22	of	of	ADP
bam-10779	81	23	contraceptives	contraceptive	NOUN
bam-10779	81	24	no	no	DET
bam-10779	81	25	13(3/81	13(3/81	NUM
bam-10779	81	26	)	)	PUNCT
bam-10779	81	27	3(7/18	3(7/18	PROPN
bam-10779	81	28	)	)	PUNCT
bam-10779	81	29	0/58	0/58	NUM
bam-10779	82	1	yes	yes	INTJ
bam-10779	82	2	4(100	4(100	NUM
bam-10779	82	3	)	)	PUNCT
bam-10779	82	4	0	0	NUM
bam-10779	83	1	age	age	NOUN
bam-10779	83	2	43.82	43.82	NUM
bam-10779	83	3	±16.23	±16.23	PART
bam-10779	83	4	43.67	43.67	NUM
bam-10779	83	5	±16.25	±16.25	NOUN
bam-10779	83	6	0.99	0.99	NUM
bam-10779	83	7	age	age	NOUN
bam-10779	83	8	at	at	ADP
bam-10779	83	9	diagnosis	diagnosis	NOUN
bam-10779	83	10	38.82	38.82	NUM
bam-10779	83	11	±15.73	±15.73	ADP
bam-10779	83	12	40.44	40.44	NUM
bam-10779	83	13	±16.52	±16.52	NOUN
bam-10779	83	14	0.90	0.90	NUM
bam-10779	83	15	bmi	bmi	NOUN
bam-10779	83	16	29.07	29.07	NUM
bam-10779	83	17	±3.48	±3.48	PROPN
bam-10779	83	18	27.67	27.67	NUM
bam-10779	83	19	±0.58	±0.58	NOUN
bam-10779	83	20	0.85	0.85	NUM
bam-10779	83	21	non	non	ADJ
bam-10779	83	22	-co	-co	PROPN
bam-10779	83	23	mmerc	mmerc	PROPN
bam-10779	83	24	ial	ial	PROPN
bam-10779	83	25	us	us	PROPN
bam-10779	83	26	e	e	NOUN
bam-10779	83	27	o	o	NOUN
bam-10779	83	28	nly	nly	ADV
bam-10779	83	29	recurrence	recurrence	NOUN
bam-10779	83	30	and	and	CCONJ
bam-10779	83	31	5	5	NUM
bam-10779	83	32	-	-	PUNCT
bam-10779	83	33	year	year	NOUN
bam-10779	83	34	survival	survival	NOUN
bam-10779	83	35	of	of	ADP
bam-10779	83	36	borderline	borderline	NOUN
bam-10779	83	37	ovarian	ovarian	ADJ
bam-10779	83	38	tumor	tumor	NOUN
bam-10779	83	39	eur	eur	PROPN
bam-10779	83	40	j	j	PROPN
bam-10779	83	41	transl	transl	PROPN
bam-10779	83	42	myol	myol	ADV
bam-10779	83	43	33	33	NUM
bam-10779	83	44	(	(	PUNCT
bam-10779	83	45	1	1	NUM
bam-10779	83	46	)	)	PUNCT
bam-10779	83	47	10779	10779	NUM
bam-10779	83	48	,	,	PUNCT
bam-10779	83	49	2023	2023	NUM
bam-10779	83	50	doi	doi	NOUN
bam-10779	83	51	:	:	PUNCT
bam-10779	83	52	10.4081	10.4081	NUM
bam-10779	83	53	/	/	SYM
bam-10779	83	54	ejtm.2023.10779	ejtm.2023.10779	NUM
bam-10779	83	55	5	5	NUM
bam-10779	83	56	are	be	AUX
bam-10779	83	57	serous	serous	ADJ
bam-10779	83	58	or	or	CCONJ
bam-10779	83	59	mucinous	mucinous	ADJ
bam-10779	83	60	,	,	PUNCT
bam-10779	83	61	while	while	SCONJ
bam-10779	83	62	other	other	ADJ
bam-10779	83	63	tumors	tumor	NOUN
bam-10779	83	64	such	such	ADJ
bam-10779	83	65	as	as	ADP
bam-10779	83	66	mixed	mixed	ADJ
bam-10779	83	67	,	,	PUNCT
bam-10779	83	68	endometrioid	endometrioid	ADJ
bam-10779	83	69	,	,	PUNCT
bam-10779	83	70	or	or	CCONJ
bam-10779	83	71	clear	clear	ADJ
bam-10779	83	72	cell	cell	NOUN
bam-10779	83	73	types	type	NOUN
bam-10779	83	74	are	be	AUX
bam-10779	83	75	rare.18	rare.18	ADJ
bam-10779	83	76	in	in	ADP
bam-10779	83	77	the	the	DET
bam-10779	83	78	present	present	ADJ
bam-10779	83	79	study	study	NOUN
bam-10779	83	80	,	,	PUNCT
bam-10779	83	81	there	there	PRON
bam-10779	83	82	was	be	VERB
bam-10779	83	83	no	no	DET
bam-10779	83	84	significant	significant	ADJ
bam-10779	83	85	difference	difference	NOUN
bam-10779	83	86	between	between	ADP
bam-10779	83	87	the	the	DET
bam-10779	83	88	two	two	NUM
bam-10779	83	89	groups	group	NOUN
bam-10779	83	90	with	with	ADP
bam-10779	83	91	and	and	CCONJ
bam-10779	83	92	without	without	ADP
bam-10779	83	93	recurrence	recurrence	NOUN
bam-10779	83	94	in	in	ADP
bam-10779	83	95	terms	term	NOUN
bam-10779	83	96	of	of	ADP
bam-10779	83	97	the	the	DET
bam-10779	83	98	type	type	NOUN
bam-10779	83	99	of	of	ADP
bam-10779	83	100	surgery	surgery	NOUN
bam-10779	83	101	,	,	PUNCT
bam-10779	83	102	history	history	NOUN
bam-10779	83	103	of	of	ADP
bam-10779	83	104	infertility	infertility	NOUN
bam-10779	83	105	,	,	PUNCT
bam-10779	83	106	history	history	NOUN
bam-10779	83	107	of	of	ADP
bam-10779	83	108	taking	take	VERB
bam-10779	83	109	contraceptives	contraceptive	NOUN
bam-10779	83	110	,	,	PUNCT
bam-10779	83	111	age	age	NOUN
bam-10779	83	112	,	,	PUNCT
bam-10779	83	113	age	age	NOUN
bam-10779	83	114	at	at	ADP
bam-10779	83	115	diagnosis	diagnosis	NOUN
bam-10779	83	116	,	,	PUNCT
bam-10779	83	117	and	and	CCONJ
bam-10779	83	118	bmi	bmi	NOUN
bam-10779	83	119	.	.	PUNCT
bam-10779	84	1	this	this	PRON
bam-10779	84	2	indicates	indicate	VERB
bam-10779	84	3	that	that	SCONJ
bam-10779	84	4	the	the	DET
bam-10779	84	5	studied	study	VERB
bam-10779	84	6	demographic	demographic	ADJ
bam-10779	84	7	and	and	CCONJ
bam-10779	84	8	clinical	clinical	ADJ
bam-10779	84	9	variables	variable	NOUN
bam-10779	84	10	were	be	AUX
bam-10779	84	11	not	not	PART
bam-10779	84	12	significantly	significantly	ADV
bam-10779	84	13	related	relate	VERB
bam-10779	84	14	to	to	ADP
bam-10779	84	15	tumor	tumor	NOUN
bam-10779	84	16	recurrence	recurrence	NOUN
bam-10779	84	17	.	.	PUNCT
bam-10779	85	1	various	various	ADJ
bam-10779	85	2	findings	finding	NOUN
bam-10779	85	3	have	have	AUX
bam-10779	85	4	shown	show	VERB
bam-10779	85	5	that	that	SCONJ
bam-10779	85	6	ovarian	ovarian	ADJ
bam-10779	85	7	cancer	cancer	NOUN
bam-10779	85	8	is	be	AUX
bam-10779	85	9	associated	associate	VERB
bam-10779	85	10	with	with	ADP
bam-10779	85	11	high	high	ADJ
bam-10779	85	12	mortality	mortality	NOUN
bam-10779	85	13	,	,	PUNCT
bam-10779	85	14	and	and	CCONJ
bam-10779	85	15	in	in	ADP
bam-10779	85	16	most	most	ADJ
bam-10779	85	17	cases	case	NOUN
bam-10779	85	18	,	,	PUNCT
bam-10779	85	19	it	it	PRON
bam-10779	85	20	is	be	AUX
bam-10779	85	21	diagnosed	diagnose	VERB
bam-10779	85	22	after	after	ADP
bam-10779	85	23	the	the	DET
bam-10779	85	24	metastasis	metastasis	NOUN
bam-10779	85	25	of	of	ADP
bam-10779	85	26	cancer	cancer	NOUN
bam-10779	85	27	beyond	beyond	ADP
bam-10779	85	28	the	the	DET
bam-10779	85	29	ovaries	ovary	NOUN
bam-10779	85	30	and	and	CCONJ
bam-10779	85	31	often	often	ADV
bam-10779	85	32	throughout	throughout	ADP
bam-10779	85	33	the	the	DET
bam-10779	85	34	abdomen	abdomen	NOUN
bam-10779	85	35	,	,	PUNCT
bam-10779	85	36	which	which	PRON
bam-10779	85	37	should	should	AUX
bam-10779	85	38	be	be	AUX
bam-10779	85	39	considered	consider	VERB
bam-10779	85	40	because	because	SCONJ
bam-10779	85	41	early	early	ADJ
bam-10779	85	42	detection	detection	NOUN
bam-10779	85	43	can	can	AUX
bam-10779	85	44	lead	lead	VERB
bam-10779	85	45	to	to	ADP
bam-10779	85	46	effective	effective	ADJ
bam-10779	85	47	treatment	treatment	NOUN
bam-10779	85	48	and	and	CCONJ
bam-10779	85	49	lower	low	ADJ
bam-10779	85	50	recurrence.19	recurrence.19	NOUN
bam-10779	85	51	-	-	PUNCT
bam-10779	85	52	21	21	NUM
bam-10779	85	53	one	one	NUM
bam-10779	85	54	of	of	ADP
bam-10779	85	55	the	the	DET
bam-10779	85	56	limitations	limitation	NOUN
bam-10779	85	57	of	of	ADP
bam-10779	85	58	this	this	DET
bam-10779	85	59	study	study	NOUN
bam-10779	85	60	was	be	AUX
bam-10779	85	61	the	the	DET
bam-10779	85	62	small	small	ADJ
bam-10779	85	63	number	number	NOUN
bam-10779	85	64	of	of	ADP
bam-10779	85	65	samples	sample	NOUN
bam-10779	85	66	studied	study	VERB
bam-10779	85	67	.	.	PUNCT
bam-10779	86	1	during	during	ADP
bam-10779	86	2	the	the	DET
bam-10779	86	3	12	12	NUM
bam-10779	86	4	years	year	NOUN
bam-10779	86	5	of	of	ADP
bam-10779	86	6	study	study	NOUN
bam-10779	86	7	,	,	PUNCT
bam-10779	86	8	we	we	PRON
bam-10779	86	9	tried	try	VERB
bam-10779	86	10	to	to	PART
bam-10779	86	11	increase	increase	VERB
bam-10779	86	12	the	the	DET
bam-10779	86	13	sample	sample	NOUN
bam-10779	86	14	as	as	ADV
bam-10779	86	15	much	much	ADV
bam-10779	86	16	as	as	ADP
bam-10779	86	17	possible	possible	ADJ
bam-10779	86	18	to	to	ADP
bam-10779	86	19	a	a	DET
bam-10779	86	20	reasonable	reasonable	ADJ
bam-10779	86	21	and	and	CCONJ
bam-10779	86	22	measurable	measurable	ADJ
bam-10779	86	23	level	level	NOUN
bam-10779	86	24	.	.	PUNCT
bam-10779	87	1	in	in	ADP
bam-10779	87	2	conclusion	conclusion	NOUN
bam-10779	87	3	,	,	PUNCT
bam-10779	87	4	fifteen	fifteen	NUM
bam-10779	87	5	percent	percent	NOUN
bam-10779	87	6	of	of	ADP
bam-10779	87	7	women	woman	NOUN
bam-10779	87	8	with	with	ADP
bam-10779	87	9	bot	bot	NOUN
bam-10779	87	10	had	have	VERB
bam-10779	87	11	a	a	DET
bam-10779	87	12	recurrence	recurrence	NOUN
bam-10779	87	13	after	after	ADP
bam-10779	87	14	60	60	NUM
bam-10779	87	15	months	month	NOUN
bam-10779	87	16	of	of	ADP
bam-10779	87	17	follow	follow	NOUN
bam-10779	87	18	-	-	PUNCT
bam-10779	87	19	up	up	NOUN
bam-10779	87	20	.	.	PUNCT
bam-10779	88	1	the	the	DET
bam-10779	88	2	overall	overall	ADJ
bam-10779	88	3	survival	survival	NOUN
bam-10779	88	4	rate	rate	NOUN
bam-10779	88	5	after	after	ADP
bam-10779	88	6	5	5	NUM
bam-10779	88	7	years	year	NOUN
bam-10779	88	8	of	of	ADP
bam-10779	88	9	follow	follow	NOUN
bam-10779	88	10	-	-	PUNCT
bam-10779	88	11	up	up	NOUN
bam-10779	88	12	was	be	AUX
bam-10779	88	13	100	100	NUM
bam-10779	88	14	%	%	NOUN
bam-10779	88	15	and	and	CCONJ
bam-10779	88	16	none	none	NOUN
bam-10779	88	17	of	of	ADP
bam-10779	88	18	the	the	DET
bam-10779	88	19	patients	patient	NOUN
bam-10779	88	20	died	die	VERB
bam-10779	88	21	after	after	ADP
bam-10779	88	22	follow	follow	NOUN
bam-10779	88	23	-	-	PUNCT
bam-10779	88	24	up	up	NOUN
bam-10779	88	25	.	.	PUNCT
bam-10779	89	1	conduction	conduction	NOUN
bam-10779	89	2	of	of	ADP
bam-10779	89	3	further	further	ADJ
bam-10779	89	4	studies	study	NOUN
bam-10779	89	5	especially	especially	ADV
bam-10779	89	6	studies	study	NOUN
bam-10779	89	7	with	with	ADP
bam-10779	89	8	larger	large	ADJ
bam-10779	89	9	sample	sample	NOUN
bam-10779	89	10	sizes	size	NOUN
bam-10779	89	11	,	,	PUNCT
bam-10779	89	12	and	and	CCONJ
bam-10779	89	13	possibly	possibly	ADV
bam-10779	89	14	the	the	DET
bam-10779	89	15	use	use	NOUN
bam-10779	89	16	of	of	ADP
bam-10779	89	17	multicenter	multicenter	ADJ
bam-10779	89	18	data	datum	NOUN
bam-10779	89	19	and	and	CCONJ
bam-10779	89	20	data	datum	NOUN
bam-10779	89	21	modeling	modeling	NOUN
bam-10779	89	22	using	use	VERB
bam-10779	89	23	cox	cox	PROPN
bam-10779	89	24	regression	regression	NOUN
bam-10779	89	25	to	to	PART
bam-10779	89	26	clarify	clarify	VERB
bam-10779	89	27	the	the	DET
bam-10779	89	28	relationship	relationship	NOUN
bam-10779	89	29	between	between	ADP
bam-10779	89	30	different	different	ADJ
bam-10779	89	31	demographic	demographic	ADJ
bam-10779	89	32	and	and	CCONJ
bam-10779	89	33	clinical	clinical	ADJ
bam-10779	89	34	variables	variable	NOUN
bam-10779	89	35	related	relate	VERB
bam-10779	89	36	to	to	ADP
bam-10779	89	37	recurrence	recurrence	NOUN
bam-10779	89	38	and	and	CCONJ
bam-10779	89	39	survival	survival	NOUN
bam-10779	89	40	of	of	ADP
bam-10779	89	41	patients	patient	NOUN
bam-10779	89	42	are	be	AUX
bam-10779	89	43	recommended	recommend	VERB
bam-10779	89	44	.	.	PUNCT
bam-10779	90	1	list	list	NOUN
bam-10779	90	2	of	of	ADP
bam-10779	90	3	acronyms	acronym	NOUN
bam-10779	90	4	bmi	bmi	NOUN
bam-10779	90	5	–	–	PUNCT
bam-10779	90	6	body	body	NOUN
bam-10779	90	7	mass	mass	NOUN
bam-10779	90	8	index	index	NOUN
bam-10779	90	9	bot	bot	NOUN
bam-10779	90	10	borderline	borderline	NOUN
bam-10779	90	11	ovarian	ovarian	ADJ
bam-10779	90	12	tumors	tumor	NOUN
bam-10779	90	13	bso	bso	PROPN
bam-10779	90	14	–	–	PUNCT
bam-10779	90	15	bilateral	bilateral	ADJ
bam-10779	90	16	salpingo	salpingo	NOUN
bam-10779	90	17	-	-	PUNCT
bam-10779	90	18	oophorectomy	oophorectomy	NOUN
bam-10779	90	19	so	so	ADV
bam-10779	90	20	salpingo	salpingo	NOUN
bam-10779	90	21	-	-	PUNCT
bam-10779	90	22	oophorectomy	oophorectomy	NOUN
bam-10779	90	23	tah	tah	PROPN
bam-10779	90	24	–	–	PUNCT
bam-10779	90	25	total	total	ADJ
bam-10779	90	26	abdominal	abdominal	ADJ
bam-10779	90	27	hysterectomy	hysterectomy	NOUN
bam-10779	90	28	contributions	contribution	NOUN
bam-10779	90	29	of	of	ADP
bam-10779	90	30	authors	author	NOUN
bam-10779	90	31	all	all	DET
bam-10779	90	32	authors	author	NOUN
bam-10779	90	33	have	have	AUX
bam-10779	90	34	read	read	VERB
bam-10779	90	35	and	and	CCONJ
bam-10779	90	36	approved	approve	VERB
bam-10779	90	37	the	the	DET
bam-10779	90	38	final	final	ADJ
bam-10779	90	39	edited	edited	ADJ
bam-10779	90	40	typescript	typescript	NOUN
bam-10779	90	41	.	.	PUNCT
bam-10779	91	1	acknowledgments	acknowledgment	NOUN
bam-10779	91	2	none	none	NOUN
bam-10779	91	3	fundingnone	fundingnone	NOUN
bam-10779	91	4	conflict	conflict	NOUN
bam-10779	91	5	of	of	ADP
bam-10779	91	6	interest	interest	NOUN
bam-10779	91	7	the	the	DET
bam-10779	91	8	authors	author	NOUN
bam-10779	91	9	declare	declare	VERB
bam-10779	91	10	no	no	DET
bam-10779	91	11	conflicts	conflict	NOUN
bam-10779	91	12	of	of	ADP
bam-10779	91	13	interest	interest	NOUN
bam-10779	91	14	.	.	PUNCT
bam-10779	92	1	ethical	ethical	ADJ
bam-10779	92	2	publication	publication	NOUN
bam-10779	92	3	statement	statement	NOUN
bam-10779	92	4	we	we	PRON
bam-10779	92	5	confirm	confirm	VERB
bam-10779	92	6	that	that	SCONJ
bam-10779	92	7	we	we	PRON
bam-10779	92	8	have	have	AUX
bam-10779	92	9	read	read	VERB
bam-10779	92	10	the	the	DET
bam-10779	92	11	journal	journal	NOUN
bam-10779	92	12	’s	’s	PART
bam-10779	92	13	position	position	NOUN
bam-10779	92	14	on	on	ADP
bam-10779	92	15	issues	issue	NOUN
bam-10779	92	16	involved	involve	VERB
bam-10779	92	17	in	in	ADP
bam-10779	92	18	ethical	ethical	ADJ
bam-10779	92	19	publication	publication	NOUN
bam-10779	92	20	and	and	CCONJ
bam-10779	92	21	affirm	affirm	NOUN
bam-10779	92	22	that	that	SCONJ
bam-10779	92	23	this	this	DET
bam-10779	92	24	report	report	NOUN
bam-10779	92	25	is	be	AUX
bam-10779	92	26	consistent	consistent	ADJ
bam-10779	92	27	with	with	ADP
bam-10779	92	28	those	those	DET
bam-10779	92	29	guidelines	guideline	NOUN
bam-10779	92	30	.	.	PUNCT
bam-10779	93	1	corresponding	correspond	VERB
bam-10779	93	2	author	author	NOUN
bam-10779	93	3	roya	roya	PROPN
bam-10779	93	4	tabatabaei	tabatabaei	NOUN
bam-10779	93	5	,	,	PUNCT
bam-10779	93	6	social	social	ADJ
bam-10779	93	7	determinants	determinant	NOUN
bam-10779	93	8	of	of	ADP
bam-10779	93	9	health	health	NOUN
bam-10779	93	10	research	research	NOUN
bam-10779	93	11	center	center	NOUN
bam-10779	93	12	,	,	PUNCT
bam-10779	93	13	department	department	NOUN
bam-10779	93	14	of	of	ADP
bam-10779	93	15	gynecology	gynecology	NOUN
bam-10779	93	16	,	,	PUNCT
bam-10779	93	17	faculty	faculty	NOUN
bam-10779	93	18	of	of	ADP
bam-10779	93	19	medicine	medicine	NOUN
bam-10779	93	20	,	,	PUNCT
bam-10779	93	21	kurdistan	kurdistan	PROPN
bam-10779	93	22	university	university	PROPN
bam-10779	93	23	of	of	ADP
bam-10779	93	24	medical	medical	ADJ
bam-10779	93	25	science	science	NOUN
bam-10779	93	26	,	,	PUNCT
bam-10779	93	27	iran	iran	PROPN
bam-10779	93	28	.	.	PUNCT
bam-10779	94	1	tel	tel	ADP
bam-10779	94	2	:	:	PUNCT
bam-10779	94	3	+98	+98	ADJ
bam-10779	94	4	-	-	PUNCT
bam-10779	94	5	5433522636	5433522636	NUM
bam-10779	94	6	,	,	PUNCT
bam-10779	94	7	fax	fax	NOUN
bam-10779	94	8	:	:	PUNCT
bam-10779	94	9	+98	+98	NOUN
bam-10779	94	10	-	-	PUNCT
bam-10779	94	11	5433518352	5433518352	NUM
bam-10779	94	12	.	.	PUNCT
bam-10779	95	1	orcid	orcid	NOUN
bam-10779	96	1	i	i	PRON
bam-10779	96	2	d	d	NOUN
bam-10779	96	3	:	:	PUNCT
bam-10779	96	4	0000	0000	NUM
bam-10779	96	5	-	-	PUNCT
bam-10779	96	6	0001	0001	NUM
bam-10779	96	7	-	-	PUNCT
bam-10779	96	8	8947	8947	NUM
bam-10779	96	9	-	-	SYM
bam-10779	96	10	4066	4066	NUM
bam-10779	96	11	e	e	NOUN
bam-10779	96	12	-	-	NOUN
bam-10779	96	13	mail	mail	NOUN
bam-10779	96	14	:	:	PUNCT
bam-10779	97	1	rm_tabatabaie@yahoo.com	rm_tabatabaie@yahoo.com	X
bam-10779	97	2	e	e	NOUN
bam-10779	97	3	-	-	NOUN
bam-10779	97	4	mails	mail	NOUN
bam-10779	97	5	and	and	CCONJ
bam-10779	97	6	orcid	orcid	NOUN
bam-10779	97	7	i	i	INTJ
bam-10779	97	8	d	d	PROPN
bam-10779	97	9	of	of	ADP
bam-10779	97	10	co	co	NOUN
bam-10779	97	11	-	-	NOUN
bam-10779	97	12	authors	author	NOUN
bam-10779	97	13	seyedeh	seyedeh	PROPN
bam-10779	97	14	reyhaneh	reyhaneh	PROPN
bam-10779	97	15	yousefi	yousefi	PROPN
bam-10779	97	16	sharami	sharami	PROPN
bam-10779	97	17	:	:	PUNCT
bam-10779	97	18	yousefi805@yahoo.com	yousefi805@yahoo.com	X
bam-10779	97	19	orcidid	orcidid	VERB
bam-10779	97	20	:	:	PUNCT
bam-10779	97	21	0000	0000	NUM
bam-10779	97	22	-	-	PUNCT
bam-10779	97	23	0002	0002	NUM
bam-10779	97	24	-	-	PUNCT
bam-10779	97	25	4050	4050	NUM
bam-10779	97	26	-	-	PUNCT
bam-10779	97	27	4137	4137	NUM
bam-10779	97	28	fariba	fariba	NOUN
bam-10779	97	29	farhadifar	farhadifar	ADV
bam-10779	97	30	:	:	PUNCT
bam-10779	97	31	none	none	NOUN
bam-10779	97	32	orcid	orcid	NOUN
bam-10779	97	33	id:0000	id:0000	NOUN
bam-10779	97	34	-	-	PUNCT
bam-10779	97	35	0001	0001	NUM
bam-10779	97	36	-	-	PUNCT
bam-10779	97	37	5823	5823	NUM
bam-10779	97	38	-	-	SYM
bam-10779	97	39	8482	8482	NUM
bam-10779	97	40	references	reference	NOUN
bam-10779	97	41	1	1	NUM
bam-10779	97	42	.	.	PUNCT
bam-10779	97	43	lalwani	lalwani	PROPN
bam-10779	97	44	n	n	CCONJ
bam-10779	97	45	,	,	PUNCT
bam-10779	97	46	prasad	prasad	PROPN
bam-10779	97	47	sr	sr	PROPN
bam-10779	97	48	,	,	PUNCT
bam-10779	97	49	vikram	vikram	PROPN
bam-10779	97	50	r	r	PROPN
bam-10779	97	51	,	,	PUNCT
bam-10779	97	52	shanbhogue	shanbhogue	PROPN
bam-10779	97	53	ak	ak	PROPN
bam-10779	97	54	,	,	PUNCT
bam-10779	97	55	huettner	huettner	PROPN
bam-10779	97	56	pc	pc	NOUN
bam-10779	97	57	,	,	PUNCT
bam-10779	97	58	fasih	fasih	ADJ
bam-10779	97	59	n.	n.	PROPN
bam-10779	97	60	histologic	histologic	PROPN
bam-10779	97	61	,	,	PUNCT
bam-10779	97	62	molecular	molecular	ADJ
bam-10779	97	63	,	,	PUNCT
bam-10779	97	64	and	and	CCONJ
bam-10779	97	65	cytogenetic	cytogenetic	ADJ
bam-10779	97	66	features	feature	NOUN
bam-10779	97	67	of	of	ADP
bam-10779	97	68	ovarian	ovarian	ADJ
bam-10779	97	69	cancers	cancer	NOUN
bam-10779	97	70	:	:	PUNCT
bam-10779	97	71	implications	implication	NOUN
bam-10779	97	72	for	for	ADP
bam-10779	97	73	diagnosis	diagnosis	NOUN
bam-10779	97	74	and	and	CCONJ
bam-10779	97	75	treatment	treatment	NOUN
bam-10779	97	76	.	.	PUNCT
bam-10779	98	1	radiographics	radiographic	NOUN
bam-10779	98	2	.	.	PUNCT
bam-10779	99	1	2011;31:625	2011;31:625	NUM
bam-10779	99	2	-	-	SYM
bam-10779	99	3	46	46	NUM
bam-10779	100	1	.	.	PUNCT
bam-10779	100	2	doi	doi	NOUN
bam-10779	100	3	:	:	PUNCT
bam-10779	100	4	10.1148	10.1148	NUM
bam-10779	100	5	/	/	SYM
bam-10779	100	6	rg.313105066	rg.313105066	PROPN
bam-10779	100	7	.	.	NOUN
bam-10779	101	1	2	2	NUM
bam-10779	101	2	.	.	X
bam-10779	101	3	kanat	kanat	NOUN
bam-10779	101	4	-	-	PUNCT
bam-10779	101	5	pektas	pektas	PROPN
bam-10779	101	6	m	m	NOUN
bam-10779	101	7	,	,	PUNCT
bam-10779	101	8	ozat	ozat	PROPN
bam-10779	101	9	m	m	PROPN
bam-10779	101	10	,	,	PUNCT
bam-10779	101	11	gungor	gungor	PROPN
bam-10779	101	12	t	t	PROPN
bam-10779	101	13	,	,	PUNCT
bam-10779	101	14	dikici	dikici	PROPN
bam-10779	101	15	t	t	PROPN
bam-10779	101	16	,	,	PUNCT
bam-10779	101	17	yilmaz	yilmaz	PROPN
bam-10779	101	18	b	b	PROPN
bam-10779	101	19	,	,	PUNCT
bam-10779	101	20	mollamahmutoglu	mollamahmutoglu	PROPN
bam-10779	101	21	l.	l.	PROPN
bam-10779	101	22	fertility	fertility	PROPN
bam-10779	101	23	outcome	outcome	NOUN
bam-10779	101	24	after	after	ADP
bam-10779	101	25	conservative	conservative	ADJ
bam-10779	101	26	surgery	surgery	NOUN
bam-10779	101	27	for	for	ADP
bam-10779	101	28	borderline	borderline	NOUN
bam-10779	101	29	ovarian	ovarian	ADJ
bam-10779	101	30	tumors	tumor	NOUN
bam-10779	101	31	:	:	PUNCT
bam-10779	101	32	a	a	DET
bam-10779	101	33	single	single	ADJ
bam-10779	101	34	center	center	NOUN
bam-10779	101	35	experience	experience	NOUN
bam-10779	101	36	.	.	PUNCT
bam-10779	102	1	arch	arch	ADJ
bam-10779	102	2	gynecol	gynecol	PROPN
bam-10779	102	3	obstet	obstet	NOUN
bam-10779	102	4	.	.	PUNCT
bam-10779	103	1	2011;284:1253	2011;284:1253	NUM
bam-10779	103	2	-	-	SYM
bam-10779	103	3	8	8	NUM
bam-10779	103	4	.	.	PUNCT
bam-10779	104	1	doi	doi	NOUN
bam-10779	104	2	:	:	PUNCT
bam-10779	104	3	10.1007	10.1007	NUM
bam-10779	104	4	/	/	SYM
bam-10779	104	5	s00404010	s00404010	NOUN
bam-10779	104	6	-	-	NOUN
bam-10779	104	7	1804	1804	NUM
bam-10779	104	8	-	-	SYM
bam-10779	104	9	7	7	NUM
bam-10779	104	10	.	.	NOUN
bam-10779	104	11	3	3	NUM
bam-10779	104	12	.	.	X
bam-10779	105	1	rauh	rauh	PROPN
bam-10779	105	2	-	-	PUNCT
bam-10779	105	3	hain	hain	PROPN
bam-10779	105	4	ja	ja	PROPN
bam-10779	105	5	,	,	PUNCT
bam-10779	105	6	krivak	krivak	PROPN
bam-10779	105	7	tc	tc	PROPN
bam-10779	105	8	,	,	PUNCT
bam-10779	105	9	del	del	X
bam-10779	105	10	carmen	carman	NOUN
bam-10779	105	11	mg	mg	PROPN
bam-10779	105	12	,	,	PUNCT
bam-10779	105	13	olawaiye	olawaiye	PROPN
bam-10779	105	14	ab	ab	PROPN
bam-10779	105	15	.	.	PUNCT
bam-10779	106	1	ovarian	ovarian	ADJ
bam-10779	106	2	cancer	cancer	NOUN
bam-10779	106	3	screening	screening	NOUN
bam-10779	106	4	and	and	CCONJ
bam-10779	106	5	early	early	ADJ
bam-10779	106	6	detection	detection	NOUN
bam-10779	106	7	in	in	ADP
bam-10779	106	8	the	the	DET
bam-10779	106	9	general	general	ADJ
bam-10779	106	10	population	population	NOUN
bam-10779	106	11	.	.	PUNCT
bam-10779	107	1	rev	rev	PROPN
bam-10779	107	2	obstet	obstet	PROPN
bam-10779	107	3	gynecol	gynecol	PROPN
bam-10779	107	4	.	.	PUNCT
bam-10779	108	1	2011;4:15	2011;4:15	NUM
bam-10779	108	2	-	-	PUNCT
bam-10779	108	3	21	21	NUM
bam-10779	108	4	.	.	PUNCT
bam-10779	109	1	4	4	X
bam-10779	109	2	.	.	X
bam-10779	109	3	reid	reid	PROPN
bam-10779	109	4	bm	bm	PROPN
bam-10779	109	5	,	,	PUNCT
bam-10779	109	6	permuth	permuth	PROPN
bam-10779	109	7	jb	jb	PROPN
bam-10779	109	8	,	,	PUNCT
bam-10779	109	9	sellers	seller	NOUN
bam-10779	109	10	ta	ta	PROPN
bam-10779	109	11	.	.	PUNCT
bam-10779	110	1	epidemiology	epidemiology	NOUN
bam-10779	110	2	of	of	ADP
bam-10779	110	3	ovarian	ovarian	ADJ
bam-10779	110	4	cancer	cancer	NOUN
bam-10779	110	5	:	:	PUNCT
bam-10779	110	6	a	a	DET
bam-10779	110	7	review	review	NOUN
bam-10779	110	8	.	.	PUNCT
bam-10779	111	1	cancer	cancer	NOUN
bam-10779	111	2	biol	biol	PROPN
bam-10779	111	3	med	me	VERB
bam-10779	111	4	.	.	PUNCT
bam-10779	112	1	2017;14:9	2017;14:9	NUM
bam-10779	112	2	-	-	SYM
bam-10779	112	3	32	32	NUM
bam-10779	112	4	.	.	PUNCT
bam-10779	113	1	doi	doi	NOUN
bam-10779	113	2	:	:	PUNCT
bam-10779	113	3	10.20892	10.20892	NUM
bam-10779	113	4	/	/	SYM
bam-10779	113	5	j.issn.20953941.2016.0084	j.issn.20953941.2016.0084	NOUN
bam-10779	113	6	.	.	PUNCT
bam-10779	114	1	5	5	X
bam-10779	114	2	.	.	X
bam-10779	114	3	lawton	lawton	PROPN
bam-10779	114	4	fg	fg	PROPN
bam-10779	114	5	,	,	PUNCT
bam-10779	114	6	pavlik	pavlik	PROPN
bam-10779	114	7	ej	ej	PROPN
bam-10779	114	8	.	.	PROPN
bam-10779	114	9	perspectives	perspective	NOUN
bam-10779	114	10	on	on	ADP
bam-10779	114	11	ovarian	ovarian	ADJ
bam-10779	114	12	cancer	cancer	NOUN
bam-10779	114	13	1809	1809	NUM
bam-10779	114	14	to	to	ADP
bam-10779	114	15	2022	2022	NUM
bam-10779	114	16	and	and	CCONJ
bam-10779	114	17	beyond	beyond	ADP
bam-10779	114	18	.	.	PUNCT
bam-10779	115	1	diagnostics	diagnostic	NOUN
bam-10779	115	2	(	(	PUNCT
bam-10779	115	3	basel	basel	PROPN
bam-10779	115	4	)	)	PUNCT
bam-10779	115	5	.	.	PUNCT
bam-10779	116	1	2022;12	2022;12	X
bam-10779	116	2	.	.	PUNCT
bam-10779	117	1	doi	doi	NOUN
bam-10779	117	2	:	:	PUNCT
bam-10779	117	3	10.3390	10.3390	NUM
bam-10779	117	4	/	/	SYM
bam-10779	117	5	diagnostics12040791	diagnostics12040791	PROPN
bam-10779	117	6	.	.	NOUN
bam-10779	118	1	6	6	NUM
bam-10779	118	2	.	.	X
bam-10779	118	3	fischerova	fischerova	PUNCT
bam-10779	119	1	d	d	X
bam-10779	119	2	,	,	PUNCT
bam-10779	119	3	zikan	zikan	NUM
bam-10779	119	4	m	m	PROPN
bam-10779	119	5	,	,	PUNCT
bam-10779	119	6	dundr	dundr	VERB
bam-10779	119	7	p	p	PRON
bam-10779	119	8	,	,	PUNCT
bam-10779	119	9	cibula	cibula	VERB
bam-10779	119	10	d.	d.	NOUN
bam-10779	119	11	diagnosis	diagnosis	PROPN
bam-10779	119	12	,	,	PUNCT
bam-10779	119	13	treatment	treatment	NOUN
bam-10779	119	14	,	,	PUNCT
bam-10779	119	15	and	and	CCONJ
bam-10779	119	16	follow	follow	VERB
bam-10779	119	17	-	-	PUNCT
bam-10779	119	18	up	up	NOUN
bam-10779	119	19	of	of	ADP
bam-10779	119	20	borderline	borderline	NOUN
bam-10779	119	21	ovarian	ovarian	ADJ
bam-10779	119	22	tumors	tumor	NOUN
bam-10779	119	23	.	.	PUNCT
bam-10779	120	1	oncologist	oncologist	NOUN
bam-10779	120	2	.	.	PUNCT
bam-10779	121	1	2012;17:1515	2012;17:1515	NUM
bam-10779	121	2	-	-	SYM
bam-10779	121	3	33	33	NUM
bam-10779	121	4	.	.	PUNCT
bam-10779	122	1	doi	doi	NOUN
bam-10779	122	2	:	:	PUNCT
bam-10779	122	3	10.1634	10.1634	NUM
bam-10779	122	4	/	/	SYM
bam-10779	122	5	theoncologist.2012	theoncologist.2012	NOUN
bam-10779	122	6	-	-	PUNCT
bam-10779	122	7	0139	0139	NUM
bam-10779	122	8	.	.	PUNCT
bam-10779	123	1	7	7	X
bam-10779	123	2	.	.	X
bam-10779	123	3	harter	harter	PROPN
bam-10779	123	4	p	p	NOUN
bam-10779	123	5	,	,	PUNCT
bam-10779	123	6	sehouli	sehouli	PROPN
bam-10779	123	7	j	j	PROPN
bam-10779	123	8	,	,	PUNCT
bam-10779	123	9	vergote	vergote	VERB
bam-10779	123	10	i	i	PRON
bam-10779	123	11	,	,	PUNCT
bam-10779	123	12	ferron	ferron	PROPN
bam-10779	123	13	g	g	PROPN
bam-10779	123	14	,	,	PUNCT
bam-10779	123	15	reuss	reuss	NOUN
bam-10779	123	16	a	a	X
bam-10779	123	17	,	,	PUNCT
bam-10779	123	18	meier	meier	PROPN
bam-10779	123	19	w	w	PROPN
bam-10779	123	20	,	,	PUNCT
bam-10779	123	21	et	et	PROPN
bam-10779	123	22	al	al	PROPN
bam-10779	123	23	.	.	PROPN
bam-10779	123	24	randomized	randomize	VERB
bam-10779	123	25	trial	trial	NOUN
bam-10779	123	26	of	of	ADP
bam-10779	123	27	cytoreductive	cytoreductive	ADJ
bam-10779	123	28	surgery	surgery	NOUN
bam-10779	123	29	for	for	ADP
bam-10779	123	30	relapsed	relapse	VERB
bam-10779	123	31	ovarian	ovarian	ADJ
bam-10779	123	32	cancer	cancer	NOUN
bam-10779	123	33	.	.	PUNCT
bam-10779	124	1	n	n	PROPN
bam-10779	124	2	engl	engl	PROPN
bam-10779	124	3	j	j	PROPN
bam-10779	124	4	med	med	PROPN
bam-10779	124	5	.	.	PUNCT
bam-10779	125	1	2021;385:2123	2021;385:2123	NUM
bam-10779	125	2	-	-	SYM
bam-10779	125	3	31	31	NUM
bam-10779	125	4	.	.	PUNCT
bam-10779	126	1	doi	doi	NOUN
bam-10779	126	2	:	:	PUNCT
bam-10779	126	3	10.1056	10.1056	NUM
bam-10779	126	4	/	/	SYM
bam-10779	126	5	nejmoa2103294	nejmoa2103294	PROPN
bam-10779	126	6	.	.	PUNCT
bam-10779	127	1	8	8	NUM
bam-10779	127	2	.	.	X
bam-10779	127	3	seong	seong	PROPN
bam-10779	127	4	sj	sj	PROPN
bam-10779	127	5	,	,	PUNCT
bam-10779	127	6	kim	kim	PROPN
bam-10779	127	7	dh	dh	PROPN
bam-10779	127	8	,	,	PUNCT
bam-10779	127	9	kim	kim	PROPN
bam-10779	127	10	mk	mk	PROPN
bam-10779	127	11	,	,	PUNCT
bam-10779	127	12	song	song	NOUN
bam-10779	127	13	t.	t.	PROPN
bam-10779	127	14	controversies	controversy	NOUN
bam-10779	127	15	in	in	ADP
bam-10779	127	16	borderline	borderline	NOUN
bam-10779	127	17	ovarian	ovarian	ADJ
bam-10779	127	18	tumors	tumor	NOUN
bam-10779	127	19	.	.	PUNCT
bam-10779	128	1	j	j	PROPN
bam-10779	128	2	gynecol	gynecol	PROPN
bam-10779	128	3	oncol	oncol	ADJ
bam-10779	128	4	.	.	PUNCT
bam-10779	129	1	2015;26:343	2015;26:343	NOUN
bam-10779	129	2	-	-	PUNCT
bam-10779	129	3	9	9	NUM
bam-10779	129	4	.	.	PUNCT
bam-10779	129	5	doi	doi	NOUN
bam-10779	129	6	:	:	PUNCT
bam-10779	129	7	10.3802	10.3802	NUM
bam-10779	129	8	/	/	SYM
bam-10779	129	9	jgo.2015.26.4.343	jgo.2015.26.4.343	NOUN
bam-10779	129	10	.	.	NOUN
bam-10779	130	1	9	9	NUM
bam-10779	130	2	.	.	X
bam-10779	130	3	abascal	abascal	PROPN
bam-10779	130	4	-	-	PUNCT
bam-10779	130	5	saiz	saiz	PROPN
bam-10779	130	6	a	a	PROPN
bam-10779	130	7	,	,	PUNCT
bam-10779	130	8	sotillo	sotillo	PROPN
bam-10779	130	9	-	-	PUNCT
bam-10779	130	10	mallo	mallo	PROPN
bam-10779	130	11	l	l	PROPN
bam-10779	130	12	,	,	PUNCT
bam-10779	130	13	de	de	PROPN
bam-10779	130	14	santiago	santiago	PROPN
bam-10779	130	15	j	j	PROPN
bam-10779	130	16	,	,	PUNCT
bam-10779	130	17	zapardiel	zapardiel	PROPN
bam-10779	130	18	i.	i.	PROPN
bam-10779	130	19	management	management	PROPN
bam-10779	130	20	of	of	ADP
bam-10779	130	21	borderline	borderline	NOUN
bam-10779	130	22	ovarian	ovarian	NOUN
bam-10779	130	23	tumours	tumour	VERB
bam-10779	130	24	:	:	PUNCT
bam-10779	130	25	a	a	DET
bam-10779	130	26	comprehensive	comprehensive	ADJ
bam-10779	130	27	review	review	NOUN
bam-10779	130	28	of	of	ADP
bam-10779	130	29	the	the	DET
bam-10779	130	30	literature	literature	NOUN
bam-10779	130	31	.	.	PUNCT
bam-10779	131	1	ecancermedicalscience	ecancermedicalscience	NOUN
bam-10779	131	2	.	.	PUNCT
bam-10779	132	1	2014;8:403	2014;8:403	NOUN
bam-10779	132	2	.	.	PUNCT
bam-10779	133	1	doi	doi	NOUN
bam-10779	133	2	:	:	PUNCT
bam-10779	133	3	10.3332	10.3332	NUM
bam-10779	133	4	/	/	SYM
bam-10779	133	5	ecancer.2014.403	ecancer.2014.403	NOUN
bam-10779	133	6	.	.	PUNCT
bam-10779	134	1	10	10	NUM
bam-10779	134	2	.	.	X
bam-10779	135	1	patrono	patrono	PROPN
bam-10779	135	2	mg	mg	PROPN
bam-10779	135	3	,	,	PUNCT
bam-10779	135	4	minig	minig	PROPN
bam-10779	135	5	l	l	PROPN
bam-10779	135	6	,	,	PUNCT
bam-10779	135	7	diaz	diaz	PROPN
bam-10779	135	8	-	-	PUNCT
bam-10779	135	9	padilla	padilla	PROPN
bam-10779	135	10	i	i	PROPN
bam-10779	135	11	,	,	PUNCT
bam-10779	135	12	romero	romero	PROPN
bam-10779	135	13	n	n	PROPN
bam-10779	135	14	,	,	PUNCT
bam-10779	135	15	rodriguez	rodriguez	PROPN
bam-10779	135	16	moreno	moreno	PROPN
bam-10779	135	17	jf	jf	PROPN
bam-10779	135	18	,	,	PUNCT
bam-10779	135	19	garcia	garcia	PROPN
bam-10779	135	20	-	-	PUNCT
bam-10779	135	21	donas	donas	PROPN
bam-10779	135	22	j.	j.	PROPN
bam-10779	135	23	borderline	borderline	PROPN
bam-10779	135	24	tumours	tumours	PROPN
bam-10779	135	25	of	of	ADP
bam-10779	135	26	the	the	DET
bam-10779	135	27	ovary	ovary	ADJ
bam-10779	135	28	,	,	PUNCT
bam-10779	135	29	current	current	ADJ
bam-10779	135	30	controversies	controversy	NOUN
bam-10779	135	31	regarding	regard	VERB
bam-10779	135	32	their	their	PRON
bam-10779	135	33	diagnosis	diagnosis	NOUN
bam-10779	135	34	and	and	CCONJ
bam-10779	135	35	treatment	treatment	NOUN
bam-10779	135	36	.	.	PUNCT
bam-10779	136	1	ecancermedicalscience	ecancermedicalscience	NOUN
bam-10779	136	2	.	.	PUNCT
bam-10779	137	1	2013;7:379	2013;7:379	NOUN
bam-10779	137	2	.	.	PUNCT
bam-10779	138	1	doi	doi	NOUN
bam-10779	138	2	:	:	PUNCT
bam-10779	138	3	10.3332	10.3332	NUM
bam-10779	138	4	/	/	SYM
bam-10779	138	5	ecancer.2013.379	ecancer.2013.379	NOUN
bam-10779	138	6	.	.	PUNCT
bam-10779	139	1	11	11	NUM
bam-10779	139	2	.	.	PUNCT
bam-10779	140	1	loizzi	loizzi	PROPN
bam-10779	140	2	v	v	NOUN
bam-10779	140	3	,	,	PUNCT
bam-10779	140	4	selvaggi	selvaggi	PROPN
bam-10779	140	5	l	l	NOUN
bam-10779	140	6	,	,	PUNCT
bam-10779	140	7	leone	leone	PROPN
bam-10779	140	8	l	l	NOUN
bam-10779	140	9	,	,	PUNCT
bam-10779	140	10	latorre	latorre	NOUN
bam-10779	140	11	d	d	NOUN
bam-10779	140	12	,	,	PUNCT
bam-10779	140	13	scardigno	scardigno	PROPN
bam-10779	140	14	d	d	PROPN
bam-10779	140	15	,	,	PUNCT
bam-10779	140	16	magazzino	magazzino	PROPN
bam-10779	140	17	f	f	PROPN
bam-10779	140	18	,	,	PUNCT
bam-10779	140	19	cormio	cormio	NOUN
bam-10779	140	20	g.	g.	PROPN
bam-10779	140	21	borderline	borderline	PROPN
bam-10779	140	22	non	non	PROPN
bam-10779	140	23	-co	-co	PROPN
bam-10779	140	24	mmerc	mmerc	PROPN
bam-10779	140	25	ial	ial	PROPN
bam-10779	141	1	us	us	PROPN
bam-10779	141	2	e	e	NOUN
bam-10779	141	3	o	o	PROPN
bam-10779	141	4	nly	nly	ADV
bam-10779	141	5	mailto:rm_tabatabaie@yahoo.com	mailto:rm_tabatabaie@yahoo.com	X
bam-10779	141	6	mailto:yousefi805@yahoo.com	mailto:yousefi805@yahoo.com	PROPN
bam-10779	141	7	recurrence	recurrence	NOUN
bam-10779	141	8	and	and	CCONJ
bam-10779	141	9	5	5	NUM
bam-10779	141	10	-	-	PUNCT
bam-10779	141	11	year	year	NOUN
bam-10779	141	12	survival	survival	NOUN
bam-10779	141	13	of	of	ADP
bam-10779	141	14	borderline	borderline	NOUN
bam-10779	141	15	ovarian	ovarian	ADJ
bam-10779	141	16	tumor	tumor	NOUN
bam-10779	141	17	eur	eur	PROPN
bam-10779	141	18	j	j	PROPN
bam-10779	141	19	transl	transl	PROPN
bam-10779	141	20	myol	myol	ADV
bam-10779	141	21	33	33	NUM
bam-10779	141	22	(	(	PUNCT
bam-10779	141	23	1	1	NUM
bam-10779	141	24	)	)	PUNCT
bam-10779	141	25	10779	10779	NUM
bam-10779	141	26	,	,	PUNCT
bam-10779	141	27	2023	2023	NUM
bam-10779	141	28	doi	doi	NOUN
bam-10779	141	29	:	:	PUNCT
bam-10779	141	30	10.4081	10.4081	NUM
bam-10779	141	31	/	/	SYM
bam-10779	141	32	ejtm.2023.10779	ejtm.2023.10779	PROPN
bam-10779	141	33	6	6	NUM
bam-10779	141	34	epithelial	epithelial	ADJ
bam-10779	141	35	tumors	tumor	NOUN
bam-10779	141	36	of	of	ADP
bam-10779	141	37	the	the	DET
bam-10779	141	38	ovary	ovary	NOUN
bam-10779	141	39	:	:	PUNCT
bam-10779	141	40	experience	experience	NOUN
bam-10779	141	41	of	of	ADP
bam-10779	141	42	55	55	NUM
bam-10779	141	43	patients	patient	NOUN
bam-10779	141	44	.	.	PUNCT
bam-10779	142	1	oncol	oncol	ADJ
bam-10779	142	2	lett	lett	PROPN
bam-10779	142	3	.	.	PUNCT
bam-10779	143	1	2015	2015	NUM
bam-10779	143	2	feb;9(2):912	feb;9(2):912	PROPN
bam-10779	143	3	-	-	SYM
bam-10779	143	4	914	914	NUM
bam-10779	143	5	.	.	PUNCT
bam-10779	144	1	doi	doi	NOUN
bam-10779	144	2	:	:	PUNCT
bam-10779	144	3	10.3892	10.3892	NUM
bam-10779	144	4	/	/	SYM
bam-10779	144	5	ol.2014.2758	ol.2014.2758	NOUN
bam-10779	144	6	.	.	PUNCT
bam-10779	145	1	epub	epub	PROPN
bam-10779	145	2	2014	2014	NUM
bam-10779	145	3	dec	dec	PROPN
bam-10779	145	4	2	2	NUM
bam-10779	145	5	.	.	PROPN
bam-10779	145	6	12	12	NUM
bam-10779	145	7	.	.	PUNCT
bam-10779	146	1	karimi	karimi	PROPN
bam-10779	146	2	zarchi	zarchi	PROPN
bam-10779	146	3	m	m	PROPN
bam-10779	146	4	,	,	PUNCT
bam-10779	146	5	mehdizadeh	mehdizadeh	PROPN
bam-10779	146	6	kashi	kashi	PROPN
bam-10779	146	7	a	a	PROPN
bam-10779	146	8	,	,	PUNCT
bam-10779	146	9	allahqoli	allahqoli	PROPN
bam-10779	146	10	l	l	NOUN
bam-10779	146	11	,	,	PUNCT
bam-10779	146	12	sadat	sadat	PROPN
bam-10779	146	13	tabatabai	tabatabai	PROPN
bam-10779	146	14	r	r	PROPN
bam-10779	146	15	,	,	PUNCT
bam-10779	146	16	shamsi	shamsi	PROPN
bam-10779	146	17	f	f	PROPN
bam-10779	146	18	,	,	PUNCT
bam-10779	146	19	hashemian	hashemian	PROPN
bam-10779	146	20	asl	asl	PROPN
bam-10779	146	21	n.	n.	VERB
bam-10779	146	22	the	the	DET
bam-10779	146	23	recurrence	recurrence	NOUN
bam-10779	146	24	and	and	CCONJ
bam-10779	146	25	5	5	NUM
bam-10779	146	26	-	-	PUNCT
bam-10779	146	27	year	year	NOUN
bam-10779	146	28	survival	survival	NOUN
bam-10779	146	29	rates	rate	NOUN
bam-10779	146	30	in	in	ADP
bam-10779	146	31	patients	patient	NOUN
bam-10779	146	32	with	with	ADP
bam-10779	146	33	borderline	borderline	NOUN
bam-10779	146	34	ovarian	ovarian	ADJ
bam-10779	146	35	tumors	tumor	NOUN
bam-10779	146	36	in	in	ADP
bam-10779	146	37	yazd	yazd	PROPN
bam-10779	146	38	from	from	ADP
bam-10779	146	39	2006	2006	NUM
bam-10779	146	40	to	to	ADP
bam-10779	146	41	2016	2016	NUM
bam-10779	146	42	.	.	PUNCT
bam-10779	147	1	journal	journal	NOUN
bam-10779	147	2	of	of	ADP
bam-10779	147	3	obstetrics	obstetric	NOUN
bam-10779	147	4	,	,	PUNCT
bam-10779	147	5	gynecology	gynecology	NOUN
bam-10779	147	6	and	and	CCONJ
bam-10779	147	7	cancer	cancer	NOUN
bam-10779	147	8	research	research	NOUN
bam-10779	147	9	(	(	PUNCT
bam-10779	147	10	jogcr	jogcr	NOUN
bam-10779	147	11	)	)	PUNCT
bam-10779	147	12	.	.	PUNCT
bam-10779	148	1	2019;4:57	2019;4:57	PROPN
bam-10779	148	2	-	-	PUNCT
bam-10779	148	3	61	61	NUM
bam-10779	148	4	.	.	NOUN
bam-10779	148	5	13	13	NUM
bam-10779	148	6	.	.	NUM
bam-10779	148	7	momenimovahed	momenimovahe	VERB
bam-10779	148	8	z	z	PROPN
bam-10779	148	9	,	,	PUNCT
bam-10779	148	10	tiznobaik	tiznobaik	NOUN
bam-10779	148	11	a	a	PRON
bam-10779	148	12	,	,	PUNCT
bam-10779	148	13	taheri	taheri	NOUN
bam-10779	148	14	s	s	PROPN
bam-10779	148	15	,	,	PUNCT
bam-10779	148	16	salehiniya	salehiniya	PROPN
bam-10779	148	17	h.	h.	PROPN
bam-10779	148	18	ovarian	ovarian	ADJ
bam-10779	148	19	cancer	cancer	NOUN
bam-10779	148	20	in	in	ADP
bam-10779	148	21	the	the	DET
bam-10779	148	22	world	world	NOUN
bam-10779	148	23	:	:	PUNCT
bam-10779	148	24	epidemiology	epidemiology	NOUN
bam-10779	148	25	and	and	CCONJ
bam-10779	148	26	risk	risk	NOUN
bam-10779	148	27	factors	factor	NOUN
bam-10779	148	28	.	.	PUNCT
bam-10779	149	1	int	int	NOUN
bam-10779	149	2	j	j	PROPN
bam-10779	149	3	womens	womens	PROPN
bam-10779	149	4	health	health	PROPN
bam-10779	149	5	.	.	PUNCT
bam-10779	150	1	2019;11:287	2019;11:287	X
bam-10779	150	2	-	-	SYM
bam-10779	150	3	99	99	NUM
bam-10779	150	4	.	.	PUNCT
bam-10779	150	5	doi	doi	NOUN
bam-10779	150	6	:	:	PUNCT
bam-10779	150	7	10.2147	10.2147	NUM
bam-10779	150	8	/	/	SYM
bam-10779	150	9	ijwh.s197604	ijwh.s197604	X
bam-10779	150	10	.	.	PUNCT
bam-10779	151	1	14	14	NUM
bam-10779	151	2	.	.	PUNCT
bam-10779	152	1	morris	morris	PROPN
bam-10779	152	2	rt	rt	PROPN
bam-10779	152	3	,	,	PUNCT
bam-10779	152	4	gershenson	gershenson	NOUN
bam-10779	152	5	dm	dm	PROPN
bam-10779	152	6	,	,	PUNCT
bam-10779	152	7	silva	silva	PROPN
bam-10779	152	8	eg	eg	PROPN
bam-10779	152	9	,	,	PUNCT
bam-10779	152	10	follen	follen	PROPN
bam-10779	152	11	m	m	PROPN
bam-10779	152	12	,	,	PUNCT
bam-10779	152	13	morris	morris	PROPN
bam-10779	152	14	m	m	PROPN
bam-10779	152	15	,	,	PUNCT
bam-10779	152	16	wharton	wharton	PROPN
bam-10779	152	17	jt	jt	PROPN
bam-10779	152	18	.	.	PROPN
bam-10779	152	19	outcome	outcome	NOUN
bam-10779	152	20	and	and	CCONJ
bam-10779	152	21	reproductive	reproductive	ADJ
bam-10779	152	22	function	function	NOUN
bam-10779	152	23	after	after	ADP
bam-10779	152	24	conservative	conservative	ADJ
bam-10779	152	25	surgery	surgery	NOUN
bam-10779	152	26	for	for	ADP
bam-10779	152	27	borderline	borderline	NOUN
bam-10779	152	28	ovarian	ovarian	ADJ
bam-10779	152	29	tumors	tumor	NOUN
bam-10779	152	30	.	.	PUNCT
bam-10779	153	1	obstet	obstet	PROPN
bam-10779	153	2	gynecol	gynecol	PROPN
bam-10779	153	3	.	.	PUNCT
bam-10779	154	1	2000;95:541	2000;95:541	NUM
bam-10779	154	2	-	-	SYM
bam-10779	154	3	7	7	NUM
bam-10779	154	4	.	.	PUNCT
bam-10779	154	5	doi	doi	NOUN
bam-10779	154	6	:	:	PUNCT
bam-10779	154	7	10.1016	10.1016	NUM
bam-10779	154	8	/	/	SYM
bam-10779	154	9	s0029	s0029	PROPN
bam-10779	154	10	-	-	PUNCT
bam-10779	154	11	7844(99)00619	7844(99)00619	NUM
bam-10779	154	12	-	-	PUNCT
bam-10779	154	13	5	5	NUM
bam-10779	154	14	.	.	NOUN
bam-10779	154	15	15	15	NUM
bam-10779	154	16	.	.	PUNCT
bam-10779	155	1	sanci	sanci	PROPN
bam-10779	155	2	m	m	PROPN
bam-10779	155	3	,	,	PUNCT
bam-10779	155	4	gultekin	gultekin	NOUN
bam-10779	155	5	e	e	NOUN
bam-10779	155	6	,	,	PUNCT
bam-10779	155	7	cingillioglu	cingillioglu	NOUN
bam-10779	155	8	b	b	NOUN
bam-10779	155	9	,	,	PUNCT
bam-10779	155	10	gultekin	gultekin	PROPN
bam-10779	155	11	oe	oe	PROPN
bam-10779	155	12	,	,	PUNCT
bam-10779	155	13	ozvural	ozvural	PROPN
bam-10779	155	14	s	s	PART
bam-10779	155	15	,	,	PUNCT
bam-10779	155	16	emirdar	emirdar	PROPN
bam-10779	155	17	v	v	NOUN
bam-10779	155	18	,	,	PUNCT
bam-10779	155	19	et	et	PROPN
bam-10779	155	20	al	al	PROPN
bam-10779	155	21	.	.	PROPN
bam-10779	156	1	second	second	ADJ
bam-10779	156	2	primary	primary	ADJ
bam-10779	156	3	cancers	cancer	NOUN
bam-10779	156	4	following	follow	VERB
bam-10779	156	5	borderline	borderline	NOUN
bam-10779	156	6	ovarian	ovarian	ADJ
bam-10779	156	7	tumors	tumor	NOUN
bam-10779	156	8	.	.	PUNCT
bam-10779	157	1	arch	arch	ADJ
bam-10779	157	2	gynecol	gynecol	PROPN
bam-10779	157	3	obstet	obstet	NOUN
bam-10779	157	4	.	.	PUNCT
bam-10779	158	1	2011;283:1391	2011;283:1391	NUM
bam-10779	158	2	-	-	SYM
bam-10779	158	3	6	6	NUM
bam-10779	158	4	.	.	PUNCT
bam-10779	158	5	doi	doi	NOUN
bam-10779	158	6	:	:	PUNCT
bam-10779	158	7	10.1007	10.1007	NUM
bam-10779	158	8	/	/	SYM
bam-10779	158	9	s00404	s00404	NOUN
bam-10779	158	10	-	-	PUNCT
bam-10779	158	11	010	010	NUM
bam-10779	158	12	-	-	PUNCT
bam-10779	158	13	1585	1585	NUM
bam-10779	158	14	-	-	PUNCT
bam-10779	158	15	z.	z.	PROPN
bam-10779	158	16	16	16	NUM
bam-10779	158	17	.	.	PUNCT
bam-10779	159	1	sobiczewski	sobiczewski	PROPN
bam-10779	159	2	p	p	X
bam-10779	159	3	,	,	PUNCT
bam-10779	159	4	kupryjanczyk	kupryjanczyk	PROPN
bam-10779	159	5	j	j	PROPN
bam-10779	159	6	,	,	PUNCT
bam-10779	159	7	michalski	michalski	PROPN
bam-10779	159	8	w	w	PROPN
bam-10779	159	9	,	,	PUNCT
bam-10779	159	10	śpiewankiewicz	śpiewankiewicz	PROPN
bam-10779	159	11	b.	b.	PROPN
bam-10779	160	1	the	the	DET
bam-10779	160	2	evaluation	evaluation	NOUN
bam-10779	160	3	of	of	ADP
bam-10779	160	4	risk	risk	NOUN
bam-10779	160	5	factors	factor	NOUN
bam-10779	160	6	associated	associate	VERB
bam-10779	160	7	with	with	ADP
bam-10779	160	8	relapse	relapse	NOUN
bam-10779	160	9	and	and	CCONJ
bam-10779	160	10	recurrence	recurrence	NOUN
bam-10779	160	11	of	of	ADP
bam-10779	160	12	borderline	borderline	NOUN
bam-10779	160	13	ovarian	ovarian	ADJ
bam-10779	160	14	tumors	tumor	NOUN
bam-10779	160	15	with	with	ADP
bam-10779	160	16	long	long	ADJ
bam-10779	160	17	-	-	PUNCT
bam-10779	160	18	term	term	NOUN
bam-10779	160	19	follow	follow	NOUN
bam-10779	160	20	-	-	PUNCT
bam-10779	160	21	up	up	NOUN
bam-10779	160	22	.	.	PUNCT
bam-10779	161	1	int	int	NOUN
bam-10779	161	2	j	j	PROPN
bam-10779	161	3	gynecol	gynecol	ADJ
bam-10779	161	4	cancer	cancer	NOUN
bam-10779	161	5	.	.	PUNCT
bam-10779	162	1	2016;26:105361	2016;26:105361	X
bam-10779	162	2	.	.	X
bam-10779	162	3	doi	doi	NOUN
bam-10779	162	4	:	:	PUNCT
bam-10779	162	5	10.1097	10.1097	NUM
bam-10779	162	6	/	/	SYM
bam-10779	162	7	igc.0000000000000722	igc.0000000000000722	NOUN
bam-10779	162	8	.	.	NOUN
bam-10779	162	9	17	17	NUM
bam-10779	162	10	.	.	PUNCT
bam-10779	163	1	yasmeen	yasmeen	PROPN
bam-10779	163	2	s	s	PROPN
bam-10779	163	3	,	,	PUNCT
bam-10779	163	4	hannan	hannan	PROPN
bam-10779	163	5	a	a	PROPN
bam-10779	163	6	,	,	PUNCT
bam-10779	163	7	sheikh	sheikh	PROPN
bam-10779	163	8	f	f	PROPN
bam-10779	163	9	,	,	PUNCT
bam-10779	163	10	syed	syed	ADJ
bam-10779	163	11	aa	aa	PROPN
bam-10779	163	12	,	,	PUNCT
bam-10779	163	13	siddiqui	siddiqui	NOUN
bam-10779	163	14	n.	n.	PROPN
bam-10779	163	15	borderline	borderline	NOUN
bam-10779	163	16	tumors	tumor	NOUN
bam-10779	163	17	of	of	ADP
bam-10779	163	18	the	the	DET
bam-10779	163	19	ovary	ovary	NOUN
bam-10779	163	20	:	:	PUNCT
bam-10779	163	21	a	a	DET
bam-10779	163	22	clinicopathological	clinicopathological	ADJ
bam-10779	163	23	study	study	NOUN
bam-10779	163	24	.	.	PUNCT
bam-10779	164	1	pak	pak	PROPN
bam-10779	164	2	j	j	PROPN
bam-10779	164	3	med	med	PROPN
bam-10779	164	4	sci	sci	PROPN
bam-10779	164	5	.	.	PUNCT
bam-10779	165	1	2017;33:369	2017;33:369	X
bam-10779	165	2	-	-	SYM
bam-10779	165	3	73	73	NUM
bam-10779	165	4	.	.	PUNCT
bam-10779	166	1	doi	doi	NOUN
bam-10779	166	2	:	:	PUNCT
bam-10779	166	3	10.12669	10.12669	NUM
bam-10779	166	4	/	/	SYM
bam-10779	166	5	pjms.332.11847	pjms.332.11847	PROPN
bam-10779	166	6	.	.	PROPN
bam-10779	166	7	18	18	NUM
bam-10779	166	8	.	.	PUNCT
bam-10779	166	9	auer	auer	PROPN
bam-10779	166	10	k	k	PROPN
bam-10779	166	11	,	,	PUNCT
bam-10779	166	12	bachmayr	bachmayr	NOUN
bam-10779	166	13	-	-	PUNCT
bam-10779	166	14	heyda	heyda	PROPN
bam-10779	166	15	a	a	NOUN
bam-10779	166	16	,	,	PUNCT
bam-10779	166	17	aust	aust	PROPN
bam-10779	166	18	s	s	PROPN
bam-10779	166	19	,	,	PUNCT
bam-10779	166	20	sukhbaatar	sukhbaatar	ADJ
bam-10779	166	21	n	n	CCONJ
bam-10779	166	22	,	,	PUNCT
bam-10779	166	23	reiner	reiner	NOUN
bam-10779	166	24	at	at	ADP
bam-10779	166	25	,	,	PUNCT
bam-10779	166	26	grimm	grimm	NOUN
bam-10779	166	27	c	c	NOUN
bam-10779	166	28	,	,	PUNCT
bam-10779	166	29	horvat	horvat	X
bam-10779	166	30	r	r	NOUN
bam-10779	166	31	,	,	PUNCT
bam-10779	166	32	zeillinger	zeillinger	NOUN
bam-10779	166	33	r	r	NOUN
bam-10779	166	34	,	,	PUNCT
bam-10779	166	35	pils	pil	VERB
bam-10779	166	36	d.	d.	PROPN
bam-10779	166	37	peritoneal	peritoneal	ADJ
bam-10779	166	38	tumor	tumor	NOUN
bam-10779	166	39	spread	spread	VERB
bam-10779	166	40	in	in	ADP
bam-10779	166	41	serous	serous	ADJ
bam-10779	166	42	ovarian	ovarian	ADJ
bam-10779	166	43	cancer	cancer	NOUN
bam-10779	166	44	-	-	PUNCT
bam-10779	166	45	epithelial	epithelial	ADJ
bam-10779	166	46	mesenchymal	mesenchymal	ADJ
bam-10779	166	47	status	status	NOUN
bam-10779	166	48	and	and	CCONJ
bam-10779	166	49	outcome	outcome	NOUN
bam-10779	166	50	.	.	PUNCT
bam-10779	167	1	oncotarget	oncotarget	NOUN
bam-10779	167	2	.	.	PUNCT
bam-10779	168	1	2015	2015	NUM
bam-10779	168	2	jul	jul	NOUN
bam-10779	168	3	10;6(19):17261	10;6(19):17261	NUM
bam-10779	168	4	-	-	SYM
bam-10779	168	5	75	75	NUM
bam-10779	168	6	.	.	PUNCT
bam-10779	169	1	doi	doi	NOUN
bam-10779	169	2	:	:	PUNCT
bam-10779	169	3	10.18632	10.18632	NUM
bam-10779	169	4	/	/	SYM
bam-10779	169	5	oncotarget.3746	oncotarget.3746	PROPN
bam-10779	169	6	.	.	PROPN
bam-10779	169	7	19	19	NUM
bam-10779	169	8	.	.	PUNCT
bam-10779	169	9	cadoo	cadoo	PROPN
bam-10779	169	10	k	k	PROPN
bam-10779	169	11	,	,	PUNCT
bam-10779	169	12	simpkins	simpkins	PROPN
bam-10779	169	13	f	f	PROPN
bam-10779	169	14	,	,	PUNCT
bam-10779	169	15	mathews	mathews	PROPN
bam-10779	169	16	c	c	PROPN
bam-10779	169	17	,	,	PUNCT
bam-10779	169	18	liu	liu	PROPN
bam-10779	169	19	yl	yl	PROPN
bam-10779	169	20	,	,	PUNCT
bam-10779	169	21	provencher	provencher	PROPN
bam-10779	169	22	d	d	PROPN
bam-10779	169	23	,	,	PUNCT
bam-10779	169	24	mccormick	mccormick	PROPN
bam-10779	169	25	c	c	PROPN
bam-10779	169	26	,	,	PUNCT
bam-10779	169	27	elnaggar	elnaggar	NOUN
bam-10779	169	28	ac	ac	PROPN
bam-10779	169	29	,	,	PUNCT
bam-10779	169	30	altman	altman	PROPN
bam-10779	169	31	ad	ad	NOUN
bam-10779	169	32	,	,	PUNCT
bam-10779	169	33	gilbert	gilbert	PROPN
bam-10779	169	34	l	l	PROPN
bam-10779	169	35	,	,	PUNCT
bam-10779	169	36	black	black	ADJ
bam-10779	169	37	d	d	PROPN
bam-10779	169	38	,	,	PUNCT
bam-10779	169	39	kabil	kabil	PROPN
bam-10779	169	40	n	n	PROPN
bam-10779	169	41	,	,	PUNCT
bam-10779	169	42	bennett	bennett	PROPN
bam-10779	169	43	j	j	PROPN
bam-10779	169	44	,	,	PUNCT
bam-10779	169	45	munley	munley	PROPN
bam-10779	169	46	j	j	PROPN
bam-10779	169	47	,	,	PUNCT
bam-10779	169	48	aghajanian	aghajanian	ADJ
bam-10779	169	49	c.	c.	PROPN
bam-10779	169	50	olaparib	olaparib	PROPN
bam-10779	169	51	treatment	treatment	NOUN
bam-10779	169	52	for	for	ADP
bam-10779	169	53	platinum	platinum	NOUN
bam-10779	169	54	-	-	PUNCT
bam-10779	169	55	sensitive	sensitive	ADJ
bam-10779	169	56	relapsed	relapse	VERB
bam-10779	169	57	ovarian	ovarian	ADJ
bam-10779	169	58	cancer	cancer	NOUN
bam-10779	169	59	by	by	ADP
bam-10779	169	60	brca	brca	PROPN
bam-10779	169	61	mutation	mutation	NOUN
bam-10779	169	62	and	and	CCONJ
bam-10779	169	63	homologous	homologous	ADJ
bam-10779	169	64	recombination	recombination	NOUN
bam-10779	169	65	deficiency	deficiency	NOUN
bam-10779	169	66	status	status	NOUN
bam-10779	169	67	:	:	PUNCT
bam-10779	169	68	phase	phase	NOUN
bam-10779	169	69	ii	ii	PROPN
bam-10779	169	70	light	light	NOUN
bam-10779	169	71	study	study	NOUN
bam-10779	169	72	primary	primary	ADJ
bam-10779	169	73	analysis	analysis	NOUN
bam-10779	169	74	.	.	PUNCT
bam-10779	170	1	gynecol	gynecol	ADJ
bam-10779	170	2	oncol	oncol	ADJ
bam-10779	170	3	.	.	PUNCT
bam-10779	171	1	2022	2022	NUM
bam-10779	171	2	sep;166(3):425431	sep;166(3):425431	PROPN
bam-10779	171	3	.	.	PUNCT
bam-10779	172	1	doi	doi	NOUN
bam-10779	172	2	:	:	PUNCT
bam-10779	172	3	10.1016	10.1016	NUM
bam-10779	172	4	/	/	SYM
bam-10779	172	5	j.ygyno.2022.06.017	j.ygyno.2022.06.017	X
bam-10779	172	6	.	.	PUNCT
bam-10779	173	1	epub	epub	VERB
bam-10779	173	2	2022	2022	NUM
bam-10779	173	3	jul	jul	PROPN
bam-10779	173	4	5	5	NUM
bam-10779	173	5	.	.	PROPN
bam-10779	173	6	20	20	NUM
bam-10779	173	7	.	.	PUNCT
bam-10779	174	1	lapke	lapke	PROPN
bam-10779	174	2	n	n	CCONJ
bam-10779	174	3	,	,	PUNCT
bam-10779	174	4	chen	chen	PROPN
bam-10779	174	5	ch	ch	PROPN
bam-10779	174	6	,	,	PUNCT
bam-10779	174	7	chang	chang	PROPN
bam-10779	174	8	tc	tc	PROPN
bam-10779	174	9	,	,	PUNCT
bam-10779	174	10	chao	chao	PROPN
bam-10779	174	11	a	a	PROPN
bam-10779	174	12	,	,	PUNCT
bam-10779	174	13	lu	lu	PROPN
bam-10779	174	14	yj	yj	PROPN
bam-10779	174	15	,	,	PUNCT
bam-10779	174	16	lai	lai	PROPN
bam-10779	174	17	ch	ch	PROPN
bam-10779	174	18	,	,	PUNCT
bam-10779	174	19	tan	tan	PROPN
bam-10779	174	20	kt	kt	PROPN
bam-10779	174	21	,	,	PUNCT
bam-10779	174	22	chen	chen	PROPN
bam-10779	174	23	hc	hc	PROPN
bam-10779	174	24	,	,	PUNCT
bam-10779	174	25	lu	lu	PROPN
bam-10779	174	26	hy	hy	PROPN
bam-10779	174	27	,	,	PUNCT
bam-10779	174	28	chen	chen	PROPN
bam-10779	174	29	sj	sj	PROPN
bam-10779	174	30	.	.	PUNCT
bam-10779	175	1	genetic	genetic	ADJ
bam-10779	175	2	alterations	alteration	NOUN
bam-10779	175	3	and	and	CCONJ
bam-10779	175	4	their	their	PRON
bam-10779	175	5	therapeutic	therapeutic	ADJ
bam-10779	175	6	implications	implication	NOUN
bam-10779	175	7	in	in	ADP
bam-10779	175	8	epithelial	epithelial	ADJ
bam-10779	175	9	ovarian	ovarian	ADJ
bam-10779	175	10	cancer	cancer	NOUN
bam-10779	175	11	.	.	PUNCT
bam-10779	176	1	bmc	bmc	NOUN
bam-10779	176	2	cancer	cancer	NOUN
bam-10779	176	3	.	.	PUNCT
bam-10779	177	1	2021	2021	NUM
bam-10779	177	2	may	may	AUX
bam-10779	177	3	4;21(1):499	4;21(1):499	NUM
bam-10779	177	4	.	.	PUNCT
bam-10779	178	1	doi	doi	NOUN
bam-10779	178	2	:	:	PUNCT
bam-10779	178	3	10.1186	10.1186	NUM
bam-10779	178	4	/	/	SYM
bam-10779	178	5	s12885	s12885	NOUN
bam-10779	178	6	-	-	PUNCT
bam-10779	178	7	021	021	NUM
bam-10779	178	8	-	-	PUNCT
bam-10779	178	9	08233	08233	NUM
bam-10779	178	10	-	-	SYM
bam-10779	178	11	5	5	NUM
bam-10779	178	12	.	.	NUM
bam-10779	178	13	21	21	NUM
bam-10779	178	14	.	.	PUNCT
bam-10779	179	1	lu	lu	PROPN
bam-10779	179	2	h	h	PROPN
bam-10779	179	3	,	,	PUNCT
bam-10779	179	4	cunnea	cunnea	PROPN
bam-10779	179	5	p	p	X
bam-10779	179	6	,	,	PUNCT
bam-10779	179	7	nixon	nixon	PROPN
bam-10779	179	8	k	k	PROPN
bam-10779	179	9	,	,	PUNCT
bam-10779	179	10	rinne	rinne	PROPN
bam-10779	179	11	n	n	CCONJ
bam-10779	179	12	,	,	PUNCT
bam-10779	179	13	aboagye	aboagye	PROPN
bam-10779	179	14	eo	eo	PROPN
bam-10779	179	15	,	,	PUNCT
bam-10779	179	16	fotopoulou	fotopoulou	ADJ
bam-10779	179	17	c.	c.	PROPN
bam-10779	179	18	discovery	discovery	PROPN
bam-10779	179	19	of	of	ADP
bam-10779	179	20	a	a	DET
bam-10779	179	21	biomarker	biomarker	NOUN
bam-10779	179	22	candidate	candidate	NOUN
bam-10779	179	23	for	for	ADP
bam-10779	179	24	surgical	surgical	ADJ
bam-10779	179	25	stratification	stratification	NOUN
bam-10779	179	26	in	in	ADP
bam-10779	179	27	high	high	ADJ
bam-10779	179	28	-	-	PUNCT
bam-10779	179	29	grade	grade	NOUN
bam-10779	179	30	serous	serous	ADJ
bam-10779	179	31	ovarian	ovarian	ADJ
bam-10779	179	32	cancer	cancer	NOUN
bam-10779	179	33	.	.	PUNCT
bam-10779	180	1	br	br	PROPN
bam-10779	180	2	j	j	PROPN
bam-10779	180	3	cancer	cancer	NOUN
bam-10779	180	4	.	.	PUNCT
bam-10779	181	1	2021;124:1286	2021;124:1286	NUM
bam-10779	181	2	-	-	SYM
bam-10779	181	3	93	93	NUM
bam-10779	181	4	.	.	PUNCT
bam-10779	182	1	doi	doi	NOUN
bam-10779	182	2	:	:	PUNCT
bam-10779	182	3	10.1038	10.1038	NUM
bam-10779	182	4	/	/	SYM
bam-10779	182	5	s41416	s41416	NUM
bam-10779	182	6	-	-	PUNCT
bam-10779	182	7	020	020	NUM
bam-10779	182	8	-	-	PUNCT
bam-10779	182	9	01252	01252	NUM
bam-10779	182	10	-	-	SYM
bam-10779	182	11	2	2	NUM
bam-10779	182	12	.	.	PUNCT
bam-10779	183	1	disclaimer	disclaimer	NOUN
bam-10779	183	2	all	all	DET
bam-10779	183	3	claims	claim	NOUN
bam-10779	183	4	expressed	express	VERB
bam-10779	183	5	in	in	ADP
bam-10779	183	6	this	this	DET
bam-10779	183	7	article	article	NOUN
bam-10779	183	8	are	be	AUX
bam-10779	183	9	solely	solely	ADV
bam-10779	183	10	those	those	PRON
bam-10779	183	11	of	of	ADP
bam-10779	183	12	the	the	DET
bam-10779	183	13	authors	author	NOUN
bam-10779	183	14	and	and	CCONJ
bam-10779	183	15	do	do	AUX
bam-10779	183	16	not	not	PART
bam-10779	183	17	necessarily	necessarily	ADV
bam-10779	183	18	represent	represent	VERB
bam-10779	183	19	those	those	PRON
bam-10779	183	20	of	of	ADP
bam-10779	183	21	their	their	PRON
bam-10779	183	22	affiliated	affiliated	ADJ
bam-10779	183	23	organizations	organization	NOUN
bam-10779	183	24	,	,	PUNCT
bam-10779	183	25	or	or	CCONJ
bam-10779	183	26	those	those	PRON
bam-10779	183	27	of	of	ADP
bam-10779	183	28	the	the	DET
bam-10779	183	29	publisher	publisher	NOUN
bam-10779	183	30	,	,	PUNCT
bam-10779	183	31	the	the	DET
bam-10779	183	32	editors	editor	NOUN
bam-10779	183	33	and	and	CCONJ
bam-10779	183	34	the	the	DET
bam-10779	183	35	reviewers	reviewer	NOUN
bam-10779	183	36	.	.	PUNCT
bam-10779	184	1	any	any	DET
bam-10779	184	2	product	product	NOUN
bam-10779	184	3	that	that	PRON
bam-10779	184	4	may	may	AUX
bam-10779	184	5	be	be	AUX
bam-10779	184	6	evaluated	evaluate	VERB
bam-10779	184	7	in	in	ADP
bam-10779	184	8	this	this	DET
bam-10779	184	9	article	article	NOUN
bam-10779	184	10	or	or	CCONJ
bam-10779	184	11	claim	claim	NOUN
bam-10779	184	12	that	that	PRON
bam-10779	184	13	may	may	AUX
bam-10779	184	14	be	be	AUX
bam-10779	184	15	made	make	VERB
bam-10779	184	16	by	by	ADP
bam-10779	184	17	its	its	PRON
bam-10779	184	18	manufacturer	manufacturer	NOUN
bam-10779	184	19	is	be	AUX
bam-10779	184	20	not	not	PART
bam-10779	184	21	guaranteed	guarantee	VERB
bam-10779	184	22	or	or	CCONJ
bam-10779	184	23	endorsed	endorse	VERB
bam-10779	184	24	by	by	ADP
bam-10779	184	25	the	the	DET
bam-10779	184	26	publisher	publisher	NOUN
bam-10779	184	27	.	.	PUNCT
bam-10779	185	1	submission	submission	NOUN
bam-10779	185	2	:	:	PUNCT
bam-10779	185	3	august	august	PROPN
bam-10779	185	4	5	5	NUM
bam-10779	185	5	,	,	PUNCT
bam-10779	185	6	2022	2022	NUM
bam-10779	185	7	revision	revision	NOUN
bam-10779	185	8	received	receive	VERB
bam-10779	185	9	:	:	PUNCT
bam-10779	185	10	august	august	PROPN
bam-10779	185	11	28	28	NUM
bam-10779	185	12	2022	2022	NUM
bam-10779	185	13	accepted	accept	VERB
bam-10779	185	14	for	for	ADP
bam-10779	185	15	publication	publication	NOUN
bam-10779	185	16	:	:	PUNCT
bam-10779	185	17	august	august	PROPN
bam-10779	185	18	29	29	NUM
bam-10779	185	19	,	,	PUNCT
bam-10779	185	20	2022	2022	NUM
bam-10779	185	21	non	non	ADJ
bam-10779	185	22	-co	-co	PROPN
bam-10779	185	23	mmerc	mmerc	PROPN
bam-10779	185	24	ial	ial	PROPN
bam-10779	185	25	us	us	PROPN
bam-10779	185	26	e	e	NOUN
bam-10779	185	27	o	o	NOUN
bam-10779	185	28	nly	nly	ADV